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Abbreviations 
 
Abbreviations 
' minute(s) 
'' second(s) 
2D two dimensional 
3D three dimensional 
A ampere 
ADF actin depolymerizing factor 
ADP adenosine diphosphate 
APS ammonium persulfate 
ARF1 ADP-ribosylation factor 1 
ATP adenosine triphosphate 
bp base pairs 
BSA bovine serum albumin 
CaCl2 calcium chloride 
cDMEM complete Dulbecco's modified Eagle's medium 
cDNA complementary DNA 
CNS central nervous system 
CO2 carbon dioxide 
d distance 
D distance from origin 
DAB1 Disabled-1 
DAPI 4',6-diamidino-2-phenylindole 
dH2O destillated H2O 
DMEM Dulbecco's modified Eagle's medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleotide triphosphate 
E. coli Escherichia coli 
ECM extracellular matrix 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
EGFRvIII epidermal growth factor receptor variant III 
F phenylalanine 
F-actin filamentous actin 
FCS fetal calf serum 
g acceleration due to gravity (9.81 m/s2) 
G418 geneticindisulfat 
G-actin globular actin 
GBM glioblastoma multiforme 
GFP green fluorescent protein 
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h hour(s) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP horseradish peroxidase 
IDH isocitrate dehydrogenase 
KCl potassium chloride 
kDa kilo Dalton 
Kip1 Cyclin-dependent kinase inhibitor 1B 
LIMK LIM (Lin-11/Isl-1/Mec-3)-domain-containing protein kinase 
MgCl2 magnesium chloride 
MGMT O-6-methylguanine-DNA methyltransferase 
MnCl2 manganese (II) chloride 
mRNA messenger RNA 
MRT magnetic resonance tomography 
NaCl sodium chloride 
NaOH sodium hydroxide 
NP-40 nonylphenolethoxylate 
O/N overnight 
p27 Cyclin-dependent kinase inhibitor 1B 
p53 tumor protein p53 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
P-cofilin phosphorylated cofilin 
PCR polymerase chain reaction 
PDGFR platelet-derived growth factor receptor 
PFA paraformaldehyde 
PI3K phosphatidylinositol-4,5-bisphosphate 3-kinase 
RNA ribonucleic acid 
RT room temperature 
SDS sodium dodecyl sulfate 
sec second(s) 
STAT signal transducer and activator of transcription 
TBS Tris-buffered saline 
TCGA The Cancer Genome Atlas 
TEMED tetramethylethylenediamine 
Triton X-100 t-octylphenoxypolyethoxyethanol 
Tween 20 polyoxyethylene (20) sorbitan monolaurate 
V volt 
v volume 
w weight 
w/o without 
WT  wildtype 
Y tyrosine 
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1 Introduction 
 
Primary tumors of the brain and spinal cord represent about 2 - 3% of all diagnosed tumors 
and are therefore rather rare cancer entities (Schlegel et al. 2003). Gliomas comprise about 
80% of all malignant brain tumors and more than half of all gliomas are glioblastomas 
(Ostrom et al. 2016). Despite extensive research, treatment of glioblastomas is still lacking 
highly effective therapies leaving patients with an average survival time of less than two years 
(Tonn et al. 2006, Louis 2007). In terms of basic research, the Reelin/Disabled-1 signaling 
pathway has emerged as a new potential tumor suppressor over the last decade.  
 
1.1 Reelin/Disabled-1 signaling pathway 
 
The role and the biological mechanisms of the Reelin/Disabled-1 signaling pathway have 
already been an object of research for the last decades. Especially its function during 
embryonic brain development as an inhibitor of neuronal migration has been the topic of 
intensive research. Much less is known about the meaning of Reelin/Disabled-1 signaling in 
cancers, especially in brain tumors. However, previous work of our laboratory for Reelin and 
Disabled-1 suggested a potential role as tumor suppressor in high-grade gliomas.  
 
1.1.1 Reelin 
 
Several studies have unraveled the functions in regulation of neuronal migration of the 
extracellular glycoprotein Reelin but, primarily, it has been discovered by D. S. Falconer at 
the Institute of Animal Genetics, Edinburgh, in the 1950s. The name of this protein is derived 
from the reeler mouse, an autosomal recessive mutant mouse showing pronounced 
neurological symptoms, like dystonia, ataxia and tremors (Falconer 1951) and striking 
abnormalities in the telencephalic and cerebellar cortices (Goffinet 1984). These mice were 
later found to lack functioning Reelin due to a certain homozygous gene mutation 
(D'Arcangelo et al. 1995). Over the last six decades, Reelin and the reeler mouse have been 
Introduction 
- 10 - 
 
extensively studied as a model for brain development, proclaiming Reelin as a key regulator 
of neuronal migration.  
The Reelin gene (RELN, GenBank-Accession-No.: AAC51105.1), is widely conserved 
through vertebrates and transcribed into a linear mRNA of 11’571 bp with an open reading 
frame (ORF) of 10,383 nucleotides. RELN is encoding for a large protein consisting of 3461 
amino acids resolving in a molecular mass of about 388 kDa (DeSilva et al. 1997). Three 
different alleles, situated at the chromosomal region 7q22, were found responsible for the 
reeler mutant, with each of them displaying a partial deletion of the RELN coding sequence 
(D'Arcangelo et al. 1995, Takahara et al. 1996).  
X-ray cristallography has revealed that Reelin comprises several domains (see Figure 1) 
consisting of a signaling sequence (S), followed by the reeler domain which can also be found 
in the extracellular proteins F-spondin and mindin (SP) (Feinstein et al. 1999). Next comes 
another unique region containing an epitope for the Cajal-Retzius cell marker 50 (CR-50) (H), 
an immunohistochemical marker for cells that are producing Reelin. The Reelin producing 
Cajal-Retzius cells are important during corticogenesis (see Figure 2). Then, the combination 
of a central epidermal growth factor (EGF) motif surrounded by two different sequences, A 
and B, is repeated eight times, each of these containing 350-390 amino acids (Yasui et al. 
2007). The final reelin domain contains a highly basic and short C-terminal region (+) with a 
length of 32 amino acids. This region is highly conserved, being 100% identical in all 
mammals. In contrast to previous results, this region is not required for secretion but is 
necessary to activate downstream signaling efficiently (Nakano et al. 2007).  
 
Introduction 
- 11 - 
 
 
Canonical signaling downstream of Reelin is mediated by binding to the very-low-density 
lipoprotein receptor (VLDLR) and the ApoE receptor 2 (ApoER2) which results in the 
activation of the cytoplasmic adapter protein Disabled-1 (DAB1) by tyrosine phosphorylation 
(Hiesberger et al. 1999). Both receptors are able to stimulate DAB1 phosphorylation, however 
clustering of these receptors at the plasma membrane is necessary for recruitment of SRC 
family tyrosine kinases (SFKs) (see chapter 1.1.2), further downstream signaling and 
especially for its effect on neuronal migration (Strasser et al. 2004).  
 
The role of Reelin during embryonic brain development has been most extensively studied in 
the neocortex of mice as a model system. Here, Reelin is required for the proper formation 
and positioning of the neuronal cell layers in the cortical plate (Honda et al. 2011). The 
cortical plate is a neuronal region that neuroblasts reach through migration guided by radial 
glia during corticogenesis to form the six layers of the neocortex (Herz & Chen 2006). 
A very profound study on the influences of deficient Reelin signaling during embryonic 
development is summed up in Figure 2:  
Figure 1: Scheme of the Reelin protein.  
Reelin exhibits a multidomain architecture that starts 
with a signaling sequence (S) and the typical reeler 
domain (SP). It further comprises an epitope for the 
Cajal-Retzius cell marker 50 (H) and eight tandem 
repeats of which each repeat is divided into two 
different subrepeats (A and B) by an epidermal growth 
factor (EGF) motif. Reelin ends with a short, highly 
basic C-terminal region (+). 
Taken from (CopperKettle 2013). 
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Generally speaking, lack of Reelin leads to an inversion of the six cell layers of the neocortex. 
The schematic drawings show a part of the cerebral cortex of an embryonic mouse brain at 
three successive points in time (i, ii and iii). The presence of Reelin is shown by the blackened 
Cajal-Retzius neurons (CR) and black dots in wild type mice (a). These cells, together with 
subplate neurons (SP), represent the preplate (PP) which will later be the marginal zone (MZ) 
of the brain. The Arabic numbers of the indicated neurons mark the future layers of the 
neocortex (1-6). The newly born neurons that are formed by wild-type mice in the ventricular 
zone (VZ) migrate past the subplate and stop beneath the marginal zone. Later generated 
neurons overtake the subplate as well as the earlier neurons and reach the top of the 
developing cortex. As a consequence, the earlier-generated neurons are located beneath the 
later-born ones.  
In reeler mice, the preplate appears to be normal. However, the Cajal-Retzius cells are unable 
to generate Reelin which is indicated by the uncolored CR neurons. Furthermore, the neurons 
of this cortex are not able to migrate past the subplate and therefore the preplate does not split 
into two layers but becomes the superplate (SPP). Thus, earlier-generated neurons stack at the 
top of the cortex whilst later-generated neurons reside in the deeper layers. Moreover, neurons 
in the upper layer near the internal plexiform zone (IPZ) show a formation of horizontally or 
even inversely oriented dendrites. Briefly summarized, the neocortex of reeler mice, opposed 
to that of wild-type mice, shows an outside-in sequence of neuronal positioning (Honda et al. 
2011). 
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However, proper lamination in the central nervous system is not only a result of direct 
interaction of Reelin with migrating neurons. Additionally, radial glial cells are activated by 
the Reelin signaling cascade. Radial glial cells of the neocortex seem in general only mildly 
affected, whereas the development of the dentate gyrus shows severely altered neuronal 
positioning and formation of radial processes in the absence of Reelin (Förster et al. 2002, 
Hartfuss et al. 2003). This considerable morphological phenotype was found independently of 
Figure 2: Development of the cerebral cortex in wild type and reeler mice. 
(a) depicts the influences that Reelin, secreted by Cajal-Retzius neurons (CR, black cells), 
has on corticogenesis at three successive points in time (i, ii, iii) whereas (b) is showing 
failed cortical development due to absence of Reelin (CR, white cells). Cajal-Retzius cells 
(CR) and subplate neurons (SP) represent the preplate (PP) becoming the marginal zone 
(MZ) later. The Arabic numbers of the indicated neurons mark the future layers of the 
neocortex (1-6).  
(a) In wild-type mice newly born neurons are formed in the ventricular zone (VZ) and 
migrate past the subplate (SP). Finally, earlier-generated neurons are located beneath the 
later-born ones. 
(b) In reeler mice neurons are not able to migrate past the subplate (SP) and therefore 
earlier-generated neurons stack at the top of the cortex, whilst later-generated neurons 
reside in the deeper layers. Further cortical anomalities found here, are formation of a 
superplate (SPP) and an internal plexiform zone (IPZ) where neurons show a formation of 
horizontally or inversely oriented dendrites. The neocortex of reeler mice shows an 
outside-in sequence of neuronal positioning. 
Modified from (Honda et al. 2011, S. 1272). 
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Reelin signaling in neurons. This suggests that Reelin is directly affecting glial cells (Brunne 
et al. 2013).  
Although the functions of Reelin/DAB1 signaling during embryonic development are very 
well understood, only little is known about its importance for the adult brain. It has been 
shown that Reelin is expressed continuously even after disappearance of the Cajal-Retzius 
cells at the end of the neuronal migration phase. Instead, Reelin is produced by a group of 
GABA-ergic (γ-aminobutyric acid) interneurons (Herz & Chen 2006). Some studies indicate 
that Reelin/DAB1 signaling influences the growth of dendrites (Jossin & Goffinet 2007) and is 
a potential modulator of neurotransmission. It was shown that Reelin and its receptors 
ApoER2 and VLDLR influence cognition and plasticity of synapses in mice. Loss of one of 
these receptors leads to defects in long term potentiation, a major cellular mechanism that 
underlies learning and memory. These findings might contribute to understand the 
pathophysiology of alterations of cognitive functions and loss of synapses in patients with 
Alzheimer’s disease (Weeber et al. 2002).  
Besides the importance for Alzheimer’s disease, further analyses showed that Reelin/DAB1 
signaling seems to play an emerging role in other neurological and neuropsychiatric disorders 
of the adult brain. Lower levels of Reelin have been found in patients suffering from 
schizophrenia, bipolar disorder and autism (Fatemi et al. 2000, Fatemi et al. 2005). Again, the 
effects of Reelin on long term potentiation which lead to a reduction of NMDA receptors 
were proposed to contribute to these disorders (Coyle 2006). Other findings suggest that 
Reelin/DAB1 signaling is required to maintain neuroanatomical integrity in the adult brain as 
Reelin malfunction leads to dispersed positioning of dentate granule cells in patients with 
epilepsy (Heinrich et al. 2006). This malpositioning of neurons is correlated to the wake of 
seizures, especially to that of temporal lobe epilepsy (Haas et al. 2002, Heinrich et al. 2006). 
Genetic defects of the Reelin gene were found to result in a form of lissencephaly with 
cerebellar hypoplasia. Lissencephaly is a human brain disorder that is characterized by the 
absence or reduction of cerebral convolutions (Hong et al. 2000).  
 
For quite a long time it was believed that only traces of Reelin could be detected outside the 
brain, however, about 15 years ago, it was shown that Reelin is present in plasma of rats, mice 
and humans. Moreover, western blotting and immunocytochemistry revealed expression in 
the liver, the pituitary gland and a subgroup of chromaffin cells in the adrenal medulla 
(Smalheiser et al. 2000). Only little is known about the physiological role of Reelin/DAB1 
signaling in these and other peripheral tissues but findings suggest rather little importance of 
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Figure 3: Protein structure of DAB1.  
Human DAB1 comprises three domains (PTB domain, DabH1 and DabH2) 
that show high sequence-homology to its related mouse gene. The percentage 
of identy is given below each region. Furthermore, DAB1 consists of four 
genetic regions (a, b, c and d) that contain five potential phosphorylation 
sites. Taken from (Howell et al. 2000). 
this pathway for normal organic functions. Nonetheless, some studies on non-brain cancers 
proposed a function in tumor suppression for the Reelin protein (see chapter 1.1.4 for more 
information).  
 
1.1.2 Disabled-1 
 
As mentioned above, the key target for further transmission of Reelin signaling in embryonic 
development of the brain is the protein Disabled-1 (DAB1) (~ 63 kDa), whose gene represents 
a homologue of the drosophila protein disabled (Ware et al. 1997). This insight was gained by 
experiments with mice that were deficient of the DAB1 gene. These mouse mutants, called 
scrambler and yotari (both of them containing different mutations of the DAB1 gene), show a 
phenotype that is indistinguishable from the one in reeler mice (Howell et al. 1997b).  
DAB1 interacts with the Reelin receptors ApoER2 and VLDLR through binding to a 
cytoplasmic domain that contains a typical sequence of amino acids. This amino-terminal 
phosphotyrosine binding (PTB) domain contains a sequence of asparagin (N), proline (P), an 
arbitrary amino acid (x) and tyrosine (Y) and is therefore abbreviated as NPxY motif (Howell 
et al. 2000). Binding of Reelin leads to clustering of its receptors which finally induces 
tyrosine phosphorylation of DAB1 (Hiesberger et al. 1999). Additionally, it could be shown 
that binding of Reelin to co-receptors like Cadherin-related neuronal receptors (CNRs) is 
necessary for the initiation of DAB1 phosphorylation through Src family kinases (SFKs) 
(Senzaki et al. 1999). 
Figure 3 explains the structure of 
the human DAB1 protein. Human 
DAB1 contains three domains, the 
PTB, DabH1 and DabH2 domain, 
that represent regions of homology 
to the related mouse gene. The 
percentage of identity varies 
between 54 and 73%. Next to the 
PTB domain, four genetic regions, containing five phosphorylation sites, Tyr185 (a), 
Tyr198/Tyr200 (b), Tyr220 (c) and Tyr232 (d), are marked (Howell et al. 2000). Additionally, 
the sequence around Tyr198 resembles a sequence of the platelet derived growth factor 
receptor containing two tyrosines (equivalent to Tyr198 and Tyr200) which are both supposed 
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to be phosphorylated (Mori et al. 1993). Two of these four sites have already been proved as 
targets for phosphorylation by analyzing several mutants replaced by phenylalanine instead of 
tyrosine. A DAB1 protein with mutation of all five tyrosines is called 5F mutant (Howell et al. 
2000).  
Tyrosine-phosphorylated DAB1 only extents its whole potential as a transmitter of Reelin 
signaling in the presence of Src family kinases (SFKs), especially of the members Src, Fyn 
and Abl. SFKs are non-receptor tyrosine kinases that interact with multiple cytosolic, nuclear 
and membrane proteins (Howell et al. 1997a). Studies show that DAB1 is a physiological 
substrate and also an activator of SFKs in neurons, meaning that DAB1 can potentiate its own 
phosphorylation level through these kinases. Furthermore, mutations of certain SFKs lead to 
similar changes of mouse cortices present in the reeler mutant, suggesting that the cellular 
reaction to Reelin normally includes activation of SFKs (Bock & Herz 2003). The above 
information on DAB1 so far is summed up in Figure 4.  
 
 
 
Another interesting finding is that the intracellular protein DAB1 is generally stable in its 
inactivated form. However, in response to its activator Reelin, it is polyubiquitinated and 
Figure 4: Hypothetical model for SFK activation by Reelin.  
Reelin binds to its receptors, the very-low-density lipoprotein receptor (VLDLR) and the ApoE receptor 2 
(apoER2), which leads to clustering of these receptors and binding of DAB1 to the intracellular NPxY amino-
acid sequence. Additionally, Reelin might bind unknown coreceptors that induce primary tyrosine-
phosphorylation (Y) of DAB1. Once activated, DAB1 is capable of amplifying its own phosphorylation 
through Src family kinases (SFK). This finally leads to reduced migration and enhanced synaptic plasticity of 
neurons. Taken from (Bock & Herz 2003). 
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degraded by proteasome complexes, proposing that tyrosine phosphorylation is important for 
the degradation of DAB1 (Arnaud et al. 2003). This conclusion is also in accordance with 
findings in reeler mutants: The levels of DAB1 protein are much higher in embryonic brain 
tissue from reeler mutant mice than compared to controls (Howell et al. 2000).  
DAB1 contains not only tyrosine phosphorylation sites but can also be phosphorylated at 
serine491 through the Cyclin-Dependent Kinase 5 (Cdk5). It has been shown that Cdk5 as 
well as its regulatory subunits p35 and p39 are regulating neuronal migration during 
corticogenesis independently of Reelin signaling. Mice that lack Cdk5, p35, or both p35 and 
p39 have defects of lamination in the neocortex similar yet not identical to reeler mice. 
Further significance of DAB1 serine phosphorylation is unknown. However, these findings 
suggest that DAB1 represents a molecular interface of two distinct signaling pathways 
regulating cell positioning (Keshvara et al. 2002). 
 
1.1.3 Overview of known downstream targets 
 
Proper development of the mammalian brain requires extensive coordination between 
migration, differentiation, proliferation and survival of future neurons and glial cells. Some of 
the known downstream targets of Reelin/DAB1 signaling are contributing to these cellular 
functions during embryonic development. 
As briefly mentioned above, it was shown that Cadherin-related neuronal receptors (CNRs) 
are co-receptors of Reelin in the cell membrane of neurons. CNR family proteins are 
supposed to be involved in formation and reorganization of synaptic connections in the 
nervous system. Inhibition of Reelin binding through antibodies against proteins of the CNR 
family (anti-RBD CNR antibody) leads to reduced tyrosine phosphorylation of DAB1 
(Senzaki et al. 1999). It has also been proved that CNRs interact with Fyn, a member of the 
SFKs (Hamada & Yagi 2001), suggesting that Reelin is also capable of modulating the 
phospho-tyrosine level of DAB1 through other receptors than ApoER2 and VLDLR. Figure 5 
gives an overview of this hypothetical pathway of Reelin signaling. 
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A proved target further downstream of Reelin/DAB1 signaling is the phosphatidylinositol 3-
kinase (PI3K). Stimulation of PI3K by Reelin leads to activation of the protein kinase B 
(PKB, also known as Akt). PI3K/PKB signaling is highly conserved in all cells of higher 
eukaryotes (Manning & Cantley 2007) and known to control a very diverse group of cellular 
functions like cell growth, proliferation, migration and intracellular trafficking. These 
components of Reelin signaling are enriched in axonal growth cones, contributing to proper 
neuronal positioning during brain development (Beffert et al. 2002). Further studies revealed 
that PI3K and PKB activity regulated through Reelin are both crucial for corticogenesis 
(Jossin & Goffinet 2007, Leemhuis & Bock 2011, Ohkubo et al. 2003). 
Besides the downstream targets above, migration and cellular motility is also often 
corresponding to expression of and interaction with integrins. These proteins are necessary for 
establishment of cell-matrix junctions. Integrins are transmembrane receptors containing two 
different chains, an α and a β subunit, and can trigger intracellular signaling pathways. 
Research on Reelin signaling has particularly turned the spotlight on two specific integrins: 
α3β1 integrin (also known as laminin receptor) and α5β1 integrin (also called fibronectin 
receptor).  
The receptor α3β1 integrin is mainly known for binding laminin but collagen I and IV or 
entactin/nidogen are described as ligands as well. However, α3β1 integrin is more than a 
Figure 5: Hypothetical pathway of Reelin interacting with CNR family proteins.  
Binding of Reelin to the N-terminal EC1 domain of Cadherin-related neuronal 
receptors (CNRs) is capable of modulating the tyrosine-phosphorylation (Y) of 
mouse DAB1 (mDab1) through Fyn, a Src family kinase. Probably, an interaction of 
CNRs and the main Reelin receptors, the very-low-density lipoprotein receptor 
(VLDLR) and the ApoE receptor 2 (ApoER2), has additional influences on the 
activation of DAB1. 
Modified from (Senzaki et al. 1999). 
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simple adhesion receptor, but has a rather complex role as signaling molecule that can 
modulate multiple cellular functions like proliferation, differentiation and migration 
(Kreidberg 2000). It was also proved that α3β1 integrin is able to bind the extracellular 
protein Reelin which leads to inhibition of neuronal migration during brain development. 
Further data suggests that activation of the laminin receptor modulates targets of Reelin 
signaling, as a reduction of DAB1 levels could be found in α3β1-deficient mice (Dulabon et 
al. 2000).  
α5β1 integrin is the primary receptor for fibronectin and able to support matrix assembly of 
fibronectin as well as promoting cell migration (Arnaout et al. 2007, Zhang et al. 1993). 
Recent studies showed that binding of Reelin to its receptors can activate integrin α5β1 
through a pathway that includes DAB1. Consequently, the activation of α5β1 integrin through 
this inside-out signaling promotes neuronal adhesion to fibronectin. Additional data indicates 
that this pathway influences neuronal migration and is crucial for proper layering of the 
neocortex during brain development (Sekine et al. 2012). 
 
Migrating cells do not only show changes of integrin activity but most often also exhibit 
mechanisms to modulate their cytoskeletal structure. It is known that Reelin is capable of 
controlling at least two pathways that reorganize the actin cytoskeleton.  
The neuronal Wiskott-Aldrich syndrome protein (N-WASP) is known to promote invasion by 
activating the Arp2/3 complex, a protein initiating the polymerization of actin and inducing 
formation of filopodia (Tang et al. 2013). Unphosphorylated/inactive DAB1 binds N-WASP 
directly and starts the signaling pathway by activating N-WASP. Phosphorylated/active DAB1 
in turn is degraded through ubiquitinylation and thus can no longer activate these mechanisms 
leading to reduced filopodia formation and decreased cell motility (Suetsugu et al. 2004). 
A second pathway influencing actin filament dynamics and reorganization includes 
ADF/cofilin family proteins (hereafter referred to as cofilin for simplicity). Active, 
unphosphorylated cofilin binds globular (G)-actin as well as filamentous (F)-actin and can 
enhance the disassembly of F-actin by stimulating severance and depolymerization of actin 
filaments. This results in higher actin turnover (Pollard & Borisy 2003). Reelin/DAB1 
signaling leads to activation of the enzyme LIM kinase 1 and 2 (LIMK1/2) which 
phosphorylates cofilin at serine3 and converts the protein into an inactive form. With this 
modification it is no longer capable of binding actin and thus promotes actin polymerization 
and cytoskeletal stability. As a consequence, actin turnover is suppressed and cell motility 
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reduced (Chai et al. 2009, Kruger et al. 2010). Figure 6 illustrates the interactions of cofilin 
and actin.  
 
 
 
1.1.4 Reelin/Disabled-1 signaling in other cancers  
 
As mentioned above in chapter 1.1.1, expression of Reelin is not restricted to the brain, but 
can be found in many other tissues. Although existing data rather suggests little importance 
for physiological mechanisms of Reelin/DAB1 signaling (Ikeda & Terashima 1997), Reelin 
might act in reducing invasion of multiple non-brain cancers. This presumption was 
established after having compared the expression of Reelin protein in several cancers (e.g. 
hepatocellular carcinoma, breast cancer, esophageal cancer or pancreatic cancer) to levels in 
normal tissues. Most of the samples showed a reduced level of expression of Reelin compared 
to the control cases (Okamura et al. 2011, Sato et al. 2006, Stein et al. 2010, Yuan et al. 
2012).  
Research on hepatocellular carcinoma revealed that up to 80% of the samples showed a 
clearly reduced level of Reelin expression. Again, about half of these tumors were found to be 
hypermethylated on the RELN gene promoter preventing synthesis of Reelin mRNA. 
Figure 6: Control of actin filament dynamics by phospho-regulation.  
Amongst other proteins, LIMK1/2 is activated by Reelin, which leads to phosphorylation of cofilin at serine3 
converting it from an active into an inactive state. Unphosphorylated cofilin is binding ADP-actin and induces 
formation of ATP-actin, leading to enhanced severing and depolymerization of actin filaments and stimulation of 
actin turnover. Phosphorylated cofilin is unable of binding actin and is therefore suppressing actin turnover by 
promoting polymerization and stabilization of actin filaments. 
Modified from (Mizuno 2013). 
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Moreover, clinical data suggested Reelin as a regulator gene being inversely correlated to the 
reoccurrence of hepatocellular carcinoma (Okamura et al. 2011).  
Similar results were found in a study on breast cancer that found that hypermethylation of 
RELN promoter leads to poorer prognosis and positive lymph node status. Besides that, it was 
proved that overexpression of Reelin and incubation with exogenous Reelin was capable of 
suppressing cell migration, invadopodia formation and invasiveness in vitro (Stein et al. 
2010). Similar findings are provided in a study on pancreatic cancer. Knockdown of RELN or 
its downstream target DAB1 using small interfering RNA in cells that retained expression of 
Reelin exhibited enhanced cell migration and invasiveness (Sato et al. 2006).  
However, a study by Perrone et al. showed a completely different result: whereas a down-
regulation of Reelin was found in the carcinomas described above and several other entities, 
an increased expression of this protein was associated with high-grade disease in prostate 
cancer. Elevated levels were significantly correlated with aggressive phenotypic behavior of 
cancer cells. Interestingly, benign prostatic tissue did not show any expression of Reelin 
(Perrone et al. 2007).  
Moreover, also the protein DAB1 has been found to function in a pathway that is promoting 
invasion and metastasis of colorectal cancers. The phosphorylation level of DAB1 as well as 
interaction with the tyrosine kinase ABL seem to play a crucial role in a signaling system that 
is induced by the transmembrane receptor protein NOTCH (Sonoshita et al. 2015). 
 
1.2 General information on glioblastoma 
 
The preceding chapter gave an overview of the pathological role of Reelin/DAB1 signaling in 
non-neoplastic tissue and multiple cancers. However, there is no existing study investigating 
the influence of this pathway on glioblastoma or other brain tumors, except for two 
immunohistochemical studies in gangliogliomas. This low-grade tumor which is often 
associated with focal epilepsy in young patients, showed significantly reduced levels of DAB1 
protein in its tissue but no mutations of the DAB1 gene could be detected (Becker et al. 2002, 
Kam et al. 2004).  
The chapter below will provide some general information on glioblastoma that is necessary to 
understand the contents and experiments of this doctoral thesis and will also give a short 
summary of the data on Reelin/DAB1 signaling in glioblastoma that was raised in our 
workgroup so far.  
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1.2.1 Overview and epidemiology 
 
Tumors of the central nervous system (CNS) represent about 2 - 3% of all cancers diagnosed 
displaying a rather seldom but most often highly-malignant tumor entity in adults (Schlegel et 
al. 2003). In childhood, in reverse, brain tumors are the most common type of neoplasms after 
leukemias (Kaatsch 2010).  
Gliomas are subdivided according to histological and biochemical similarities to astrocytic, 
oligodendroglial or ependymal cells. However, the cellular origin of gliomas is still unknown 
but studies of tumor suppressor mouse models suggest that gliomas arise from 
stem/progenitor cells (Alcantara Llaguno et al. 2009). Another study states that gliomas can 
also be induced by oncogenes via dedifferentiation of both neurons and astrocytes 
(Friedmann-Morvinski et al. 2012). Astrocytic gliomas are the most common primary tumors 
of the CNS (Tonn et al. 2006). 
Gliomas are classified by means of histological and molecular criteria as stated in the World 
Health Organisation (WHO) classification of tumors of the central nervous system in its latest 
version from 2016 (first edition: 1979). The WHO classification is dividing brain tumors in 
four grades by assigning a certain grade of malignancy ranging from WHO grade I (benign) 
to WHO grade IV (highly malignant) to each histological subtype. Tumor classification is 
necessary for finding suitable therapeutic strategies and can give a prediction on the patient’s 
prognosis (Louis et al. 2016).  
WHO grade I tumors display neoplasms that show only a low proliferation rate and little 
degeneration. As they are normally histologically well-circumscribed, they can be cured 
completely by radical and maximal surgical resection. A typical grade I glioma is the 
pilocytic astrocytoma which is also the most common primary brain tumor in pediatric 
patients (Tonn et al. 2006, Louis 2007).  
Tumors classified as WHO grade II, e.g. the diffuse astrocytoma, also show a low 
proliferation rate but are infiltrating healthy surrounding brain tissue in contrast to WHO 
grade I tumors. Therefore, these tumors tend to reoccur after surgical excision and the median 
survival is reduced to 4 years (Medical Disability Guidelines 2012). 
A WHO grade III neoplasia like the anaplastic astrocytoma is characterized by microscopic 
features of malignancy and is normally accompanied by restricted life expectancy. 
Histologically, these tumors show nuclear and cellular atypia, as for example chromatin 
richness, disproportion of nuclear-cytoplasm ratio and an elevated mitotic activity (Tonn et al. 
2006, Louis 2007). 
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Glioblastomas, also known as glioblastoma multiforme (GBM), are highly malignant tumors 
due to diffuse infiltration of healthy brain tissue and high mitotic and proliferative activity. 
They are therefore classified as WHO grade IV tumors. Besides high cellularity, nuclear and 
cytoplasmic pleomorphism, the presence of microvascular proliferation and central necrosis is 
essential for the diagnosis. Without effective treatment, these tumors have an average survival 
time of only a few months that can be extended to about 15 months with the standard of 
current therapy including surgery, chemotherapy and radiation. Due to the overall poor 
prognosis, patients have a 2-year survival rate of about 27% (Tonn et al. 2006, Louis 2007, 
Omuro 2013).  
Table 1 gives an overview on classification and grading of the most common glioma entities. 
 
Table 1: Classification and grading of the most common astrocytic gliomas according to the WHO classification of 
tumors of the central nervous system.  
Modified from (Huse et al. 2013, Louis et al. 2007, Riemenschneider & Reifenberger 2009). 
 
Tumor type WHO grade 
Astrocytic gliomas with more circumscribed growth 
Pilocytic astrocytoma 
 Pilomyxoid astrocytoma 
Pleomorphic xanthoastrocytoma 
Subependymal giant cell astrocytoma 
I 
II 
II 
I 
Diffusely infiltrating astrocytic gliomas 
Diffuse astrocytoma 
Anaplastic astrocytoma 
Glioblastoma 
 Giant cell glioblastoma 
 Gliosarcoma 
II 
III 
IV 
IV 
IV 
Mixed gliomas 
Oligoastrocytoma 
Anaplastic oligoastrocytoma 
II 
III 
 
Glioblastomas are deemed to be the most prevalent and also most aggressive primary brain 
tumors accounting for approximately half of all functional tissue CNS tumor cases and 20% 
of all intracranial tumors (Ohgaki & Kleihues 2005). It is estimated that approximately 2 - 3 
new cases per 100’000 residents occur annually in western countries affecting slightly more 
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men than women. Glioblastomas may appear at any age, but older people with a peak of 
incidence between 50 and 70 years are more often afflicted (Tonn et al. 2006).  
The majority of glioblastomas develops in the cerebral hemispheres and can spread into the 
basal ganglia or the contralateral hemisphere. The brain stem is a rare localization in adults 
but can be particularly found in children. Macroscopically, these tumors present most often as 
necrotic masses with frequent central hemorrhages that are surrounded by oedematous brain 
tissue (Tonn et al. 2006) as shown in Figure 7.  
 
 
 
1.2.2 Etiology 
 
Research efforts from many individual groups and more recent data collections from 
multiinstitutional research networks, like The Cancer Genome Atlas (TCGA) (Brennan et al. 
2013), identified several genetic mutations (see chapter 1.2.4) and novel aspects on the 
etiology of glioblastomas. Besides that, genetic syndromes caused by inherited mutations, like 
Li-Fraumeni syndrome or Neurofibromatosis, are found in about 1% of all glioblastoma 
patients (Farrell & Plotkin 2007). 
Most patients with glioblastomas present with a very short clinical history due to the very fast 
and spontaneous development of these tumors. Without any evidence of longer precedent 
malignant progression, these neoplasms are called primary glioblastomas. Opposed to these, 
cases of secondary glioblastomas are less common and evolve from pre-existing low-grade 
diffuse or anaplastic astrocytoma. Secondary glioblastomas are more common in younger 
adults (30-45 years), whereas primary glioblastomas occur mostly in older patients (mean age 
55 years) (Kleihues et al. 2002). A morphological differentiation between both entities is not 
possible because of identical histological features; however, these tumors can be distinguished 
by their genetic and epigenetic aberrations (Huse et al. 2013). More information on the 
molecular pathology in glioblastoma can be found in chapter 1.2.4.  
Figure 7: Glioblastoma of the temporal lobe.  
A necrotic mass with central hemorrhages can be 
identified in the temporal lobe. Most likely, 
macroscopic appearance suggests glioblastoma 
multiforme.  
Taken from (Tonn et al. 2006). 
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1.2.3 Symptoms, diagnosis and treatment  
 
Due to the rapid growth of glioblastomas, health complaints usually arise within only a few 
weeks or months. Most patients primarily suffer from non-specific neurological symptoms 
like nausea, vomiting and headache which can be accompanied by seizures, memory loss or 
hemiparesis. However, the array of symptoms produced by these tumors is very diverse and 
depends highly on their localization. A glioblastoma of the frontal cerebral lobe might lead to 
personality changes, whereas a tumor next to the optic nerve can cause visual loss. Other 
locations lead rather to cerebral oedema and increased cerebral pressure which explains the 
general symptoms listed above (Kleihues et al. 2002).  
Malignant cells of glioblastomas carried in the cerebrospinal fluid can result in gliomatosis of 
the meninges or may spread to the spinal cord. Metastases beyond the central nervous system 
are extremely unusual but dissemination to regional lymph nodes, lung, pleura, liver and bone 
has been described in very rare cases (Frappaz et al. 1999, Pasquier et al. 1980).  
 
Nowadays, patients with newly developed unclear neurological symptoms are usually quickly 
subjected to cranial tomography like magnetic resonance imaging (MRI). Here, glioblastomas 
normally appear as an intracerebral space-occupying lesion with ring-enhancement due to 
peripheral vascularization of the mass and a central hypointense area which is corresponding 
to tumor necrosis. These radiological findings underscore the suspicion of a glioblastoma, 
however, cerebral abscess or metastasis of another malignant tumor have to be taken into 
account as differential diagnoses (Smirniotopoulos et al. 2007). A definitive diagnosis of 
glioblastoma requires a stereotactic biopsy or a craniotomy with tumor resection and 
pathologic confirmation by an experienced neuropathologist. Lately, diagnostic methods have 
been extended by more advanced imaging, like measurement of blood perfusion or of tumor 
metabolite concentration. However, neuropathologic examination remains the gold standard 
for diagnosis of a glioblastoma (Nikiforova & Hamilton 2011).  
 
The goal of glioblastoma therapy is to slow down the tumor growth and improve the quality 
of life. All therapy strategies are non-curative interventions but are at most life-prolonging. 
The standard treatment of glioblastoma is based on three pillars: surgery, radiation and 
chemotherapy.  
Surgical intervention is usually the first step intending to remove as much tumor as possible 
without destroying any functional brain tissue and thus increasing survival (Lacroix et al. 
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2001). Normally, the operation is followed by a combined radio- and chemotherapy in which 
radiation is the mainstay of treatment for glioblastoma. Studies could show that patients who 
received a radiotherapy had a median survival time of more than double of those who did not 
(Walker et al. 1978). The chemotherapeutic drug of choice at the moment is temozolomide 
which seems to sensitize the tumor cells to radiation but also has direct anti-tumorigenic 
effects itself (Chamberlain et al. 2007). This treatment showed a significant influence as 
patients receiving radio- and chemotherapy survived 2.5 months longer than a control group 
with radiation alone, extending the median survival from 12.1 to 14.6 months (Stupp et al. 
2005). Besides this, older patients whose tumor tissue exerts MGMT-methylation (see chapter 
1.2.4) are exclusively treated with temozolomide due to the high toxicity of combined 
chemoradiation. These patients have a higher benefit from temozolomide alone (Malmstrom 
et al. 2012). 
 
1.2.4 Molecular diagnosis and pathology of gliomas 
 
Molecular markers are gaining more and more importance in neurooncology as histology no 
longer serves as sole diagnostic tool for correct brain tumor classification (Louis et al. 2016). 
Additionally, molecular testing attributes to survival prognosis of tumor patients and can give 
predictive information on response to certain treatments (Dietmaier et al. 2015).  
As the schematic representation of molecular markers during pathogenesis of gliomas in 
Figure 8 explains, a large number of biological alterations is known in glioblastomas and 
astrocytic tumors of which the following represent important markers for everyday clinical 
practice or have been reported to be involved in glioma cell migration and invasion.  
The methylation level of the O6-Methylguanin-DNA-methyltransferase (MGMT)-gene 
promoter is among the most frequently analyzed molecular markers in human brain tumors 
(Dietmaier et al. 2015). This gene, located on the chromosomal region 10q26, encodes for a 
DNA repair gene that removes alkyl groups from the O
6
 of guanine (Watanabe et al. 2007) 
and is hypermethylated in 40% of all glioblastomas. Elevated methylation levels of the 
MGMT promoter predict a better response to treatment with the alkylating chemotherapeutic 
drug temozolomide which is translating into a prolonged patient survival (Hegi et al. 2005).  
Mutations of the substrate binding domain of the isocitrate dehydrogenase (IDH) 1 gene and 
its homologue IDH2 display another biological marker analyzed frequently that allows to 
differentiate between several low-grade astrocytomas. For example, approximately 70% of 
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diffuse astrocytomas show a mutation of amino acid 132 in the IDH1 gene whereas pilocytic 
astrocytomas express mainly wildtype IDH1. Furthermore, 90% of all secondary 
glioblastomas, opposed to primary glioblastomas, are also tested positive for this mutation as 
they most often develop from these precursor lesions (Dietmaier et al. 2015, Yan et al. 2009).  
Besides MGMT promoter methylation and IDH1/2 methylation, complete loss of the long arm 
of chromosome 1 and the short arm of chromosome 19 (1p/19q deletion) is an entity-defining 
alteration in oligodendroglial tumors and may guide to consideration of oligodendroglial 
differentiation in diagnosis of oligoastrocytomas (Louis et al. 2016). Additionally, detection 
of 1p19q deletion predicts favorable prognosis for tumors with oligodendroglial features and 
responsiveness to polychemotherapy with procarbazine, lomustine and vincristine (Cahill et 
al. 2015, Cairncross et al. 2006, Dietmaier et al. 2015, Riemenschneider et al. 2013). 
Apart from these biochemical markers analyzed with regard to diagnosis of brain tumors, 
gliomas show multiple genetic alterations like mutation of the epidermal growth factor 
receptor (EGFR), of the tumor suppressor protein p53 or of PI3 kinase pathway genes. These 
markers are less applicable for molecular diagnosis as usually no information on prognosis or 
response to treatment is gained due to their identification (Ceccarelli et al. 2016, Huse et al. 
2013, Riemenschneider & Reifenberger 2009). 
Numerous studies have shown that the EGFR is not only frequently amplified or 
overexpressed in glioblastomas but also in multiple other cancers. Very often, a truncated 
EGFR protein which forms a constitutively active mutant called EGFR variant III (EGFRvIII) 
is present in these tumor cells (Libermann et al. 1985, Schlegel et al. 1994, Sugawa et al. 
1990). With regards to gliomas, a positive correlation between EGFR overexpression and 
enhanced invasiveness of tumor cells (Lund-Johansen et al. 1990) as well as promotion of 
glioblastoma cell migration and tumor growth by the epidermal growth factor (EGF), a ligand 
of the EGFR (Tysnes et al. 1997), was reported.  
The p53 protein is among the best known of all tumor suppressors and – when mutated – is 
capable of promoting migration and invasion, as well as inhibiting cellular aging and 
apoptosis in various human cancers (Muller et al. 2011). It was recently shown that p53 has a 
crucial role in gliomagenesis by inducing accumulation of cooperative oncogenic alterations 
(Wang et al. 2009). It is therefore reasonable that mutations of p53 are frequently found and 
can be similarly observed in lower grade malignant gliomas like diffuse astrocytoma as well 
as in secondary glioblastomas (Ohgaki et al. 2004). 
Besides EGFR and p53 mutations, oncogenes of the PI3 kinase pathway play a crucial role in 
development of glioblastomas. PI3 kinases are involved in many cellular functions such as 
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cell growth, differentiation, motility and survival and are hence capable of promoting 
tumorigenesis when misregulated. Additionally, the phosphatase and tensin homologue 
(PTEN), an antagonist of the PI3 kinase pathway, is absent in up to 30% of all primary 
glioblastomas (Bleeker et al. 2014, Huse et al. 2013, Riemenschneider & Reifenberger 2009).  
An overview on known molecular alterations that are frequently found in astrocytic gliomas is 
given in Figure 8. Some of the genetic mutations listed below have been explained in greater 
detail in this chapter. Additionally, a distinction is made between alterations that are 
preferentially found in primary glioblastomas on the one hand and secondary glioblastomas 
on the other. 
 
 
1.3 Reelin/DAB1 signaling in glioblastoma 
 
As explained extensively in chapter 1.1.4, Reelin/DAB1 signaling has an important effect on 
non-brain tumors suggesting a tumor supressive function in several cancers like 
hepatocellular carcinoma, breast cancer, esophageal cancer or pancreatic cancer (Okamura et 
al. 2011, Sato et al. 2006, Stein et al. 2010, Yuan et al. 2012). Although Reelin acts 
particularly during development of the central nervous system, none of these studies have 
Figure 8: Schematic representation of the molecular pathogenesis and progression of astrocytic gliomas. 
Note that a distinction between genetic mutations that are preferentially found in primary or secondary 
glioblastomas can be made. Taken from (Riemenschneider & Reifenberger 2009).  
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ever examined the influence of Reelin and members of its canonical signaling on gliomas so 
far.  
Previous work of our laboratory supports the hypothesis of Reelin being a tumor suppressor, 
as promising data on the methylation status of the RELN promoter and mRNA levels of 
Reelin and DAB1 in glioblastoma and astrocytic tumors was raised. Furthermore, an influence 
of Reelin/DAB1 signaling on the proliferation of glioblastoma cells could be proved. The 
following chapters are briefly summarizing these findings. 
 
1.3.1 RELN promoter hypermethylation 
 
Real-time PCR analysis of mRNA levels of Reelin and DAB1 revealed that these proteins 
show reduced expression in multiple tested astrocytic tumor samples. Furthermore, 
downregulation of Reelin and DAB1 correlates with higher grade of malignancy, whereas at 
the same time, the Reelin receptors VLDLR and ApoER2 are upregulated with increasing 
WHO grade (Violonchi 2009). Survival analysis of data of the Rembrandt and The Cancer 
Genome Atlas (TCGA) databases reinforced these findings (data raised by Dr. Markus 
Schulze). As a reason for the reduced expression of Reelin, a hypermethylation pattern of the 
RELN promoter sequence was found via bisulfite conversion which is seen particularly often 
in glioblastomas. Treatment of these tumors with demethylating agents led to strong 
reexpression of Reelin mRNA compared to untreated controls (Violonchi 2009).  
 
1.3.2 DAB1 induced proliferation block 
 
Not only the genomic analysis of RELN in glioblastoma cells, but also cell biological testing 
of cell growth had revealed promising results proposing Reelin/DAB1 signaling as an 
important tumor suppressor pathway. A proliferation assay in U87 and U251 cells stably 
overexpressing the downstream target DAB1 showed that Reelin is significantly inhibiting cell 
division in a DAB1-dependent fashion compared to control cells with only very low 
endogenous DAB1 expression or cells expressing the 5F DAB1 mutant (data raised by Dr. 
Markus Schulze).  
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1.4 Aims of this study 
 
As a basis for this doctoral thesis, preliminary findings of our laboratory revealed that 
Reelin/DAB1 signaling is associated with the grade of malignancy in glioblastomas and 
generated the hypothesis that Reelin acts as a tumor suppressor in astrocytic tumors. A crucial 
characteristic for highly malignant cancers is increased cell motility and diffuse infiltration of 
healthy tissue. It is also known that these cell processes can be influenced by Reelin/DAB1 
signaling. In order to follow up on this hypothesis, the research for this doctoral thesis aimed 
at analyzing the effects of the Reelin/DAB1 signaling pathway on the migrational and invasive 
phenotype of glioblastoma cells. 
  
To investigate on the overall role of Reelin on these cellular functions and to distinguish 
between DAB1-dependent and -independent effects a unique set of experiments was 
performed: 
- The preceding chapters already displayed that Reelin and DAB1 are regulators of 
neuronal migration, thus the main part of my research focused on glioblastoma 
migration and the contribution of the canonical Reelin signaling axis. Therefore, a live 
imaging based assay to observe 2D cell migration on fibronectin and laminin was used 
to examine the influences of Reelin and the involvement of integrin binding in motility 
of glioblastoma cells. 
- To pursue the findings obtained in the migration assay, these experiments were 
extended through an invasion assay. Reelin has already been described as an inhibitor 
of diffuse tumor infiltration in multiple other cancers. Therefore, we sought to 
examine the influences of Reelin/DAB1 signaling in a classical invasion assay. The 
invasive behavior of the same set of cells as in the migration assay was observed on 
matrigel, a protein mixture which resembles complex extracellular matrix found in 
many tissues.  
- Cell lines that show a migratory phenotype often exhibit altered regulation of the actin 
cytoskeleton. As the assay for migration delivered promising results, 
immunocytochemistry of filamentous actin and of the actin reorganizing protein 
phospho-cofilin was performed to examine morphological changes like formation of 
stress fibers or cell membrane ruffling under Reelin stimulation. 
- Only little information on downstream targets of Reelin/DAB1 signaling in cancers is 
available. For further investigation on these molecular mechanisms, protein analysis of 
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multiple known and potential members of this signaling cascade was performed using 
the standard western blotting technique. Amongst others, the phosphorylation levels 
under Reelin stimulation of the following proteins were analyzed:  
 Focal adhesion kinase (FAK), a regulator of cell-matrix junctions, 
 Total phospho-tyrosine levels via the antibody 4G10, 
 Kip1/p27, a CDK inhibitor, 
 STAT3, an activator of transcription and 
 Cofilin, a reorganizing protein of the cytoskeleton. 
 
The experiments of this study were chosen to contribute to a deeper understanding of the role 
of Reelin/DAB1 signaling in astrocytic tumor pathogenesis and pathology. The results of this 
doctoral thesis on migration and invasion of glioblastoma are hopefully one day conducive to 
an effective anti-invasive therapy of brain tumors.  
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2 Materials 
2.1 Chemicals 
 
Chemical Manufacturer 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 
Roth 
4',6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich 
Ammonium persulfate (APS) Roth 
Bovine serum albumin Applichem 
Calcium chloride (CaCl₂) Roth 
Dimethylsulfoxide (DMSO) Roth 
Ethanol 100% Roth 
Ethanol 70% Fischar 
Ethylenediaminetetraacetic acid (EDTA) Roth 
Glycerol Roth 
Glycine Roth 
Hydrochloric acid (HCl) Roth 
Hydrogen peroxide (H₂O₂) Sigma-Aldrich 
Igepal Fluka 
Isopropanol Merck 
Magnesium chloride (MgCl2)  Roth 
Manganese (II) chloride (MnCl2) Roth 
Methanol Rotipuran 99.9% Roth 
Nonfat dry milk powder Roth 
Normal goat serum PANᵀᴹ-Biotech 
Paraformaldehyde (PFA) Sigma-Aldrich 
Phosphatase Inhibitor Cocktail Roche 
Phos-tag
TM
 Wako Pure Chemical Industries 
Ponceau S Solution Sigma Life Science 
Potassium chloride (KCl) Roth 
Protease Inhibitor Cocktail Roche 
RNAse free water Roth 
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Rotiphorese® Gel 30 (37.5:1) Acrylamide 30% Roth 
Saponin Sigma Life Science 
Sodium azide (NaN₃) Roth 
Sodium chloride (NaCl) Roth 
Sodium deoxycholate Roth 
Sodium dodecyl sulfate (SDS) Roth 
Sodium hydroxide (NaOH) Roth 
SYBR Green 2x SensiFAST SYBR Green Bioline 
Tetramethylethylenediamine (TEMED) Roth 
TrisBase Trizma® base SAFC® 
Tris-HCl Roth 
Triton X-100 Roth 
Tween-20 Sigma-Aldrich 
β-mercaptoethanol Roth 
 
2.2 Cell culture reagents 
 
Reagent Manufacturer 
CO₂-Independent Medium gibco® life technologies 
Dulbecco´s modified Eagle´s medium 4.5 g/l glucose  Sigma Life Science 
Dulbecco´s modified Eagle´s medium w/o phenolred 
4.5 g/l glucose 
Sigma Life Science 
Dulbecco´s phosphate buffered saline  Sigma Life Science 
Fetal calf serum PANᵀᴹ-Biotech 
Fibronectin, human Sigma Aldrich 
Geneticindisulfate (G418) 50.0 mg/ml Calbiochem® Millipore 
Hank's balanced salt solution Sigma Life Science 
Laminin, human Sigma Aldrich 
L-glutamine gibco® life technologies 
Penicillin / streptomycin gibco® life technologies 
Poly-L-lysine 0.01% solution Sigma Life Science 
Trypsin / EDTA Sigma Life Science 
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2.3 Cell culture materials 
 
Material Manufacturer 
µ-Slide 8 well ibiTreat ibidi® 
24 well plate Corning Life Sciences 
Cell culture flasks 75 cm
2
 CellStar® Breiner Bio-One 
Control inserts 8.0 Micron  Corning BioCoatᵀᴹ 
Cryo Pure Tube 1.6ml Sarstedt 
Falcon tube 15 ml Sarstedt 
Falcon tube 50 ml Sarstedt 
Growth Factor Reduced Corning® Matrigel® 
Invasion Chamber 8.0 Micron 
Corning BioCoatᵀᴹ 
Lab-Tek II Chamber Slide 8 well LAB-TEK® Thermo Fisher Scientific 
Plastic pipettes 5 ml, 10 ml, 25 ml, 50 ml Sarstedt 
Tissue culture dishes Ø 15, 30 and 100 mm Sarstedt 
 
2.4 Primers 
 
All primers used for this doctoral thesis were obtained by Eurofins MWG/Eurofins Genomics, 
Ebersberg, Germany. Detailed information will be listed in the corresponding chapter (see 
chapter 3.2.3). 
 
2.5 Antibodies for western blotting 
2.5.1 Primary antibodies 
 
Antibody Target species Host  Dilution Manufacturer 
4G10 all mouse  1:1000 Millipore 
Cofilin human rabbit 1:1000 Cell Signaling 
P-DAB1 (Tyr220) human rabbit 1:1000 Cell Signaling 
P-FAK (Tyr297) human/mouse rabbit 1:1000 Invitrogen 
P-Kip1/P-p27 (Thr198) human rabbit 1:1000 R&D 
P-STAT3 (S727) human rabbit 1:1000 Cell Signaling 
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Total DAB1  human/mouse rabbit 1:1000 Cell Signaling 
Total Kip1/p27 human rabbit 1:1000 Cell Signaling 
Total STAT3 human/mouse mouse 1:1000 Cell Signaling 
Tubulin (Clone DM1A) human/mouse mouse 1:10.000 Sigma-Aldrich 
 
2.5.2 Secondary antibodies 
 
Antibody Conjugat Dilution Manufacturer 
Goat anti-mouse IgG HRP 1:10.000 Santa Cruz Biotechnology 
Goat anti-rabbit IgG HRP 1:10.000 Santa Cruz Biotechnology 
 
2.6 Antibodies and dyes for immunocytochemistry 
 
Antibody/dye Target/target 
species 
Raised 
in  
Conjugate Dilution Manufacturer 
4',6-diamidino-2-
phenylindole 
(DAPI) 
DNA - - 2µg/ml Sigma-Aldrich 
AlexaFluor® 555 
phalloidin 
Filamentous actin - AlexaFluor® 
555 
1:50 Invitrogen/Life 
Technologies 
Primary 
antibody:  
P-Cofilin 
mouse/ human/ 
rat cofilin 
rabbit - 1:50 Cell Signaling 
Secondary 
antibody: 
Flourescein goat 
anti-rabbit IgG 
- goat FITC 1:200 Invitrogen/Life 
Technologies 
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2.7 Cell lines 
2.7.1 HEK 293T cells 
 
For the stimulation of classical glioblastoma cells, mouse Reelin (mRELN) that was produced 
by stably transfected HEK 293T cells was used. These cells, originally obtained by ATCC
®
 
(American Type Culture Collection), express Reelin from the vector pcDNA3 that comprises 
the complete open reading frame (ORF) of the mRELN gene (D'Arcangelo et al. 1997). As a 
control, cells that had been stably transfected with a vector encoding for the green fluorescent 
protein (GFP) were used. HEK 293T cells containing the Reelin vector, as well as cells 
transfected with the GFP vector were kindly provided by Prof. Dr. rer. nat. Eckart Förster 
(Institut für Neuroanatomie, Universitätsklinikum Hamburg-Eppendorf). 
 
2.7.2 Human glioblastoma cells 
 
2.7.2.1 U87 and U251 glioblastoma cell lines 
For the experiments, the classical glioblastoma cell lines U87 and U251, originally obtained 
by ATCC
®
, were modified by transfection to fit the particular needs of research on 
Reelin/DAB1 signaling. Both the U87 and the U251 cell line are classified as WHO grade IV 
astrocytomas with epithelial morphology. U87 cells were collected from a 44 year old male 
Caucasian, whilst U251 cells are derived from a 75 year old male Caucasian patient. Both 
patients were diagnosed with primary glioblastoma. 
 
2.7.2.2 Constructs used for stable cell lines 
In total, three types of stably transfected cells were established for the experiments using the 
pIRESneo2 vector by Clontech which is depicted in Figure 9.  
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First, as a control, cells were transfected with the empty pIRESneo2 vector (EV). Secondly, to 
analyze the effects of DAB1 overexpression in U87 and U251 cells, the human DAB1 gene 
was cloned into this vector with the restriction enzymes Nhe I and Not I (DAB1). Finally, as 
an additional control to investigate on DAB1-independent Reelin effects, cells that stably 
express the 5F mutant of DAB1 were created (5F). This mutant was established by replacing 
the 5’ end of human DAB1 with the construct of a murine 5F mutant that was kindly provided 
by Jonathan A. Cooper (Fred Hutchinson Cancer Research Center, Seattle). Therefore, the 
restriction site Afl III was used. As the preceding amino-acid sequence until Afl III is 
completely conserved in murine and human DAB1, the resulting construct is encoding for a 
human 5F mutant protein as the amino-acid alignment (see Figure 10) proves. In total, three 
different stably transfected cell lines were generated from each classical glioblastoma cell 
line: the empty vector cells (hereafter named U87/U251 EV), cells with DAB1 overexpression 
(hereafter named U87/U251 DAB1) and cells expressing the 5F DAB1 mutant (hereafter 
named U87/U251 5F).  
Figure 9: Restriction Map and Multiple Cloning Site of the pIRESneo2 vector by Clontech. 
Wildtype DAB1 or the 5F mutant gene have been cloned into this plasmid using the restriction sites 
Nhe I and Not I. Taken from (Masonoda) . 
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2.7.2.3 Establishment of stable cell lines 
Transfection of the cells was performed according to the following protocol:  
First, 8 x 10
5
 cells were precultured in complete Dulbecco´s modified Eagle´s medium 
(cDMEM) (see chapter 2.12.1) into Ø 100 mm culture dishes for 24 h and then incubated 
with 12 ml of prewarmed Opti-MEM. Then a mix of 250 µl of Opti-MEM and 1.5 µg of the 
indicated RNA or DNA concentration, as well as a mix of 250 µl of Opti-MEM and 12 µl of 
the transfection reagent Lipofectamine 2000, was prepared and kept for 5’ at room 
temperature (RT) in polystyrene tubes. Afterwards, these solutions were mixed and incubated 
for another 20’ in order to achieve formation of transfection complexes. This mixture was 
applied to the cultured cells in a dropwise fashion and then incubated for 4 hours. Finally, the 
Opti-MEM medium containing the transfection complexes was exchanged by complete 
Figure 10: Protein sequence alignment of wildtype DAB1 (Query) and 5F mutant (Sbjct).  
The five tyrosines (Y) which are changed into phenylalanine (F) in the 5F mutant are highlighted yellow. 
Kindly provided by Markus Schulze. 
DAB1   1    MSTETELQVAVKTSAKKDSRKKGQDRSEATLIKRFKGEGVRYKAKLIGIDEVSAARGDKL  60 
            MSTETELQVAVKTSAKKDSRKKGQDRSEATLIKRFKGEGVRYKAKLIGIDEVSAARGDKL 
5F     1    MSTETELQVAVKTSAKKDSRKKGQDRSEATLIKRFKGEGVRYKAKLIGIDEVSAARGDKL  60 
 
Query  61   CQDSMMKLKGVVAGARSKGEHKQKIFLTISFGGIKIFDEKTGALQHHHAVHEISYIAKDI  120 
            CQDSMMKLKGVVAGARSKGEHKQKIFLTISFGGIKIFDEKTGALQHHHAVHEISYIAKDI 
Sbjct  61   CQDSMMKLKGVVAGARSKGEHKQKIFLTISFGGIKIFDEKTGALQHHHAVHEISYIAKDI  120 
 
Query  121  TDHRAFGYVCGKEGNHRFVAIKTAQAAEPVILDLRDLFQLIYELKQREELEKKAQKDKQC  180 
            TDHRAFGYVCGKEGNHRFVAIKTAQAAEPVILDLRDLFQLIYELKQREELEKKAQKDKQC 
Sbjct  121  TDHRAFGYVCGKEGNHRFVAIKTAQAAEPVILDLRDLFQLIYELKQREELEKKAQKDKQC  180 
 
Query  181  EQAVYQTILEEDVEDPVYQYIVFEAGHEPIRDPETEENIYQVPTSQKKEGVYDVPKSQPV  240 
            EQAV+QTILEEDVEDPV+Q+IVFEAGHEPIRDPETEENI+QVPTSQKKEGV+DVPKSQPV 
Sbjct  181  EQAVFQTILEEDVEDPVFQFIVFEAGHEPIRDPETEENIFQVPTSQKKEGVFDVPKSQPV  240 
 
Query  241  SAVTQLELFGDMSTPPDITSPPTPATPGDAFIPSSSQTLPASADVFSSVPFGTAAVPSGY  300 
            SAVTQLELFGDMSTPPDITSPPTPATPGDAFIPSSSQTLPASADVFSSVPFGTAAVPSGY 
Sbjct  241  SAVTQLELFGDMSTPPDITSPPTPATPGDAFIPSSSQTLPASADVFSSVPFGTAAVPSGY  300 
 
Query  301  VAMGAVLPSFWGQQPLVQQQMVMGAQPPVAQVMPGAQPIAWGQPGLFPATQQPWPTVAGQ  360 
            VAMGAVLPSFWGQQPLVQQQMVMGAQPPVAQVMPGAQPIAWGQPGLFPATQQPWPTVAGQ 
Sbjct  301  VAMGAVLPSFWGQQPLVQQQMVMGAQPPVAQVMPGAQPIAWGQPGLFPATQQPWPTVAGQ  360 
 
Query  361  FPPAAFMPTQTVMPLPAAMFQGPLTPLATVPGTSDSTRSSPQTDKPRQKMGKETFKDFQM  420 
            FPPAAFMPTQTVMPLPAAMFQGPLTPLATVPGTSDSTRSSPQTDKPRQKMGKETFKDFQM 
Sbjct  361  FPPAAFMPTQTVMPLPAAMFQGPLTPLATVPGTSDSTRSSPQTDKPRQKMGKETFKDFQM  420 
 
Query  421  AQPPPVPSRKPDQPSLTCTSEAFSSYFNKVGVAQDTDDCDDFDISQLNLTPVTSTTPSTN  480 
            AQPPPVPSRKPDQPSLTCTSEAFSSYFNKVGVAQDTDDCDDFDISQLNLTPVTSTTPSTN 
Sbjct  421  AQPPPVPSRKPDQPSLTCTSEAFSSYFNKVGVAQDTDDCDDFDISQLNLTPVTSTTPSTN  480 
 
Query  481  SPPTPAPRQSSPSKSSASHASDPTTDDIFEEGFESPSKSEEQEAPDGSQASSNSDPFGEP  540 
            SPPTPAPRQSSPSKSSASHASDPTTDDIFEEGFESPSKSEEQEAPDGSQASSNSDPFGEP 
Sbjct  481  SPPTPAPRQSSPSKSSASHASDPTTDDIFEEGFESPSKSEEQEAPDGSQASSNSDPFGEP  540 
 
Query  541  SGEPSGDNISPQAGS  555 
            SGEPSGDNISPQAGS 
Sbjct  541  SGEPSGDNISPQAGS  555 
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medium. For the establishment of stably transfected cells the antibiotic G418 was added to the 
complete medium in a concentration of 0.2 mg/ml for U87 respectively 0.4 mg/ml for U251 
after 24 hours and the cells were cultured for another two weeks until resistant and stably 
proliferating cells emerged. Only transfected cells containing the G418 resistance gene and 
therefore also a transfection vector are able to survive this selection pressure.  
The transfected cells for this research were kindly provided by Dr. Markus Schulze of the 
Department for Neuropathology, Universität Regensburg.  
 
2.8 Devices 
 
Device Manufacturer Application 
AF-6000 LX Life Cell 
Imaging System 
Leica Microsystems Live cell imaging/high 
magnification images 
Balance PBJ6200-2M Kern Buffer preparation 
BX61 microscope Olympus Quantitative immunocytochemistry 
Casting Stand Bio-Rad SDS-PAGE gel casting 
Fastblot B44 Biometra SDS-PAGE gel blotting 
FE20 – FiveEasy™ Mettler Toledo pH measurement 
Heracell™ Heraeus CO₂ incubator 
Heracell™ 240i  Thermo Scientific CO₂ incubator 
HERAsafe laminar flow Heraeus Cell culture 
HERAsafe laminar flow Thermo Scientific Cell culture 
ImageQuant LAS 4000 mini GE Healthcare Life Sciences Processing of western blots 
IX81 microscope Olympus Image acquisition for transwell 
assay 
MIKRO 200R  Hettich Zentrifugen Sample centrifugation 
Mini Protean® Tetra System Bio-Rad SDS gel electrophoresis 
NanoDrop2000 Thermo Scientific/peqlab Measurement of DNA/RNA 
concentrations 
PowerPacᵀᴹ Basic (300 V, 400 
mA, 75 W) 
Bio-Rad Power supply 
Rotina 420R  Hettich Zentrifugen Sample centrifugation 
Schüttelmaschine LS10 gerhardt Shaking of western blot membranes 
SHAKER DOS-10L neoLAB®  Shaking of western blot membranes 
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StepOnePlus Applied Biosystems  Real-time PCR 
T3000 Biometra Thermocycler 
Thermomixer® compact eppendorf Sample preparation 
 
2.9 Software 
 
Software Manufacturer Application 
Cell^P Olympus Quantitative immunocytochemistry 
CellProfiler 2.1.1 Broad Institute 
Imaging Platform 
Cell image analysis of Actin /  
P-Cofilin stainings 
CellSens Dimension 1.9 Olympus Image acquisition for transwell assay 
Chemotaxis and Migration Tool 
V2.0 
ibidi® Tracking of cell migration  
Excel 2007 Microsoft Office Data analysis 
GraphPad Prism 4 GraphPad Software Statistical analysis 
Image Quant TL 8.1 GE Healthcare Life 
Sciences 
Quantification of western blotting  
ImageJ 1.48v NIH Image Quantification of cell invasion 
Leica Application Suite LAS X 
1.x 
Leica Microsystems Live cell imaging/high magnification 
images 
 
2.10 Kits  
 
Kit  Manufacturer 
RNeasy Mini Kit Qiagen 
SuperScript™ II Reverse Transcriptase Invitrogen/life technologies 
SuperSignal West Pico Substrate Thermo Fisher Scientific 
SuperSignal West Femto Maximum Sensitivity Substrate Thermo Fisher Scientific 
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2.11 Other materials 
 
Material Manufacturer 
Bottle-Top Vacuum Filter Systems Corning® 
Chemical pipettes 0.5-10, 2-20, 20-200, 100-1000 µl  eppendorf 
Chemical pipettes 1-10, 2-20, 20-100, 50-200, 200-1000 µl  Gilson 
Cover slips 18x18 mm, 24x50 mm Roth 
Disposable Scalpel No. 10 Feather 
Fluoromount-G  SouthernBiotech 
MagicMark
TM
 Western Protein Standard (20-220 kDa) Life Technologies 
Microscope slides Marienfeld 
Needle 20G x 1.5''  Becton Dickinson 
SafeSeal microtubes 0.5 ml, 1.5 ml, 2 ml Sarstedt 
Syringe 1 ml Becton Dickinson 
 
2.12 Solutions, buffers and media 
2.12.1 Cell culture 
 
Solutions, buffers, media Composition  
Complete medium for HEK293T In DMEM 4.5 g/l glucose  
Fetal calf serum    10% (v/v)  
L-glutamine     2 mM  
Penicillin     100 U/ml 
Streptomycin     100 μg/ml 
Complete medium for U87 In DMEM 4.5 g/l glucose  
Fetal calf serum    10% (v/v)  
L-glutamine     2 mM  
Penicillin     100 U/ml 
Streptomycin     100 μg/ml 
G418      0.2 mg/ml 
Complete medium for U251 In DMEM 4.5 g/l glucose  
Fetal calf serum    10% (v/v)  
L-glutamine     2 mM  
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Penicillin     100 U/ml 
Streptomycin     100 μg/ml 
G418      0.4 mg/ml 
Freezing medium  In fetal calf serum 
DMSO     15% (v/v) 
Blocking buffer for plate coating In PBS 
Bovine serum albumin (BSA)   0.5% (v/v) 
 
2.12.2 Western blotting 
 
Solutions, buffers, media Composition (in dH2O, unless mentioned otherwise) 
Radio Immuno Precipitation Assay 
buffer (RIPA) lysis buffer  
Sodium chloride   150 mM  
Triton X-100    1.0% (v/v)  
Sodium deoxycholate   0.5% (w/v)  
SDS     0.1% (w/v)  
Tris base, pH 8.0   50 mM 
Running gel (lower gel) buffer Tris base     1.5 M  
adjust pH to 8.8 
SDS     0.4%  
Stacking Gel (upper gel) buffer Tris base     0.5 M   
adjust pH to 6.8 
SDS     0.4% 
10 x Running buffer SDS Gels Tris base    150 mM  
Glycine    2 M   
SDS     1% 
Blotto buffer Non fat dry milk    5.0% (w/v)  
Tris-HCl pH = 8,0   50.0 mM  
NaCl      80.0 mM  
CaCl2     2.0 mM 
NP-40     0.2% (v/v) 
Antibody dilution buffer BSA     1.0% (w/v)  
HEPES     10.0 mM  
NaCl     0.5 M   
NaN3     0.02% (w/v)  
Tween-20    0.2% (v/v) 
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10x TBS (concentrated Tris-
buffered Saline) 
Tris base    0.2 M 
NaCl in dH2O    1.5 M 
adjust pH to 7.6 with 12N HCl 
TBS-T  In 1x TBS  
Tween-20     0.05% (v/v) 
Anode I buffer Tris base    0.3 M  
Methanol    20% (v/v) 
Anode II buffer Tris base    25.0 mM  
Methanol     20% (v/v)  
Cathode buffer Tris base     25.0 mM  
Glycine     40.0 mM  
Methanol     10% (v/v)  
SDS      0.005% (w/v) 
10x Towbin buffer Tris base    250 mM 
Glycine    2 M 
1x Towbin buffer dH2O     700 ml  
10x Towbin buffer   100 ml 
Methanol     200 ml 
Phos-tag
TM
 solution D in dH2O containing 3% methanol (v/v)  
Phos-tag
TM
    5 mM 
Phos-tag
TM
 solution E MnCl2     10 mM 
4x Laemmli buffer SDS     8% (w/v) 
β-mercaptoethanol   10% (v/v) 
Glycerol    20% (v/v) 
Bromophenol blue   0.004% (w/v) 
Tris-HCl    0.125 M 
adjust pH to 6.8 
SuperSignal West Pico Substrate Luminol/Enhancer   2.5 ml 
Stable Peroxide buffer   2.5 ml 
SuperSignal West Femto Maximum 
Sensitivity Substrate 
Luminol/Enhancer   2.5 ml 
Stable Peroxide buffer   2.5 ml 
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2.12.3  2D migration assay 
 
Solutions, buffers, media Composition  
Complete CO2 independent medium In CO2 independent Medium 
Fetal calf serum   5% (v/v)  
L-glutamine    2 mM  
Penicillin    100 U/ml 
Streptomycin    100 μg/ml 
 
2.12.4 Transwell invasion assay 
 
Solutions, buffers, media Composition  
Paraformaldehyde  In PBS  
Paraformaldehyde   4% (w/v)  
adjust pH to 7.2 
Complete medium 10% FCS In DMEM w/o phenolred 4.5 g/l glucose  
Fetal calf serum   10% (v/v)  
L-glutamine    2 mM  
Penicillin    100 U/ml 
Streptomycin    100 μg/ml 
Complete medium 0.5% FCS In DMEM  w/o phenolred 4.5 g/l glucose  
Fetal calf serum   0.5% (v/v)  
L-glutamine    2 mM  
Penicillin    100 U/ml 
Streptomycin    100 μg/ml 
 
2.12.5 Immunocytochemistry 
 
Solutions, buffers, media Composition (in PBS, unless mentioned otherwise) 
Complete medium 5% FCS In DMEM  4.5 g/l glucose  
Fetal calf serum   5% (v/v)  
L-glutamine    2 mM  
Penicillin    100 U/ml 
Streptomycin    100 μg/ml 
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Blocking buffer Normal goat serum   5% (v/v)  
Saponin    0.3% (w/v) 
Antibody dilution buffer Normal goat serum   1.0% (v/v)  
Saponin    0.3% (w/v) 
Washing buffer Saponin    0.3% (w/v) 
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3 Methods 
3.1 Cell biological methods 
 
3.1.1 Cell lines and cell culture conditions 
 
All cells were cultured with sterile equipment and all working steps were performed under a 
laminar airflow bench. HEK 293T cells, as well as the two glioblastoma cell lines U87 and 
U251 were cultured in complete DMEM (see chapter 2.12.1), in a humidified atmosphere at 
37°C and 5% CO2. Additionally, the medium for the transfected U87 and U251 cell lines 
contained 0.2 mg/ml respectively 0.4 mg/ml G418.  
 
3.1.1.1 Cell passaging 
Cells were cultured to a confluency of 80 - 90% and then splitted. For this purpose, their 
medium was aspirated and the adherent cells were washed with 5 ml of PBS. After that, 3 ml 
of trypsin/EDTA were added and 2.5 ml reaspirated leaving the cells covered with 0.5ml of 
trypsin/EDTA. The cells were allowed to detach for 3’ at 37°C and were subsequently 
resuspended in 9.5 ml complete medium. For a 1:10 dilution, 1 ml of this cell suspension was 
plated onto a new culture dish. The total volume in the 75 cm
2
 culture flask and the Ø 100 
mm culture dish was 12.5 ml. 
 
3.1.1.2 Freezing cells 
For purposes of long term storage, cells were cryoconserved. Therefore, cells were grown to 
80% confluency on 75 cm
2
 culture flasks and harvested by trypsinization according to chapter 
3.1.1.1. Then, the cells were resuspended in 5 ml of complete medium and collected by 
centrifugation for 5’ at 99 x g. The cell pellet was resuspended in complete medium 
containing FCS 20% (v/v) and DMSO 10% (v/v), immediately transferred into a cryo tube 
and put on ice. Finally, the cells were stored at -80°C overnight and then transferred into 
liquid nitrogen on the next day. 
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3.1.1.3 Thawing cells 
For rethawing, the cells were thawn in a waterbath at 37°C, until only a small ice crystal was 
left in the cryo tube. The cell suspension from the cryo tube was mixed with 5 ml of complete 
medium in a 15 ml falcon tube and then the cells were collected by centrifugation at 99 x g 
for 5’. The cells were resuspended in 3 ml of complete medium and then plated on to a 75 cm2 
culture flask in a total volume of 12.5 ml. 
 
3.1.2 Plate coating 
 
For immunocytochemistry and analysis of cell migration, plates were protein-coated to 
simulate an extracellular matrix. Plate coating was performed in µ-Slide 8 wells ibiTreat and 
Lab-Tek II Chamber Slide 8 wells. Therefore, these slides were washed with sterile H2O and 
then coated with 5 µg/ml fibronectin diluted in PBS or 2 µg/ml laminin diluted in Hank’s 
Buffered salt solution (HBSS) for 60 minutes at RT. Afterwards, the coating solution was 
removed and the slides were washed with 300 µl of sterile H2O. The laminin coated plates 
were allowed to dry for 45’ in between at RT. Finally, the plates were incubated with PBS 
containing 0.5% bovine serum albumin (BSA) for 30’ to block uncoated binding sites of the 
plates and then washed with sterile H2O again.  
Coated plates were stored under sterile conditions at 4°C. 
 
3.1.3 Preparation of Reelin/GFP conditioned medium 
 
For most of the experiments mentioned below, the U87 and U251 cells were stimulated by a 
conditioned medium that was produced by HEK 293T cells synthesizing either the 
extracellular protein Reelin or the green fluorescent protein (GFP) as a control.  
For 2D migration assays, 2 x 10
6
 HEK 293T cells expressing Reelin or GFP were seeded 
three days prior to the experiment in complete DMEM and incubated overnight in a 
humidified atmosphere at 37°C and 5% CO2. The next day, the medium was replaced by 
complete CO2 independent medium and cells were incubated for another 48h. On the day of 
the assay, the supernatant was collected and centrifuged at about 200 x g for 4’ to remove 
remaining HEK cells. Then 9 ml of this conditioned medium were collected and used for the 
assay. 
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For 3D invasion assays, complete medium 10% FCS w/o phenolred (see chapter 2.12.4) was 
applied instead of the complete CO2 independent medium. For immunochemistry, complete 
medium 5% FCS (see chapter 2.12.5) was used. 
 
3.2 Molecular biological methods 
3.2.1 RNA isolation 
 
To examine the expression of specific genes via polymerase chain reaction (PCR), it is 
necessary to isolate RNA from the cells that shall be analyzed. Total RNA was isolated using 
the RNeasy Mini Kit according to the manufacturer’s protocol. Therefore an amount of 
approximately 5 x 10
6
 cells was harvested from a plate and lysed in 600 µl of the delivered 
RLT buffer supplemented with β-mercaptoethanol diluted 1:100. Subsequently, genomic 
DNA (gDNA) was sheared by centrifugation through a Quiashredder column for 2’ at 9500 x 
g and isolated RNA was collected in a tube. Then a mix of RNA and 600 µl of 70% ethanol 
was prepared, added to a Spin Column and centrifuged for 1’ at 9500 x g. The flow through 
was discarded. Then, the RNA was washed by applying 350 µl of RW1 buffer and 
centrifuging for 1’ at 9500 x g. After that, remaining DNA was removed by incubation with a 
mix of 10 µl of DNAse and 70 µl of RDD buffer for 15’ and centrifugation with 350 µl of 
RW1 buffer for 1’ at 9500 x g. Then, RNA was washed two times with 500 µl of RPE buffer 
(1’ at 9500 x g) eluted by applying two times 50 µl of RNAse free water (1’ at 9500 x g). 
Finally, the yield and the purity of the collected RNA were measured using a NanoDrop2000. 
 
3.2.2 cDNA synthesis 
 
The following procedure provides the oligonucleotides needed for PCR applications by 
converting RNA templates into complementary DNA (cDNA). For cDNA synthesis the 
SuperScript II Kit by Invitrogen was used following the manufacturer’s protocol.  
 
 
For each RNA sample a mix of  
Total RNA (1 µg)      x µl 
Random Hexamer Primer pd(N) (250 ng/µl)  1 µl 
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dNTPs (10 mM)      1 µl 
RNAse free dH2O      add to a volume of 12 µl 
was incubated at a temperature of 65°C for 15 minutes to denature RNA secondary structures. 
Afterwards, the reaction was chilled on ice.  
Then  
5 x First Strand buffer     4 µl 
0.1 M DTT       1 µl 
RNAsin Plus       1 µl 
were added, followed by incubation for 2’ at RT.  
Finally, 1 µl of SuperScript Reverse Transcriptase was added and conversion of RNA into 
cDNA was performed at 42°C for 50´. The reaction was inactivated by incubating at 70°C for 
15’. Eventually, the samples were stored at -20°C. 
 
3.2.3 Real-time quantitative PCR 
 
This method is used to accurately analyze the amount of gene expression via amplifying 
specific nucleic acid fragments in a sample of cDNA. For this study, the accumulation of the 
PCR product was measured by quantifying the fluorescence of SYBR Green I, a dye capable 
of intercalating with double-stranded DNA (dsDNA). SYBR Green I only shows fluorescence 
(wavelength 520 nm) after having bound dsDNA and being stimulated by blue light 
(wavelength 497 nm) (Sigma-Aldrich 2015, Zipper et al. 2004). The master mix reaction per 
well was composed as shown in Table 2. Information on the primers used is given in Table 3. 
 
Table 2: Master mix for real-time quantitative PCR.  
 
Reagent Volume per well 
SYBR Green I 12.5 µl 
H2O 6 µl 
Primer forward (diluted 1:10) 0.75 µl 
Primer reverse (diluted 1:10) 0.75 µl 
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Table 3: Primer sequences used for real-time quantitative PCR. 
 
Target Primer Sequences 
ARF1 Primer forward  GAC CAC GAT CCT CTA CAA GC 
 Primer reverse  TCC CAC ACA GTG AAG CTG ATG 
RELN Primer forward  GGG GAT CCA CTG TGA GAC AA 
 Primer reverse  AAA TGT TGT CCA GTG CCC AC 
 
20 µl of the final master mix and 5 µl of 1:20 diluted cDNA were pipetted into a 96 well 
plate, using three technical replicates per sample. Then expression levels were analyzed by a 
StepOnePlus Real-time PCR system using the following cycling conditions: 
 
Denaturation    95.0°C  2’ 
Denaturation   95.0°C  5’’ 
Annealing/Elongation 60.0°C  15’’ 
+ melt curve  
 
The StepOnePlus system detects the cycle at which the amount of fluorescence exceeds a 
certain threshold and plots it logarithmically. This threshold cycle (Ct) correlates to the 
quantity of cDNA targeted by the primers, as the amount of SYBR Green I bound to dsDNA 
increases. To measure the relative expression in the samples tested, the 2
-ΔΔCt
 method was 
applied (Livak & Schmittgen 2001). To calculate the ΔCt, the Ct of a housekeeping gene, here 
ADP ribosylationfactor-1 (ARF1; GenBank-Accession-No.: M36340.1), is subtracted from 
the Ct of the target gene. Afterwards, the relative expression of the target gene is related to a 
control to define ΔΔCt of the samples as follows: ΔΔCt = ΔCt, sample - ΔCt, control. To inverse the 
logarithmic values, the formula 2
-ΔΔCt
 was used, resulting in the relative expression of the fold 
changes of the analyzed target gene. 
 
40 cycles 
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3.3 Protein biochemistry 
3.3.1 Western blotting 
3.3.1.1 Cell lysis 
For analysis of protein abundance by western blotting, the cultured cells have to be lysed in a 
suitable buffer. Therefore, approximately 150.000 cells were seeded into a Ø 15 mm tissue 
culture dish and incubated for 48 h in complete medium for U87 respectively U251 in a 
humidified atmosphere at 37°C and 5% CO2. Afterwards, cells were washed with ice cold 
PBS and lysed by using 150 µl of Radio Immuno Precipitation Assay (RIPA) lysis buffer with 
added Phospatase and Protease Inhibitor Cocktail and kept strictly on ice. Finally, the lysed 
cells were collected in a tube and stored at -80°C. The lysates were processed as fast as 
possible in order to keep protein and phosphorylation degradation at a minimum. 
 
3.3.1.2 SDS - Polyacrylamide Gel casting 
The following tables show the material composition of separating gels containing 15%, 10% 
and 8% acrylamide and of the stacking gel. The volumes are adapted for two gels using Bio-
Rad casting stands. Gels with a concentration of 15% SDS were used for proteins considered 
to have a lower molecular weight (~30 kDa); consequently, proteins with a higher molecular 
weight (~125 kDa) were analyzed on an 8% SDS gel. 
 
Table 4: SDS – Polyacrylamide separating gels. 
 
Chemical/solution 15% Gel 10% Gel 8% Gel 
H2O 2.5 ml 4.17 ml 4.83 ml 
Acrylamide 5.0 ml 3.33 ml 2.67 ml 
Lower Gel buffer 2.5 ml 2.5 ml 2.5 ml 
APS 75 µl 75 µl 75 µl 
TEMED 7.5 µl 7.5 µl 7.5 µl 
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Table 5: SDS – Polyacrylamide stacking gel. 
 
Chemical/solution Volume 
H2O 3.74 ml 
Acrylamide 0.78 ml 
4x Upper Gel buffer 1.5 ml 
APS 30 µl 
TEMED 7.5 µl 
 
3.3.1.3 Phos-tagTM SDS - Polyacrylamide Gel casting 
Phosphate binding Tag
TM
 (Phos-tag
TM
) is a molecule capable of capturing phosphomonoester 
dianions bound to serine, threonine and tyrosine residues. Phosphorylated proteins show 
slower migration of bands in SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) with 
polyacrylamide bound Phos-tag
TM
 compared to the corresponding dephosphorylated protein 
(Kinoshita et al. 2006). 
The composition of Phos-tag
TM
 SDS-Polyacrylamide gels is the same as for normal 
polyacrylamide gels as described above, except for adding 50 µl of each Phos-tag
TM
 D and 
Phos-tag
TM
 E solution to the mixture of the separating gel.  
 
3.3.1.4 SDS - Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE is a common tool to separate proteins by their molecular weight and is based on a 
modified protocol of the Laemmli method (Laemmli 1970).  
For SDS-PAGE, 150 µl of the protein lysates (as prepared in chapter 3.3.1.1) were diluted in 
50 µl of 4x Laemmli-buffer and mixed by using a 1 ml syringe and a 20G x 1.5'' needle to 
remove gDNA. Afterwards, the lysates were kept in a heating block at 70° C for about 3’ to 
denature remaining protein structures and finally, 28 µl of the samples were applied to the 
gels. As a molecular weight marker, 5 µl of MagicMark
TM
 Western Protein Standard (Life 
Technologies) were used. Running of the gels was performed at a constant voltage of 80 V for 
30’ (stacking gel) followed by 140 V for 60’-70’ (separating gel), depending on the 
polyacrylamide concentration of the gels.  
Then the protein was transferred onto a nitrocellulose membrane by using a semi-dry or a 
wet-tank blotting procedure as described below. 
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3.3.1.5 Semi-dry western blotting 
The semi-dry western blotting method was applied for all SDS-PAGE gels, except for Phos-
tag
TM
 gels (see below), and performed as follows:  
Two whatman papers were soaked with anode I buffer, another one was incubated in anode II 
buffer and three more in cathode buffer. Before assembling the blotting sandwich as shown in 
the figure below in a Fastblot B44 (Biometra), the nitrocellulose membrane was wetted with 
anode II buffer and the gel containing the separated proteins was washed briefly in cathode 
buffer. 
 
 
 
The proteins were transferred from the gel onto a nitrocellulose membrane using a constant 
current of 150 mA over a period of 60’ and subsequently, the transfer was confirmed with 
Ponceau S for 5’. 
 
3.3.1.6 Wet-tank transfer 
Proteins from Phos-tag
TM
 gels were transferred onto a nitrocellulose membrane according to 
the subsequent protocol using a wet-tank blotting method: 
Directly after gel electrophoresis, the separating gel was washed for 10’ in a solution of 
Towbin containing 10 mM EDTA, being followed by three more washing steps of 4’ using 
Figure 11: Sandwich for semi-dry western blotting. Taken from (Schulze M 2014). 
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pure Towbin buffer. For blotting, four whatman papers were equilibrated in Towbin buffer 
and assembled together with a nitrocellulose membrane and the separating gel in a Fastblot 
B44 (Biometra) as shown in the figure below.  
 
 
The proteins were transferred using a constant current of 150 mA over a period of 60’.  
 
3.3.1.7 Detection of proteins after western blotting 
After protein transfer to nitrocellulose, the membrane was blocked using Blotto buffer for 60’ 
followed by incubation in primary antibody overnight at 4°C. The primary antibodies were 
diluted 1:10’000 (Tubulin [Clone DM1A]) or 1:1’000 (all other primary antibodies) using the 
antibody dilution buffer (see chapter 2.12). The next day, the membrane was washed three 
times in TBS-T for 2’ and then the secondary antibody, either anti-rabbit or anti-mouse IgG 
linked to horseradish peroxidase diluted 1:10,000 in Blotto buffer, was added to the 
membranes and incubated for 90’ at RT. 
To visualize the primary antibodies bound to the target protein, the membranes were washed 
in TBS-T and incubated in horseradish peroxide substrate (HRP) containing luminol and 
peroxide solution for 2’. Chemiluminescence was detected using the ImageQuant LAS 4000 
mini. For standard protein detection the SuperSignal West Pico Substrate was used. To reveal 
weak bands due to low protein expression (especially P-Kip1/P-p27) the SuperSignal West 
Femto Maximum Sensitivity Substrate was preferred.  
For sequential detection with the same nitrocellulose membrane, HRP activity linked to the 
secondary antibody was irreversibly inhibited by applying a PBS solution containing 15% of 
Figure 12: Sandwich for wet-tank protein transfer. Modified from (Schulze M 2014). 
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H2O2 for 30’. After washing with TBS-T for four times, the inactivation was completed and 
incubation with primary antibodies could be conducted again. 
For quantification of protein expression, the signal intensities acquired with the ImageQuant 
LAS 4000 mini were measured using the ImageQuant TL software. Values were normalized 
to EV + GFP cells. 
For Phos-tag
TM
 western blotting, the phosphorylation ratio is easily calculated by using the 
intensities of the phosphorylated (P-protein) and unphosphorylated protein as follows:  
 
         
             
  
         
                                  
 
 
3.3.2 Immunocytochemistry and F-actin staining 
 
Immunocytochemical assays deliver data on cytomorphological changes additionally to 
information on altered protein expression levels.  
Laminin coated Lab-Tek II Chamber Slide 8 wells (see chapter 3.1.2) and Reelin/GFP 
conditioned medium containing 5% FCS for stimulation as prepared under chapter 3.1.3 were 
used for the immunocytochemical assays. 
 
3.3.2.1 Cell seeding 
 
Cells were trypsinized as usual, then resuspended in complete medium with 5% FCS and 
adjusted to 142 cells /µl. Afterwards, the wells of the Lab-Tek Slide were filled with 140 µl of 
Reelin or GFP conditioned medium containing 5% FCS and about 10,000 cells were seeded 
by adding 70 µl of the cell suspension. Before starting the staining procedure, cells were 
allowed to adhere overnight.  
 
3.3.2.2 Staining 
 
After incubation overnight, the cells were washed briefly with PBS and then fixed 
immediately with 12 ml of prewarmed 4% PFA at room temperature for 15’. Cells were 
washed again with PBS for 5’ and then 12 ml of blocking buffer were applied for 1 h to 
permeabilize the cell membranes. From this step on, the slides were kept in a wet chamber in 
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the dark. Then, cells were washed two times with PBS containing 0.3% of the detergent 
saponin for 5’ each and stained overnight using 150 µl of the primary antibody P-Cofilin 
diluted 1:50 in antibody dilution buffer. The next day, cells were washed three times with 
PBS + 0.3% saponin and then the secondary antibody Fluorescein anti-rabbit IgG diluted 
1:200 and Phalloidin 555 diluted 1:50 for staining of actin filaments were applied for 2 h at 
room temperature. The slides were washed again two times with PBS containing 0.3% 
saponin and then counterstained with DAPI at a concentration of 2 µg/ml for 5’. Afterwards, 
the slides were washed two times with pure PBS and then visualized with the fluorescence 
microscope Olympus BX61 for quantitative analysis at 40x magnification and with a Leica 
AF-6000 for high magnification imaging at 63x magnification.  
 
3.3.2.3 Automated image analysis 
 
For analysis of immunocytochemistry at least 50 cells per condition (normally about 70) were 
evaluated in each of three independent experiments using the open-source software 
CellProfiler (Carpenter et al. 2006).  
CellProfiler can accurately identify nuclei and cell edges and is capable of differentiating 
between crowded cells, thus being an effective tool for image analysis.  
For this work, DAPI stained nuclei were used for identification of primary objects and 
afterwards the outlines of a cell surrounding a nucleus were detected using the P-Cofilin 
stained fluorescence images. Figure 13 exemplarily displays the steps taken in CellProfiler to 
identify the glioblastoma cells. The threshold methods applied for U87 and U251 were 
identical except for minor adjustments concerning the allowed diameter of objects. 
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Besides cell detection, CellProfiler also delivers numerous ready-to-use modules for 
quantitative measurements like analysis of fluorescence intensity or evaluation of cell shape 
and size. In the case of this doctoral thesis, a parameter called ‹Form Factor› was obtained for 
each cell condition to analyze potential effects that Reelin and DAB1 might have on the 
morphology of glioblastoma cells. The form factor, also known as shape factor or 
‹Circularity›, measures the roundness of objects. This figure is calculated as  
        
          
  
and lies between 0 and 1, with 1 describing a perfect circle and values much less than 1 the 
shape of a star. The perimeter is determined as the length of the boundaries of an identified 
object. 
To investigate further on the expression of the Reelin/DAB1 signaling downstream targets, the 
average fluorescence intensities per cell of actin and P-Cofilin were measured for each cell 
line using another standard module of CellProfiler. 
 
Figure 13: Identification of primary (nuclei) and secondary objects (cells) in CellProfiler. CellProfiler’s algorithms are 
effectively detecting nuclei (B) in the DAPI raw image (A). Once these primary objects are identified, the software can spot 
cell edges surrounding the nuclei in the P-Cofilin stained raw image (C) and succeeds at distinguishing clumped cells as seen 
on the left side and in the upper and lower right corners of (D). 
B 
C 
A 
D 
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3.4 2D migration assay  
 
The study of cell migration is of great importance to understand features of malignant cancers 
and can often give further clues towards underlying biological processes.  
For the 2D migration assays, 8 well µ-Slide ibiTreat plates with fibronectin- or alternatively 
laminin-coating were used (see chapter 3.1.2). The cancer cells were stimulated with 
Reelin/GFP conditioned CO2 independent medium as prepared under chapter 3.1.3.  
 
3.4.1 Cell seeding 
 
First, the cells were trypsinized as usual, resuspended in complete CO2 independent medium 
and then adjusted to 60 cells per µl, taking care that only single cells were present. 
Afterwards, 200 µl of Reelin or GFP conditioned medium were filled into each of the wells 
and finally 100 µl of the cell suspensions containing about 6’000 cells were added and mixed 
by pipetting. Ahead of starting the time lapse experiment, cells were allowed to adhere for 6 
h.  
 
3.4.2 Cell tracking 
 
Cell motility was analyzed using a Leica AF-6000 (Leica Microsystems) microscope and a 
microscope stage incubator to keep the temperature at 37°C. Pictures were taken every 20’ 
over a period of 12 h.  
At least 50 randomly chosen cells from each condition were tracked using ImageJ (Schneider et 
al. 2012) and the Manual Tracking plugin (Cordelières F 2011). Immotile cells and cells that 
divided during the observation period were excluded from tracking. Immotile cells were defined 
as cells that did not migrate more than one cell perimeter during the observation period. 
To analyze these tracks, the Chemotaxis and Migration Tool by ibidi® was used. This 
software measures the accumulated distance d and then calculates the two parameters velocity 
and directionality. The accumulated distance d is the sum of the travelled distances (d1, d2, …, 
di) of a cell between the first time t0 and the last time ti. The velocity is the accumulated 
distance d divided by the total time: velocity = d/t. The directionality is calculated by dividing 
the distance from origin D through the accumulated distance d: directionality = D/d. The 
distance from origin is measured according to Figure 14.  
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Figure 14: Calculation of the accumulated distance (d1, d2, d3,…) and the distance from origin (D) for cell migration 
analysis. Taken from (Schulze M 2014).  
 
3.5 Transwell invasion assay 
 
Besides the migration assay (see chapter 3.4), a classical invasion assay was used to extend 
our knowledge on the effects of Reelin/DAB1 signaling on motility of glioblastoma cells. For 
this experiment, growth factor reduced matrigel-coated transwell chambers with 8 μm pores 
were used in a 24-well plate format. As preparation, 600’000 glioblastoma cells were 
precultured 72 h prior to the assay in Ø 6 cm culture dishes. Reelin and GFP conditioned 
medium was prepared as explained under chapter 3.1.3 with phenolred-free complete DMEM 
containing 0.5% FCS. 
 
3.5.1 Cell seeding  
 
On the day of the experiment, the Corning BioCoatᵀᴹ transwells were thawn for 20’ and 
rehydrated with 500 µl of DMEM w/o phenolred for both the insert and the well over a period 
of 2 h according to the manufacturer’s protocol. For seeding, cells were trypsinized as usual, 
resuspended in 0.5% FCS complete medium and adjusted to 2 x 10
5
 cells per ml. Then this 
suspension was further diluted 1:1 using Reelin or GFP conditioned medium, resolving in a 
concentration of 1 x 10
5
 cells per ml. Subsequently, 750 µl of Reelin or GFP conditioned 
medium containing 5% FCS, which was obtained by equally mixing 10% FCS DMEM and 
conditioned medium with 0.5% FCS, were put into the well. Eventually, 500 µl of the 
prepared cell suspension, corresponding to about 5 x 10
4
 cells, were pipetted carefully into 
each matrigel coated transwell chamber using two technical replicates per condition and 
experiment. Then the seeded cells were incubated at 37°C and 5% CO2 for 18 h, allowing 
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them to migrate through the matrigel and the 8 μm pore following the gradient from 0.5% to 
5% FCS. 
 
3.5.2 Cell staining and computer-based analysis 
 
After incubation, the non-invading cells were removed from the upper side of the transwell 
and cells that migrated successfully through the pores were fixed in 4% PFA for 15’ at room 
temperature. Then, nuclei were stained in PBS containing DAPI in a concentration of 2 µg/ml 
and 0.3% of the detergent Triton X-100 for permeabilization of cell membranes. Finally, the 
stained cells were washed briefly in pure PBS and the membranes were cut out from the 
culture inserts and mounted onto microscopy glass slides.  
Afterwards, the cells were visualized at 20x magnification using an Olympus IX81 
fluorescence microscope. Each membrane was divided into four equal parts of which three 
were chosen randomly to take a picture of. Finally, the cells were counted automatically for 
each condition tested applying the built-in method «Analyze Particles…» of ImageJ.  
 
3.6 Data analysis 
 
All graphs and all statistical analysis shown in this doctoral thesis were created with either 
Microsoft Office Excel 2007 or GraphPad Prism 4 including t-test analyses, calculation of the 
standard error of the mean (SEM) and the standard deviation as a statistical parameter. The t-
test is a statistical hypothesis test that was performed to determine if two sets of data are 
significantly different from each other, given the null hypothesis that both means are the same 
and assuming a normal distribution. The p-value is a measure for the probability that this null 
hypothesis is true. P-values of < 0.05% (*) and < 0.01% (**) were considered as statistically 
significant. 
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4 Results 
4.1 Reelin induced DAB1 phosphorylation in U87 and U251 
glioblastoma cell lines 
 
To study the effects of Reelin on migration, invasion, cell morphological changes and on 
protein expression, it was necessary to verify whether Reelin is capable of activating DAB1 in 
glioblastoma cells. Therefore, the presence of Reelin/DAB1 signaling in glioblastoma cells 
was tested by analyzing DAB1 phosphorylation levels. 
As for all the other experiments, Reelin, biosynthesized by HEK 293T cells, was used to 
stimulate U87 and U251 cells, which were transfected with wildtype DAB1 or an inactive 
DAB1 mutant as explained in chapter 2.7.  
 
4.1.1 Reelin produced by HEK 293T  
 
As a first step, it was controlled if the HEK 293T cells stably transfected with a vector 
encoding for the murine RELN gene (mRELN) were indeed biosynthesizing Reelin. Hence, a 
real-time polymerase chain reaction (PCR) was performed to analyze the relative expression 
of Reelin in HEK cells transfected with mRELN (HEK + mRELN) compared to control cells 
treated with a vector containing the green fluorescent protein (GFP) gene (HEK + GFP). 
Primers specific for the murine RELN gene were used. As a reference, the housekeeping gene 
ARF1 was used. Expression of Reelin was barely detectable in HEK + GFP cells whereas the 
expression of Reelin is about 10
7
 to 10
8
 times higher in HEK + mRELN cells than in control 
cells (see Figure 15).  
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4.1.2 DAB1 phosphorylation in U87/U251 cells 
 
As described in chapter 2.7.2, a set of three different stably transfected glioblastoma cells of 
the U87 and the U251 cell lines was used for the experiments: Firstly, transfection with an 
empty vector (U87/U251 EV) was performed to generate control cells that express only 
endogenous DAB1. Secondly, to analyze the effects of Reelin/DAB1 signaling, cells stably 
overexpressing DAB1 (U87/U251 DAB1) were established. Finally, as a second control, cells 
were transfected with a gene encoding for the DAB1 5F (U87/U251 5F) mutant that cannot be 
phosphorylated through Reelin as the typical phosphorylation sites are changed from tyrosine 
to phenylalanine. To validate DAB1 expression on protein level, protein lysates of these cells 
were examined via western blotting using an anti-DAB1 antibody (see Figure 16 (A) for U87 
and (C) for U251). In U87 glioblastoma cells (A), a main band at approximately 60 kDa can 
be identified in cells overexpressing DAB1 (DAB1, lanes 3 and 4) as well as for DAB1 5F 
mutant cells (5F, lanes 5 and 6). In EV cells (lanes 1 and 2) this band cannot be detected.  
For the U251 cell line (C), these findings are similar except for the loss of the band at 60 kDa 
in DAB1 cells (lanes 3 and 4). Instead, a signal at a lower apparent molecular weight of about 
45 kDa below and also a signal above at >120 kDa with slower electrophoretic mobility is 
Figure 15: Real-time PCR data of relative expression of Reelin in control (HEK + GFP) and transfected 
HEK cells (HEK + mRELN). As a reference, the housekeeping gene ARF1 was used (n = 2). Shown are 
arithmetic mean and +/- SEM.  
The expression of Reelin is about 107 to 108 times higher in HEK + mRELN cells than in control cells (HEK + 
GFP). 
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found, when compared to EV and 5F cells. These bands are also present in U87 DAB1 cells 
but are not found in any of the EV or 5F cells.  
Besides protein analysis with the anti-DAB1 antibody, phosphorylated DAB1 was also 
detected with anti-Phospho-DAB1 antibody (P-DAB1) (see Figure 16 (B) for U87 and (D) for 
U251). To examine DAB1 phosphorylation, cells were stimulated with control (GFP) or 
Reelin-containing (mRELN) HEK-cell supernatant and western blots were incubated with an 
antibody specific for the phosphorylation site Y220 of DAB1. The amino-acid Y220 is 
mutated to phenylalanine in 5F mutant cells. A single band at approximately 60 kDa is found 
for U87 cells overexpressing DAB1, when stimulated with Reelin (DAB + mRELN, lane 4). 
In U251 cells showing overexpression of DAB1, a protein at approximately 45 kDa is detected 
by the anti-Phospho-DAB1 antibody in both GFP and mRELN stimulated cells. In addition, a 
less intensive band in DAB1 + mRELN (lane 4) can be detected at about 60 kDa. 
Furthermore, there is another signal found at 60 kDa with low intensity in U251 for 5F + GFP 
and mRELN, respectively (lanes 5 and 6).  
Further explanation of the observed bands in western blotting can be found in the discussion 
of this doctoral thesis (see chapter 5.1). 
A 
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B 
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Figure 16: Analysis of DAB1 (DAB1) and phosphorylated DAB1 (P-DAB1) by western blotting in human 
glioblastoma cells. Transfected U87 (A, B) and U251 (C, D) cells were incubated with a control supernatant (GFP) or 
Reelin-containing supernatant (mRELN). The cell lysates (EV: empty vector, DAB1: overexpression of DAB1 and 5F: 
DAB1 mutant without phosphorylation sites) show different responses to Reelin stimulation.  
(A) U87 cell lysates analyzed with anti-DAB1 antibody: A signal at about 60 kDa is detected for both DAB1 and 5F cells. 
Additional signals are found at >120 kDa and 45 kDa for the DAB1 cell line. 
(B) U87 cell lysates analyzed with anti-Phospho-DAB1 antibody: DAB1 cell lysates that were previously incubated with 
Reelin (DAB1 + mRELN) show a band at about 60 kDa and another less intensive one at approximately 45 kDa. 
(C) U251 cell lysates analyzed with anti-DAB1 antibody: DAB1 cells show a signal at about 45 kDa and at >120 kDa. A 
less intensive band can be detected around 60 kDa. 5F cells exhibit a very strong signal at about 60 kDa. 
(D) U251 cell lysates analyzed with anti-Phospho-DAB1 antibody: A band is detected in DAB1 + mRELN at about 45 
kDa and less intensive bands can be found in DAB1 + GFP (at approximately 45 kDa) and in 5F cells (at about 60 kDa). 
 
 
 
4.2 Analysis of migration under the influence of Reelin/DAB1 
signaling 
 
To analyze the migratory phenotype of the glioblastoma lines U87 and U251 after 
manipulation of the Reelin/DAB1 signaling pathway, cell motility was measured on both 
fibronectin and laminin after treatment with either Reelin (mRELN) or control supernatant 
(GFP). For this assay, the same set of transfected cells as for the DAB1 protein expression 
analysis was used. Glioblastoma cell motility was evaluated based on the two parameters 
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velocity and directionality. These values are complemented by an exemplary plot featuring 
the cell tracks for each condition of one experiment.  
Briefly summarized, it is a reoccurring finding throughout this whole series of experiments 
that cells which are overexpressing DAB1 and are stimulated by Reelin (DAB1 + mRELN) 
show the lowest velocities compared to all other conditions, whereas the highest velocities are 
observed in EV + GFP and 5F + GFP cells. As a general difference between both 
glioblastoma cell lines it can be found that U87 cells show higher velocities with about 0.7 
µm/min opposed to U251 cells with 0.3 µm/min at maximum.  
The following subchapters will give more detailed information on the results of each 
experiment. 
 
4.2.1 Fibronectin 
 
Firstly, the migratory behavior of U87 and U251 glioblastoma cells on fibronectin-coated 
plates was observed via analysis of the parameters velocity and directionality. Additionally, 
exemplary plots of the corresponding cell tracks are given below (see Figure 17).  
As can be seen in (A) and (B), neither Reelin stimulation nor overexpression of wildtype 
DAB1 changes the directionality of U87 and U251 cells on fibronectin.  
Graphs (C) and (D), however, show that velocity is changed due to mRELN stimulation 
and/or DAB1 overexpression:  
For U87 glioblastoma cells on fibronectin, a significant decrease of velocity can be found in 
Reelin stimulated 5F cells (5F + GFP vs. 5F + mRELN: p = 0.0153, two-tailed t-test, n = 3) 
(see Figure 17 (C)). Additionally, a nearly significant reduction of speed can be found in 
control medium stimulated DAB1 cells compared to 5F cells (DAB1 + GFP vs 5F + GFP: p = 
0.0531, two-tailed t-test, n = 3). Finally, mRELN stimulated EV and DAB1 cells also show 
reduced velocities compared to stimulation with GFP, but a statistically significant change 
cannot be detected for these conditions. Overall, U87 cells overexpressing DAB1 show the 
lowest velocities when stimulated with Reelin (DAB1 + mRELN).  
Figure 17 (D) shows that the velocity of U251 cells overexpressing DAB1 (DAB1 + GFP, 
DAB1 + mRELN) is significantly lower than in the control cells EV and 5F (DAB1 + GFP vs. 
EV + GFP: p = 0.0468, two-tailed t-test, n = 3, DAB1 + GFP vs. 5F + GFP: p = 0.0372, two-
tailed t-test, n = 3). However, there is no major effect of Reelin on the velocity in all of the 
tested cells compared to control medium (GFP).  
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The exemplary plots in Figure 17 (E + F) are visualizing the results of the analyses above in a 
different manner. It can be observed that cells are equally migrating to the left (black) and to 
the right side (red). In accordance with the reduced velocities found in cells overexpressing 
DAB1 or being stimulated by mRELN medium, less scattered and more compact tracks can be 
found in these plots compared to EV or 5F cells that were treated with control medium. 
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4.2.2 Laminin 
 
Besides fibronectin, the migratory behavior of U87 and U251 glioblastoma cells was observed 
on laminin-coating via analysis of the parameters velocity and directionality. Additionally, 
exemplary plots of the corresponding cell tracks are given below (see Figure 18).  
As for fibronectin, neither Reelin nor DAB1 are significantly altering the directionality (see 
Figure 18 (A) and (B)), but again the diagrams for velocity (C) and (D) show multiple 
significant changes in U87 and U251.  
For U87 cells on laminin, Figure 18 (C), a highly significant reduction of cell motility, 
independently of mRELN, is found for cells overexpressing DAB1, if compared to EV and 5F 
cells (DAB1 + GFP vs. EV + GFP: p = 0.0016, two-tailed t-test, n = 3, DAB1 + GFP vs. 5F + 
GFP: p = 0.0153, two-tailed t-test, n = 3). At the same time, a decrease of speed can be found 
for both EV and DAB1 mutant 5F cells under stimulation with mRELN (EV + GFP vs. EV + 
mRELN: p = 0.0166, two-tailed t-test, n = 3, 5F + GFP vs. 5F + mRELN: p = 0.0555, two-
tailed t-test, n = 3). In contrast, Reelin treatment of DAB1 expressing cells (DAB1 + mRELN) 
does not significantly alter the velocity compared to stimulation with a control supernatant 
(DAB1 + GFP). 
Similar results can be found for U251 glioblastoma cells on laminin as is presented in graph 
(D). Again, a significant decrease of velocity, which is found independently of Reelin, can be 
seen for DAB1 cells (DAB1 + GFP vs. EV + GFP: p = 0.0214, two-tailed t-test, n = 3, DAB1 
+ GFP vs. 5F + GFP: p = 0.0312, two-tailed t-test, n = 3). Contrary to U87, there is no 
Figure 17: Analysis of glioblastoma cell directionality and velocity on fibronectin for U87 and U251 cells (n = 3). 
Exemplary tracks of U87 and U251 for each condition. Shown are arithmetic mean and +/- SEM. 
(A) Quantification of directionality of U87 cells in a 2D migration experiment on fibronectin: No significant changes 
were observed after DAB1 overexpression or Reelin stimulation (two-fold t-test). 
(B) Quantification of directionality of U251 cells in a 2D migration experiment on fibronectin: No significant changes 
were observed after DAB1 overexpression or Reelin stimulation (two-fold t-test). 
(C) Quantification of velocity of U87 cells in a 2D migration experiment on fibronectin: A significant decrease of 
velocity can be found for 5F cells under Reelin stimulation opposed to control medium (5F + GFP vs. 5F + mRELN: p = 
0.0153, two-fold t-test). A nearly significant reduction is found for control medium stimulated DAB1 cells compared to 5F 
cells (DAB1 + GFP vs 5F + GFP: p = 0,0531, two-fold t-test). A remarkable, yet not significant, decrease can also be seen 
for EV and DAB1 cells after Reelin stimulation, compared to GFP. 
(D) Quantification of velocity of U251 cells in a 2D migration experiment on fibronectin: The velocity of DAB1 cells is 
significantly reduced compared to EV and 5F cells (DAB1 + GFP vs. EV + GFP: p = 0.0468, two-fold t-test, DAB1 + GFP 
vs. 5F + GFP: p = 0.0372, two-fold t-test). No significant changes can be found for cells after Reelin stimulation. 
(E) Rose plots for U87 cells in a 2D migration experiment on fibronectin: Cells are equally migrating to the left and to 
the right. The plot of DAB1 + mRELN shows a more compact configuration than plots of the other conditions. 
(F) Rose plots for U251 cells in a 2D migration experiment on fibronectin: Cells are equally migrating to the left and to 
the right. The plots of DAB1 + GFP respectively DAB1 + mRELN show a more compact configuration than plots of the 
other conditions. 
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significant influence of Reelin compared to control supernatant in any of the tested U251 
cells, however, small changes of velocity in EV, DAB1 and 5F cells can still be observed.  
Figure 18 (E) + (F) display exemplary tracks for all experimental conditions and are 
combining the results for both directionality and velocity. It can be observed that cells are 
equally migrating to the left (black) and to the right side (red). In accordance with the reduced 
velocities found in cells overexpressing DAB1 (DAB1 + GFP and DAB1 + mRELN), less 
scattered and more compact tracks can be found in these plots compared to EV or 5F cells that 
were treated with control medium.  
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4.3 Influences of the Reelin/DAB1 pathway on cell invasion  
 
To pursue the findings obtained in the migration assay, the invasive behavior of the same set 
of cells was examined in a matrigel invasion assay. Matrigel is a protein mixture consisting 
mainly of structural proteins such as laminin, entactin, collagen and heparan sulfate 
proteoglycans to simulate a natural cellular environment (Hughes et al. 2010). 
 
The ability to migrate through Matrigel was analyzed for U87 (n = 2) and U251 (n = 1) 
glioblastoma cells (see Figure 19). Empty vector cells stimulated with control medium were 
used as a reference. As can be seen in (A), U87 cells that are overexpressing DAB1 show the 
lowest amount of invading cells when treated with Reelin (DAB1 + mRELN), as the number 
of cells is reduced to about 60% compared to the EV + GFP condition. Additionally, DAB1 
cells under stimulation with control medium (DAB1 + GFP) also show a decreased amount of 
cells to approximately 80%. In contrast, the capability of 5F mutant cells to migrate through 
Matrigel is increased since the amount of cells was three times higher for 5F + GFP, 
respectively two times higher for 5F + mRELN, than for EV + GFP cells. Finally, also EV 
cells stimulated with mRELN medium exhibit a 1.5-fold higher number of cells that migrated 
through the invasion chambers. None of the alterations described above were statistically 
significant. 
 
In contrast to U87 cells, U251 cells (B) overexpressing the 5F mutant of DAB1 show the 
lowest amount of invading cells as the number of cells is reduced to about 30% for both, 
Figure 18: Analysis of glioblastoma cell directionality and velocity on laminin for U87 and U251 cells (n = 3). Exemplary 
tracks of U87 and U251 for each condition. Shown are arithmetic mean and +/- SEM. 
(A) Quantification of directionality of U87 cells in a 2D migration experiment on laminin: No significant changes were 
observed after DAB1 overexpression or Reelin stimulation (two-fold t-test). 
(B) Quantification of directionality of U251 cells in a 2D migration experiment on laminin: No significant changes were 
observed after DAB1 overexpression or Reelin stimulation (two-fold t-test). 
(C) Quantification of velocity of U87 cells in a 2D migration experiment on laminin: A highly significant reduction of 
velocity is observed for cells overexpressing DAB1, if compared to the control cells EV and 5F (DAB1 + GFP vs. EV + GFP: p 
= 0.0016, two-fold t-test, DAB1 + GFP vs. 5F + GFP: p = 0.0153, two-fold t-test). Velocity is also significantly decreased in 
both EV and 5F cells after Reelin stimulation (EV + GFP vs. EV + mRELN: p = 0.0166, two-fold t-test, 5F + GFP vs. 5F + 
mRELN: p = 0.0555, two-fold t-test), whereas no such alterations can be found for DAB1 cells. 
(D) Quantification of velocity of U251 cells in a 2D migration experiment on laminin: A significant decrease of velocity 
can be seen for DAB1 cells compared to EV and 5F (DAB1 + GFP vs. EV + GFP: p = 0.0214, two-fold t-test, DAB1 + GFP vs. 
5F + GFP: p = 0.0312, two-fold t-test). However, U251 cells do not show significant changes after stimulation with Reelin. 
(E) Rose plots for U87 cells in a 2D migration experiment on laminin: Cells are equally migrating to the left and to the right. 
The plots of DAB1 + GFP and DAB1 + mRELN show a more compact configuration than plots of the other conditions. 
(F) Rose plots for U251 cells in a 2D migration experiment on laminin: Cells are equally migrating to the left and to the 
right. The plots of DAB1 + GFP, respectively DAB1 + mRELN show a more compact configuration than plots of the other 
conditions. 
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stimulation with and without, Reelin. Additionally, glioma cells expressing DAB1 deliver 
results similar to EV cells and Reelin stimulation does not affect the number of cells that 
migrated through Matrigel in any of the tested conditions. 
Table 6 and Table 7 show the standard deviations as a percentage of the arithmetic mean for 
each condition of an exemplary experiment. The mean value refers to the number of cells 
counted on the bottom of the invasion chambers. A variation up to 30 or 40% (below: green, 
above: red) is generally accepted as a reliable finding for this experiment. As can be seen, 
these criteria were not always satisfyingly achieved, especially not for U251 5F cells. 
However, preliminary experiments with self-coated invasion chambers for U251 cells gave 
results that hinted towards the same direction with a reduced amount of 5F cells that were 
capable of migrating through Matrigel (data not shown).  
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Figure 19: Matrigel invasion analysis of U87 and U251 cells. The number of cells that were able to migrate through 
Matrigel is given relatively to that of EV + GFP cells.  
(A) U87 Invasion assay (n = 2): The number of cells counted on the bottom of the invasion chambers is reduced to about 
80% for DAB1 + GFP and 60% for DAB1 + mRELN. For 5F + GFP and 5F + mRELN the number of cells is threefold, 
respectively twofold the number of EV + GFP. EV + mRELN cells exhibit a 1.5-fold higher number of cells than EV + GFP. 
Here, the arithmetic mean and +/- SEM of both experiments are shown. None of these changes are statistically significant. 
(B) U251 Invasion assay (n = 1): The ability of 5F cells to migrate through Matrigel is reduced to about 30% compared to 
that of EV + GFP. DAB1 cells show similar numbers of cells counted on the bottom of the invasion chambers as found for 
EV cells. Here, the amount of cells normalized to EV + GFP and +/- SEM within this one experiment is given. None of these 
changes are statistically significant. Preliminary experiments with self-coated chambers showed similar results (data not 
shown). Therefore only one experiment using factory-coated chambers was performed here. 
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Table 6: Standard deviations of each experimental condition in U87 cells, presented as a percentage of the arithmetic 
mean (Sd %). Green: below 40%. Red: above 40%. 
 
 
Table 7: Standard deviations of each experimental condition in U251 cells, presented as a percentage of the arithmetic 
mean (Sd %).  Green: below 40%. Red: above 40%. 
 
 
4.4 Analysis of the cytoskeleton under the influence of 
Reelin/DAB1 signaling 
 
Migrating cells show multiple cellular alterations compared to non-migrating cells of which 
probably the most crucial ones have implications for the cytoskeleton. As an influence of 
Reelin/DAB1 signaling on the actin cytoskeleton has already been published and the own 
preceding experiments already confirmed an effect of both Reelin and DAB1 on the migratory 
behavior of glioblastoma cells, an analysis of the actin cytoskeleton via immunocytochemistry 
was performed on laminin coating. Additionally, the levels of phosphorylated cofilin, a 
downstream target of Reelin/DAB1 signaling that is capable of controlling actin conversion 
(Chai et al. 2009, Kruger et al. 2010), were determined.  
Firstly, the total levels of filamentous actin were detected. The signal intensities are given 
relatively to empty vector cells under treatment with control medium (EV + GFP). 
Furthermore, the ‹Form Factor› was calculated, a figure between 0 and 1 characterizing the 
morphology of a cell as rather a star (0) or a perfect circle (1). By the means of high 
magnification pictures (see Figure 21 and Figure 22), the intracellular array of actin, 
particularly the formation of stress fibers or the development of membrane ruffling, was 
analyzed. Stress fibers are contractile actin bundles that play an important role in a number of 
cellular functions like cell adhesion and motility (Hall 1998). Membrane ruffles, on the other 
hand, are an indicator of inefficient lamellipodia adhesion and represent compartments of 
U87 EV + GFP EV + mRELN DAB1 + GFP DAB1 + mRELN 5F + GFP 5F + mRELN 
Mean 164.83 192.33 95.67 83.67 324.67 286.83 
Sd % 56.95 38.28 37.07 29.56 39.88 36.45 
U251 EV + GFP EV + mRELN DAB1 + GFP DAB1 + mRELN 5F + GFP 5F + mRELN 
Mean 420.50 495.50 414.17 373.17 144.17 153.50 
Sd % 33.62 21.63 38.16 32.41 69.00 88.25 
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actin reorganization (Borm et al. 2005). Therefore, alterations in both membrane ruffling and 
formation of stress fibers are hinting at changes in migratory behavior.  
The levels of phosphorylated cofilin (P-Cofilin) were quantified via immunocytochemical 
detection as well as via protein analysis in western blotting using the Phos-tag
TM
 SDS-PAGE 
method (see chapter 3.3.1.3). The findings are given relatively to EV + GFP. Applying this 
special western blotting technique, a second band showing a lower electrophoretic mobility 
can be observed. It was shown that this retarded band is cofilin that was phosphorylated at 
serine3 (Kinoshita et al. 2006, Schulze et al. 2016).  
 
4.4.1 Analysis of the actin cytoskeleton  
 
The immunocytochemical experiments of this doctoral thesis revealed that neither the levels 
of actin nor the ‹Form Factor› (B) and (D) is changed in U87 and U251 glioblastoma cells 
overexpressing DAB1 compared to EV or 5F cells (see Figure 20). In addition, these 
parameters are not altered after Reelin stimulation. 
The exemplary high magnification pictures of U87 (Figure 21) and U251 (Figure 22) are 
intended to give a further overview on the morphology and especially on the formation of 
stress fibers and membrane ruffles in these glioblastoma cells. The pseudocolor blue is 
indicating the DAPI stained nucleus, filamentous actin in turn is stained red via AlexaFluor® 
555 phalloidin. Qualitative analysis showed that the ruffling activity is particularly high in 
U87 cells for all conditions. In contrast, U251 cells present primarily with formation of stress 
fibers which can be particularly observed in 5F cells, (E) and (F), and less pronounced in EV 
and DAB1 cells, (A) to (D). Additionally in U251, the 5F mutant glioblastoma cells are also 
showing membrane ruffling at several of their cell protrusions, whereas the other cells are 
barely exhibiting membrane ruffles.  
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Figure 20: Quantification of actin levels and cell morphology (Form Factor) in glioblastoma cells. The levels of actin 
are given relatively to the levels measured in EV + GFP cells (n = 3). Shown are arithmetic mean and +/- SEM. 
No significant changes were observed after DAB1 overexpression or Reelin stimulation (two-fold t-test).  
(A) Quantification of actin levels in U87. 
(B) Quantification of the Form Factor in U87. 
(C) Quantification of actin levels in U251. 
(D) Quantification of the Form Factor in U251. 
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A B 
C D 
E F 
U87 
Figure 21: U87 high magnification images.  
The cellular anatomy of U87 is primarily dominated by membrane ruffling that can be observed throughout all experimental 
conditions.  
(A) EV + GFP. 
(B) EV + mRELN. 
(C) DAB1 + GFP. 
(D) DAB1 + mRELN. 
(E) 5F + GFP. 
(F) 5F + mRELN. 
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A B 
C D 
E F 
U251 
Figure 22: U251 high magnification images.  
U251 cells exhibit primarily formation of stress fibers which can be particularly observed in 5F cells (E and F) and less 
pronounced in EV and DAB1 cells (A – D). Additionally, ruffling of the cell membrane can be seen in 5F cells, whereas the 
other cells do barely show membrane ruffles. 
(A) EV + GFP. 
(B) EV + mRELN. 
(C) DAB1 + GFP. 
(D) DAB1 + mRELN. 
(E) 5F + GFP. 
(F) 5F + mRELN. 
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4.4.2 Analysis of the P-Cofilin to Cofilin ratio 
 
The levels of phosphorylated cofilin were analyzed for U87 and U251 cells in an 
immunocytochemical assay using an anti-P-Cofilin antibody and in western blotting using an 
anti-Cofilin antibody detecting phosphorylation via Phos-tag
TM
. Additionally, two exemplary 
blots of both U87 and U251 are given (see Figure 23). The upper band in these blots is 
phosphorylated cofilin (P-Cofilin), exhibiting slower electrophoretic mobility, whereas 
unphosphorylated cofilin is found at a lower apparent molecular weight, showing enhanced 
electrophoretic mobility. The P-Cofilin to Cofilin ratio is easily calculated by using the 
intensities of phosphorylated and unphosphorylated cofilin as follows:  
 
         
             
  
         
                                  
 
 
A statistically significant effect could be found for U87 DAB1 cells after Reelin stimulation in 
the immunocytochemical experiment, as Phospho-Cofilin levels are about 20% higher than 
when compared to stimulation with control medium (DAB1 + GFP vs. DAB1 + mRELN: p = 
0.0296, two-fold t-test, n = 3) or compared to EV and 5F cells. There was no statistically 
significant difference between U251 glioblastoma cells in this assay (B), but the levels of 
phosphorylated cofilin are increased to about 25% (DAB1 + GFP) and approximately 15% 
(DAB1 + mRELN) above those of EV and 5F cells.  
In Phos-tag
TM 
western blotting, no changes could be detected in the lysates of neither U87 nor 
U251 as the graphs (C) and (D) show.  
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Figure 23: Analysis of P-Cofilin to Cofilin ratio via immunocytochemistry and via Phos-tagTM western blotting in U87 
and U251 (n = 3). Shown are arithmetic mean and +/- SEM. 
(A) Quantification of P-Cofilin levels in U87 cells via immunocytochemistry: Cells overexpressing DAB1 show 
statistically significant changes of phosphorylated cofilin after Reelin stimulation (U87 DAB1 + mRELN vs. U87 DAB1 + 
GFP: p = 0.0296, two-fold t-test).  
(B) Quantification of P-Cofilin levels in U251 cells via immunocytochemistry: No statistically significant changes can be 
observed (two-fold t-test), but elevated levels of phosphorylated cofilin are observed independently of Reelin stimulation for 
cells overexpressing wildtype DAB1.  
(C) Quantification of P-Cofilin levels in U87 cells via Phos-tagTM western blotting: No statistically significant changes 
can be observed (two-fold t-test). 
(D) Quantification of P-Cofilin levels in U251 cells via Phos-tagTM western blotting: No statistically significant changes 
can be observed (two-fold t-test). 
(E) and (F) Representative Phos-tagTM western blots of U87 and U251 lysates with anti-Cofilin antibody: The upper 
band is corresponding to phosphorylated cofilin (P-Cofilin) and the lower band to unphosphorylated cofilin. P-Cofilin and 
unphosphorylated cofilin are equivalent to total cofilin levels. 
4.5 Analysis of downstream targets in Reelin/DAB1 signaling 
 
Another aim of this doctoral thesis was to discover further downstream targets of 
Reelin/DAB1 signaling in glioblastoma cells that might mediate the migratory phenotype 
found in the other experiments.  
Prior to the experiments of this doctoral thesis, U87 cells were screened for potential 
downstream targets of Reelin/DAB1 signaling by performing a proteome profiler array of 
Reelin stimulated DAB1 cells that provided multiple phosphoproteins of which Kip1 (also 
known as p27) and STAT3 (Signal Transducer and Activator of Transcription 3) appeared as 
potential targets. To verify this finding, western blot analysis of these proteins was performed. 
For both proteins, Kip1 and STAT3, the levels of the phosphorylated form (T198 for Kip1 
and Y705 for STAT3) and the total levels of this protein were measured allowing detection of 
altered protein expression or degradation (see Figure 24 and Figure 25).  
Furthermore, the phosphorylation of the focal adhesion kinase (FAK) was analyzed. This 
protein is commonly modulated in migrating cells including glioblastoma cells due to its 
important role in cell-matrix interaction (Riemenschneider et al. 2005). Only levels of 
phosphorylated FAK were quantified here.  
Finally, the levels of total tyrosine phosphorylation were measured using the 4G10 antibody.  
However, none of the phosphoproteins analyzed showed significant and reproducible changes 
in response to Reelin or DAB1 (see Figure 24 to Figure 27). The values of intensity presented 
are given relatively to empty vector cells treated with control medium (EV + GFP).  
No statistically significant changes in any of the experiments described above were found. 
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Figure 24: P-Kip1 (P-p27) (A), total level of Kip1 (p27) (B) and P-Kip1 to Total Kip1 Ratio (C) in U251 cells (n = 3). 
Shown are arithmetic mean and +/- SEM. 
No statistically significant changes can be observed (two-fold t-test). 
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Figure 25: P-STAT3 (A), total level of STAT3 (B) and P-STAT3 to total STAT3 Ratio (C) in U87 cells (n = 3). Shown 
are arithmetic mean and +/- SEM. 
No statistically significant changes can be observed (two-fold t-test). 
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Figure 27: Total tyrosine phosphorylation level (4G10) in U87 (n = 2).  
No statistically significant changes can be observed (two-fold t-test). 
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Figure 26: Phosphorylation level of the focal adhesion kinase (FAK) in U87 (n = 2).  
No statistically significant changes can be observed (two-fold t-test). 
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5 Discussion 
 
Reelin/DAB1 signaling is known as a crucial regulator for brain development during 
embryogenesis by preventing neuronal migration in the neocortex (Honda et al. 2011). 
Moreover, Reelin and DAB1 also act as tumor suppressors in various human cancers e.g. 
hepatocellular carcinoma, breast cancer, pancreatic cancer or esophageal cancer (Okamura et al. 
2011, Sato et al. 2006, Stein et al. 2010, Yuan et al. 2012). However, the relevance of 
Reelin/DAB1 signaling in diffusely infiltrating astrocytic gliomas like the glioblastoma (WHO 
grade IV) was largely unknown until now. From the experiments of this doctoral thesis it can be 
concluded that Reelin and DAB1 both influence glioma cell migration and might bear tumor 
suppressive functions in gliomas. 
Reelin and DAB1 are up to date known for a large number of physiological molecular 
interactions. Furthermore, data indicates that influence of Reelin/DAB1 signaling on integrins 
might have an important role in glioblastomas. Among others, α3β1 integrin (also known as 
laminin receptor) and α5β1 integrin (also called fibronectin receptor) might be of importance for 
the results found in the experiments of this work. It is known that binding of Reelin to α3β1 
integrin can lead to inhibition of neuronal migration during brain development and is capable of 
modulating intracellular levels of DAB1 (Dulabon et al. 2000). Furthermore, Reelin can activate 
α5β1 integrin through an inside-out signaling mechanism that includes DAB1. This pathway 
improves neuronal adhesion to fibronectin (Sekine et al. 2012). Results of this doctoral thesis 
show that both Reelin and DAB1 are significantly influencing the migratory behavior of U87 and 
U251 cells on fibronectin and on laminin in a tumor suppressive manner. More interestingly, it 
was also possible to differentiate between DAB1-dependent and -independent effects that Reelin 
had on glioblastoma cells, which will be further explained below. 
In addition, reorganization of the cytoskeleton via phosphorylation of cofilin (Chai et al. 2009, 
Kruger et al. 2010) or modulation of N-WASP (Suetsugu et al. 2004) might serve as downstream 
targets that may mediate inhibition of tumor cell migration found after activation of Reelin/DAB1 
signaling. 
 
In summary, the results of this doctoral thesis strongly suggest tumor suppressive functions of 
Reelin/DAB1 signaling in high-grade gliomas. The executed experiments of this work have 
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definitely identified Reelin and DAB1 as novel players in the regulation of glioblastoma cell 
migration (see chapter 5.2.1 for more detailed information).  
 
5.1 Reelin stimulation induces DAB1 phosphorylation in 
glioblastoma cells 
 
For almost all the experiments of this doctoral thesis, the two cell lines U87 and U251, 
derived from primary glioblastoma tumor patients, were used. Both of these cell lines are well 
established for transfection and functional analyses as performed for this work. Despite their 
origin and classification as WHO grade IV tumors (Beckman et al. 1971, Torsvik et al. 2014), 
these cell lines behaved very differently under certain conditions, due to their unique genetic 
aberrations and their distinctive protein expression.  
 
5.1.1 DAB1 levels in glioblastoma cell lines U87 and U251 
 
The analyses of the DAB1 protein levels in U87 and U251 (see chapter 4.1.2) show that 
Reelin is capable of properly phosphorylating DAB1 in these glioblastoma cell lines.  
Cells that were transfected with an empty vector (EV) did not show any detectable DAB1 
band as the endogenous protein expression of DAB1 is rather low in both U87 and U251 cells. 
Cells transfected with DAB1 or 5F mutant DAB1, by contrast, showed a signal at the expected 
molecular weight of DAB1 around 65 kDa. In U87 cells overexpressing DAB1, additional 
bands at 45 kDa and at >120 kDa can be found, which seem to be most likely a degradation 
product of DAB1 or, respectively, polyubiquitinated DAB1. Both of these modified proteins 
can still be bound by the anti-DAB1 antibody. Detection of these proteins indicates that in 
these cells DAB1 is successfully phosphorylated which leads to proteasomal degradation 
(Arnaud et al. 2003). Since no such protein bands could be found in 5F cells, evidence is 
given that this mutant cannot be phosphorylated and also cannot be activated. 
Interestingly, the pattern of bands appears differently in U251 cells that are overexpressing 
DAB1 compared to the ones of U87 cells. The band at 65 kDa, which is supposed to be the 
full length DAB1 protein, was much weaker than in U87, but enhanced signals were found for 
the potential degradation product of DAB1 and for polyubiquitinated DAB1. As this could be 
observed independently of Reelin stimulation, these findings suggest that a large amount of 
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DAB1 protein is already phosphorylated through alternative signaling mechanisms in U251 
leading very likely to a higher basal activation level of DAB1. The transmembrane proteins 
VLDLR and ApoER2 (upstream of DAB1) are not only bound by Reelin but are receptors for 
a large amount of ligands. Among others, the ligand Thrombospondin-1 (THBS1, HGNC ID: 
11785), a glycoprotein that influences tumorigenesis via mediating cell-cell and cell-matrix 
interactions, might explain these results observed in U251 glioblastoma cells. It was shown 
that Thrombospondin-1 leads to phosphorylation of DAB1 in neurons (Blake et al. 2008) and, 
additionally, previous work of our laboratory revealed that Thrombospondin-1 is expressed in 
U251 but not in U87 cells (Data raised by Sabine Hoja). Besides all this, a cell type specific 
activation of DAB1 through SRC family tyrosine kinases (Bock & Herz 2003), through other 
still unknown tyrosine kinases or due to tumor specific aberrations of the U251 genome may 
also provide possible explanations found for this phenotype.  
 
5.1.2 Reelin induced DAB1 activation levels in U87 and U251 
 
It is known that extracellular Reelin is capable of inducing DAB1 phosphorylation in neurons 
during embryogenesis by binding to the VLDL receptor or the ApoE lipoprotein receptor 2 
(Hiesberger et al. 1999). Data of this work clearly proves that Reelin is also inducing this 
cascade in U87 and U251 cells (see chapter 4.1.2). In U87, only cells that show 
overexpression of DAB1 respond to stimulation with Reelin-containing medium in terms of 
revealing elevated levels of Tyr220 phosphorylated DAB1. Likewise, U251 cells that are 
transfected with DAB1 and stimulated by Reelin exhibit highest levels of activated DAB1, but 
in contrast, remarkable levels of phosphorylated DAB1 can also be observed without Reelin. 
This finding supports again the hypothesis that DAB1 could already be phosphorylated 
otherwisely, leading to constitutively active Reelin/DAB1 signaling in U251 as opposed to 
U87.  
In western blots of U251 cells that were performed with anti-Phospho-DAB1 antibody 
(Y220), very slight bands around 65 kDa can be found in 5F cells, although the mutant DAB1 
protein in these cells should not be able to be phosphorylated per definition. As there are no 
other signals detected in 5F cells, particularly no bands that correspond to polyubiquitinated 
or degraded DAB1, these signals are most likely due to only minor unspecific binding of the 
antibody. It is rather improbable that these bands might correspond to endogenous DAB1 as 
no similar signal was detected in EV cells. 
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5.2 Reelin/DAB1 preferentially reduces cell migration in 
glioblastoma cells 
 
The test design of six conditions (EV + GFP, EV + mRELN, DAB1 + GFP, DAB1 + 
mRELN, 5F + GFP, 5F + mRELN) used for the experiments of this doctoral thesis made it 
possible to efficiently distinguish between the effects of Reelin and DAB1 on glioblastoma 
cells. A distinction can be made between cellular phenotypes that are mediated through DAB1 
independently of Reelin (DAB1 + GFP), characteristics that are communicated by Reelin 
independently of DAB1 (EV + mRELN and 5F + mRELN) and between effects that are a 
combination caused by interaction of both proteins in terms of direct activation of DAB1 
through Reelin (DAB1 + mRELN). 
 
5.2.1 Cell migration 
 
The results of the cell migration assay presented in chapter 4.2 clearly show that Reelin/DAB1 
signaling has a significant impact on the motility of both U87 and U251 cells. These results 
also suggest that the activation of DAB1 through Reelin is rather less important compared to 
the effects that each of these proteins itself exerts on reduction of cell migration. Furthermore, 
experiments proved that the results obtained here are clearly dependent on the cell type and, 
to a lesser extent, also dependent on the extracellular environment (fibronectin or laminin). 
Considered more specifically, for U87 on fibronectin, a significant effect on cellular motility 
is observed in cells that express the 5F DAB1 mutant when treated with Reelin, suggesting a 
strong influence of Reelin independently of DAB1 on cell migration. Nonetheless, data also 
shows that DAB1 independently of Reelin is reducing cell motility to values that are nearly 
significant. However, cells that are treated with Reelin and are overexpressing DAB1, only 
show little reduction of cell migration, proposing that Reelin/DAB1 interaction has a rather 
minor role compared to Reelin and DAB1 themselves. 
 
For U87 cells on laminin, nearly similar results as on fibronectin can be found. Again, an 
effect of Reelin independently of DAB1 but also influences of DAB1 independently of Reelin 
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were observed in the assays. Furthermore, interplay of Reelin and DAB1 did not have any 
effect on migration of U87 cells. 
In the U251 cell line, significant changes can only be found for DAB1 independently of Reelin 
on both fibronectin and laminin. Neither Reelin alone nor the interaction of Reelin and DAB1 
are significantly reducing migration in these cells. As mentioned above, the VLDLR and 
ApoER2 ligand Thrombospondin-1, expressed only by U251 and not by U87 cells, might 
cause this finding. However, other alternative molecular interactions leading to elevated levels 
of phosphorylated DAB1 might serve as a possible explanation for results found in this assay. 
Since Reelin barely effects the migration of these cells, but, on the other hand, a significant 
change of cell motility is observed in cells overexpressing the DAB1 protein, it appears 
plausible that DAB1 is already activated in U251 cells. These findings are in accordance with 
the results obtained in western blotting with anti-DAB1 and anti-Phospho-DAB1 antibodies as 
explained in chapter 5.1. Nonetheless, it remains unclear which biochemical mechanisms 
cause constitutive activation of DAB1 in U251, but by identifying an upregulated expression 
of Thrombospondin-1 in these cells a reasonable explanation was found.  
Besides Reelin and Thrombospondin-1, other ligands of the VLDLR and ApoER2, e.g. 
clusterin and ApoE might influence the changes of migratory behavior observed here. 
Clusterin, also known as apolipoprotein J, is a glycoprotein with broad tissue distribution and 
capable of triggering Reelin-like signaling via phosphorylation of DAB1 in neurons (Leeb et 
al. 2014). In addition, Apolipoprotein E, which is carrying cholesterol and phospholipids is a 
very common ligand for lipoprotein receptors like VLDLR and ApoER2 and is important for 
neuronal synaptogenesis. Apart from this, Apolipoprotein E might also be influencing 
Reelin/DAB1 signaling due to its receptor affinity (Boyles et al. 1989, Herz & Chen 2006). 
 
Analysis of U251 cells on laminin (see chapter 4.2.2, Figure 18), revealed that there was a 
tendency to decreased cell migration for all tested cells (EV, DAB1 and 5F) after Reelin 
treatment that might be obscured by the influences of DAB1. Modulation of the laminin 
receptor (α3β1 integrin) and inhibition of neuronal migration via Reelin independently of 
DAB1 phosphorylation might be a plausible explanation here (Dulabon et al. 2000). 
Furthermore, a significant effect of Reelin independently of DAB1 was also found in U87 
cells on laminin. It therefore appears possible that the direct interaction of Reelin and α3β1 
integrin might be of importance for glioma cell migration.  
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With regards to the migration assay of U87 and U251 cells on fibronectin, latest research 
revealed that Reelin can activate the fibronectin receptor (α5β1 integrin) via an intracellular 
pathway that involves DAB1 as a signaling molecule leading to activation of neuronal 
adhesion (Sekine et al. 2012). The data raised in this doctoral thesis underlines that this 
signaling cascade might also play a role in gliomas, as U87 cells and U251 cells 
overexpressing DAB1, exhibited the lowest migratory velocities after Reelin treatment (see 
chapter 4.2.1, Figure 17 and Figure 18). The influences of Reelin via this pathway might be 
obscured due to the strong effect of DAB1 alone, especially in U251.  
In conclusion, it must be stated that the relationships in Reelin/DAB1 signaling are complex. 
They may be influenced by alternative ligand binding, extracellular matrix molecules and 
integrin receptors and other additional molecular factors yet unknown. 
 
Figure 28 is presenting the hypothetical pathways of Reelin/DAB1 signaling including α3β1 
and α5β1 integrin. Results of this work suggest that these molecular interactions are of 
notable importance for glioblastoma cell migration.  
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Figure 28: Hypothetical pathway of Reelin interacting with the laminin receptor (α3β1) (A) and of modulating the 
fibronectin receptor (α5β1) (B) in glioblastoma cells leading to decreased migration. Apart from Reelin, other ligands 
of the VLDL lipoprotein receptor (VLDLR) and the Apolipoprotein E receptor 2 (ApoER2), like Thromobospondin-1 
(THBS1), might influence this signaling pathway.  
(A) Laminin receptor (α3β1): Reelin is known to bind α3β1 integrin leading to upregulated expression of DAB1 in neurons 
(Dulabon et al. 2000). Data of this work suggests that similar mechanisms might cause inhibition of migration due to 
Reelin/DAB1 signaling in glioblastomas.  
(B) Fibronectin receptor (α5β1): It is known that Reelin can activate α5β1 integrin via intracellular phosphorylation of 
DAB1 in neurons (Sekine et al. 2012). Similar interactions might also lead to reduced cell migration in glioblastoma cells in 
response to Reelin/DAB1 signaling. 
 
A 
B 
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Briefly summarized, the migration assays showed that Reelin/DAB1 signaling is reducing 
migration indicating tumor suppressive functions for glioblastoma cells. However, data 
reveals that it is not necessarily a direct activation of DAB1 through Reelin that exerts the 
strongest influence on the phenotypes observed here. It is much more probable that both 
proteins exert individual and partly independent effects on cell motility that might include 
Reelin interactions with α3β1 and α5β1 integrins on the one hand and DAB1 activation 
through alternative ligand binding on the other hand. 
 
5.2.2 Matrigel invasion assay 
 
To pursue the promising results found for glioma cell migration on laminin and fibronectin, a 
Matrigel invasion assay was performed to study the behavior of U87 and U251 cells in a 3D 
environment after activation of the Reelin/DAB1 signaling pathway. However, opposed to the 
migration assay, only cell line specific effects could be observed in this assay. 
 
Chapter 4.3 and Figure 19 clearly show that Reelin and DAB1 have tumor suppressive 
functions for U87 in terms of reduced migration through matrigel. Here, the lowest amount of 
cells was counted for DAB1-overexpressing cells after Reelin treatment (DAB1 + mRELN). 
However, DAB1 alone without Reelin stimulation (DAB1 + GFP) already has nearly the same 
effect on U87 cells opposed to control cells, suggesting primarily an influence of DAB1 
independently of Reelin on cell invasion. The fact, that cells overexpressing the 5F mutant of 
DAB1 show values that are much higher than in DAB1 or EV cells, affirms this hypothesis. 
All of these results support the theory of Reelin/DAB1 being able to reduce invasion of U87 
glioblastoma cells. However, it can not be explained why Reelin seems to have some minor 
pro-invasive capabilities in empty vector cells as invasion was increased after Reelin 
stimulation (EV + mRELN).  
Opposed to U87 cells, the invasion assay for U251 shows a completely different result: Cells 
overexpressing the 5F mutant of DAB1 show drastically reduced invasive properties 
compared to EV and DAB1 cells. Additionally, preliminary experiments for U251 with self-
coated invasion chambers gave results that hinted towards the same direction exhibiting a 
reduced amount of 5F cells that were capable of migrating through Matrigel. If Reelin and 
DAB1 had the same tumor suppressive functions in U251 as for U87 cells, one would rather 
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expect decreased invasion for cells overexpressing the wildtype DAB1 than the inactive 5F 
mutant.  
A possible explanation for this finding might be that the complex protein mixture of Matrigel, 
containing mainly the structural proteins laminin, entactin, collagen and heparan sulfate 
proteoglycans (Hughes et al. 2010), is additionally triggering unknown signaling pathways in 
U251, other than in U87, causing the pro-invasive phenotype observed in 5F mutants. 
However, as mentioned before, the data raised for U251 has to be interpreted with caution as 
the standard deviations presented in Table 6 and Table 7 of chapter 4.3 are varying up to 88% 
especially in 5F cells whereas standard deviations up to only 30 or 40% are generally 
accepted as reliable. It appears that these glioblastoma cells might not be suitable for this kind 
of invasion assay or that further, very time-consuming adaptations of the protocol would be 
necessary to generate trustworthy results.  
 
Generally spoken, the extremely high standard deviations of this invasion assay are casting 
doubts upon the reliability of these experiments. In conclusion, a clear statement cannot be 
made whether Reelin/DAB1 signaling is reducing invasiveness of glioblastoma cells in 
general and further research is needed. However, at least for U87 cells, the invasion assay 
seems to point in a similar direction as the migration assays. Further research, implying other 
invasion assays or adaptations to the existing protocol are still necessary to accurately 
evaluate what kind of effects Reelin/DAB1 signaling has on glioblastoma cell invasion. 
 
5.2.3 Cofilin, actin cytoskeleton and other downstream targets 
 
As the results found in the migration assay suggest tumor suppressive functions of Reelin and 
DAB1, potential downstream targets that might mediate the effects of Reelin and DAB1 were 
examined.  
It is already known that Reelin/DAB1 signaling leads to activation of the LIM kinases 1 and 2 
which convert cofilin into a phosphorylated/inactive form in neurons. This inactive form is no 
longer capable of disassembling filamentous (F)-actin and is therefore promoting actin 
polymerization and cytoskeletal stability. As a consequence, actin turnover is suppressed and 
cell motility reduced (Chai et al. 2009, Kruger et al. 2010). 
For this doctoral thesis, the levels of phosphorylated/inactive cofilin were analyzed via both 
Phos-tag
TM
 western blotting and immunocytochemistry. Data suggests that the mechanism of 
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cofilin inactivation described above might also be present in glioblastoma cells, because a 
significant increase of phosphorylated cofilin was observed after Reelin stimulation for U87 
cells overexpressing DAB1. U251 cells overexpressing DAB1 also exhibited increased, yet not 
significant levels of inactive cofilin. However, these changes could only be found for the 
immunocytochemical assay where cells were cultured on laminin. For Phos-tag
TM
 western 
blotting, cells were cultured on uncoated dishes and no significant changes were detected. 
Probably, the extracellular matrix – in this case laminin – plays an important role as trigger 
for such molecular interactions. This finding emphasizes the relevance of integrins, like e.g. 
α3β1 or α5β1 integrin, for the function of Reelin/DAB1 signaling as it has already been 
explained in chapter 5.2.1.  
Nonetheless, the changes of phosphorylated cofilin observed here are rather minor alterations 
and do not exceed the values of control cells by more than 20 to 25%. Therefore, it appears 
probable that Reelin/DAB1 might also trigger different, unknown pathways which regulate the 
cytoskeleton and contribute to reduced cell migration. It is already known that Reelin is 
capable of inactivating the neuronal Wiskott-Aldrich syndrome protein (N-WASP) which 
should also stabilize the actin cytoskeleton and reduce the formation of filopodia (Tang et al. 
2013). 
 
Besides cofilin, also actin levels and cell morphology were examined via 
immunocytochemistry for this doctoral thesis. However, neither analyses of actin levels nor 
evaluation of cell morphological changes generated data that suggests connections between 
Reelin/DAB1 signaling and the actin cytoskeleton as a mediator for cell migration. 
These findings might suggest that the influence of Reelin/DAB1 signaling on cofilin and actin 
is of rather minor importance for migration of glioblastoma cells. On the other hand, new 
questions arise about the underlying mechanisms causing the tumor suppressive functions of 
Reelin and DAB1 in glioblastomas. Possibly, interaction of Reelin/DAB1 with microtubules 
through τ-protein might be important (Hiesberger et al. 1999). Additionally, in vitro analyses 
suggested that contraction of myosin II behind the nuclei and endocytosis of adhesion 
molecules just proximal to the cell somata are involved in neuronal migration (Schaar BT et 
al. 2005, Shieh JC et al. 2011). Similar molecular interactions might mediate the influences of 
Reelin and DAB1 on migration of glioblastoma cells, too. Studying such underlying 
biochemical mechanisms of Reelin/DAB1 signaling exceeded the scope of this doctoral thesis, 
thus further research is needed. 
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As far as the other analyzed downstream targets are concerned (Kip1/p27, STAT3, focal 
adhesion kinase and the overall tyrosine phosphorylation via the 4G10 antibody), none of 
these proteins showed significant changes in response to Reelin and DAB1. All of these 
western blots were performed using lysates of glioblastoma cells that had been cultured on 
uncoated dishes. As mentioned earlier, data of this doctoral thesis suggests that the functions 
of Reelin and DAB1 are linked to cell-matrix interaction. Probably, experiments should be 
repeated with laminin- or fibronectin-coated culture dishes.  
 
5.3 Conclusions 
 
This doctoral thesis analyzes the in vitro biochemical influences of Reelin/DAB1 signaling on 
migration and invasion of highly-malignant astrocytic tumors in vitro. The classical 
glioblastoma cell lines U87 and U251 were used here. This monography also makes a 
contribution to the understanding of further involved intracellular targets that mediate the 
effects of these signaling proteins on a molecular level. 
To sum up, the data raised within this doctoral thesis clearly demonstrates that Reelin and 
DAB1 both have tumor suppressive functions in terms of reducing migration of glioblastoma 
cells. However, results indicate that it is not necessarily only the direct activation of DAB1 
through Reelin but that both proteins, independently of each other, are capable of inhibiting 
migration. Additionally, data suggests that cell-matrix interactions probably via integrins 
might as well play a crucial role for the tumor suppressive functions of Reelin and DAB1.  
Despite numerous efforts, it remained uncertain through which downstream targets 
Reelin/DAB1 signaling mediates the phenotypical changes in glioblastomas observed in this 
doctoral thesis. Potential follow-up studies on this topic could imply investigation on 
signaling intermediates on laminin- or fibronectin-coated culture dishes. The research on 
Reelin/DAB1 signaling in glioblastomas will be continued by the research lab of the 
Department of Neuropathology at the University Hospital of Regensburg.  
 
Parts of this work were published in the research acrticle “RELN signaling modulates 
glioblastoma growth and substrate-dependent migration” in Brain Pathology on the 10th of 
January 2018 (Schulze et al. 2017). 
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6 Abstract 
 
The proteins Reelin and Disabled-1 (DAB1) are known to be key regulators in embryonal 
development of the central nervous system by controlling neuronal migration. Latest research 
revealed that Reelin/DAB1 signaling exhibits tumor suppressive functions in several cancers 
(e.g. hepatocellular carcinoma, breast cancer, esophageal cancer or pancreatic cancer), but 
until now, effects of Reelin and DAB1 on brain tumors were mostly unknown. As previous 
work of our laboratory indicated frequent epigenetic inactivation of Reelin in high-grade 
gliomas, research was pursued by examining the motility of glioblastoma cells in response to 
Reelin/DAB1 signaling.  
In the present doctoral thesis, migration and invasion of U87 and U251 cells, overexpressing 
either the intracellular protein DAB1 or the corresponding inactive 5F mutant, was analyzed 
after Reelin stimulation. Both, U87 and U251 cells, showed significantly reduced migration 
on fibronectin and laminin under the influence of Reelin and DAB1. Further data suggests that 
effects of DAB1-independent Reelin signaling, as e.g. on integrins (α3β1 and α5β1 integrin, 
for example), might contribute considerably to the tumor suppressive functions of this 
pathway. Besides this, also Reelin-independent DAB1 effects induced by other upstream 
mediators might play a major role in regulating glioblastoma invasion. Further experiments 
comprised matrigel invasion assays as well as the investigation of the underlying downstream 
targets of Reelin and DAB1. 
Taken together, Reelin and DAB1 were identified as novel players in the regulation of 
glioblastoma cell migration suggesting tumor suppressive functions of Reelin/DAB1 signaling 
in high-grade gliomas.  
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7 Deutschsprachige Zusammenfassung 
 
Die Proteine Reelin und Disabled-1 (DAB1) sind bekannt für ihren bedeutenden Einfluss auf 
die Migration von Neuronen während der embryonalen Entwicklung des zentralen 
Nervensystems. Neueste Untersuchungen zeigen, dass der Reelin/DAB1 Signalweg auch 
Tumor-supprimierende Wirkungen in zahlreichen Karzinomen, wie beispielsweise dem 
Mamma-, Ösophagus-, Pankreas- oder heptatozellulären Karzinom, aufweist. Dennoch ist die 
Bedeutung von Reelin und DAB1 für gliale Tumoren bis dato weitestgehend unbekannt. Da 
frühere Arbeiten unseres Labors eine epigenetische Inaktivierung von Reelin in hochgradig 
malignen Gliomen ergaben, wurden diese Ergebnisse durch Motilitäts-Analysen von 
Glioblastomzellen nach Modulation des Reelin/DAB1 Signalweges weitergehend funktionell 
untersucht. 
Die vorliegende Doktorarbeit untersuchte die Migration und Invasion von U87 und U251 
Glioblastomzellen, die entweder das intrazelluläre Protein DAB1 oder das inaktivierte 5F 
DAB1 überexprimierten. Die Experimente erfolgten ohne oder mit Stimulation durch Reelin. 
Sowohl U87, als auch U251 Zellen zeigten hier signifikant verminderte Migration auf 
Fibronektin und Laminin unter dem Einfluss von Reelin und DAB1. Darüberhinaus lassen 
unsere Daten erkennen, dass Reelin auch DAB1-unabhängige Effekte auf die Migration zeigt 
(z.B. durch α3β1 und α5β1 Integrin vermittelt). Außerdem ergaben sich auch Hinweise auf 
Reelin-unabhängige DAB1-Effekte auf die Migration, die z.B. durch alternative 
vorgeschaltete Mediatoren induziert werden. Weitere Experimente in dieser Doktorarbeit 
umfassen Matrigel-basierte Invasions-Assays und eine Analyse möglicher nachgeschalteter 
Moleküle im Reelin/DAB1-Signalweg. 
Zusammengefasst konnten Reelin und DAB1 im Rahmen dieser Doktorarbeit als neue 
Regulatoren der Migration in Glioblastomen nachgewiesen werden, was belegt, dass der 
Reelin/DAB1 Signalweg in hochgradig malignen Gliomen Tumor-supprimierende Funktionen 
besitzt. 
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Abstract
Glioblastoma (GBM) represents the most common and most malignant type of primary brain
tumor and signiﬁcantly contributes to cancer morbidity and mortality. Invasion into the
healthy brain parenchyma is a major feature of glioblastoma aggressiveness. Reelin (RELN)
is a large secreted extracellular matrix glycoprotein that regulates neuronal migration and
positioning in the developing brain and sustains functionality in the adult brain. We here
show that both RELN and its main downstream effector DAB1 are silenced in glioblastoma
as compared to non-neoplastic tissue and mRNA expression is inversely correlated with
malignancy grade. Furthermore, RELN expression is positively correlated with patient
survival in two large, independent clinically annotated datasets. RELN silencing occurs via
promoter hypermethylation as shown by both database mining and bisulﬁte sequencing of
the RELN promoter. Consequently, treatment with 50-Azacytidine and trichostatin A induced
RELN expression in vitro. On the functional level, we found RELN to regulate glioblastoma
cell migration both in a DAB1 (tyrosine phosphorylation)-dependent and -independent
fashion, depending on the substrate provided. Moreover, stimulation of RELN signaling
strongly reduced proliferation in glioblastoma cells. This phenotype depends on DAB1
stimulation by RELN, as a mutant that lacks all RELN induced tyrosine phosphorylation
sites (DAB1-5F) failed to induce a growth arrest. Proteomic analyzes revealed that these
effects are mediated by a reduction in E2F targets and dephosphorylation of ERK1/2. Taken
together, our data establish a relevance of RELN signaling in glioblastoma pathology and
thereby might unearth novel, yet unrecognized treatment options.
INTRODUCTION
Glioblastoma (GBM) represents the most common and most malig-
nant form of primary brain tumor. Despite an aggressive combina-
tion of surgery followed by radiochemotherapy and numerous
clinical trials on innovative treatment options, the overall improve-
ments achieved are moderate (45). Thus, the identiﬁcation of novel
molecules and signaling pathways involved in glioblastoma pathol-
ogy are urgently needed. A hallmark of glioblastoma malignancy is
the inﬁltration of tumor cells into the healthy brain parenchyma
that makes complete surgical resection of the tumor impossible.
Among others, integrins are believed to play a major role in this
context as they mediate the contact of the cells to the extracellular
matrix (ECM) (37). However, there are still many unanswered
questions regarding the development and regulation of the invasive
glioma phenotype.
The large secreted protein reelin (RELN) was discovered as a
regulator of neuronal migration in reeler mice. In these mice,
cortical neurons fail to reach their normal position in the cortex,
resulting in an inside out layering (19). RELN also has been shown
to regulate neural precursor cell cycle exit (25) and differentiation
(23). It inhibits signaling via integrins by directly disrupting the
binding of a3b1 integrin to laminin (14) and the binding of a5b1
integrin to ﬁbronectin in a DAB1-dependent manner (41). In addi-
tion, RELN mediates coﬁlin phosphorylation in neuronal cells (11)
with alterations in coﬁlin activity exerting strong effects on glioma
cell invasion (34). In the canonical signaling cascade, APOER2 and
VLDLR mediate the tyrosine phosphorylation of the intracellular
adaptor protein DAB1 through RELN binding. This phosphoryla-
tion event is catalyzed by SRC family kinases and reinforced by
phosphorylated DAB1 in a positive feedback loop (19). Impor-
tantly, kinases of the SRC family are well known as important play-
ers in tumorigenesis and attractive drug targets in glioblastoma (1),
connecting RELN signaling and tumorigenesis mechanistically.
Although primarily studied in post-mitotic neurons in the central
nervous system (CNS), both RELN and DAB1 are also expressed
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in a variety of tissues outside of the CNS (43). In a cancer context,
it has been shown that RELN is involved in the regulation of inva-
sion and proliferation of breast cancer (36, 44). Moreover, RELN
was found to inhibit both migration and invasion of pancreatic can-
cer cells (39). Silencing of reelin in these tumors (breast, pancreatic
and gastric cancer) occurred via hypermethylation of the CpG
island containing the RELN promoter (13, 39, 44). Of note, also
the DAB1 gene maps to a site frequently deleted in different
cancers (32).
In contrast to epithelial tumors, a role for RELN signaling has
not yet been implicated in brain tumors. In a single investigation
on gangliogliomas, transcriptional downregulation of DAB1 was
observed but the tumors lacked DAB1 mutations (21). Also,
the data on neuroblastoma, a peripheral tumor, are controversial
(4, 16). Another study reported decreased RELN expression in
various tumor types (including glioblastoma) by analyzing
TCGA data (9). This prompted us to follow up on the potential
tumor suppressive functions of DAB1 and RELN in gliomas.
Interestingly, it has been recently suggested that malignant glio-
mas can also originate from neural progenitors and/or differenti-
ated neurons (2, 17) and DAB1 as well as RELN have been
implicated in the regulation of neuronal differentiation (23, 35).
Therefore, it seemed likely that crossconnections between RELN
signaling and glioma pathology might exist.
MATERIALS AND METHODS
In silico analysis
Prenormalized expression datasets from glioblastoma samples and
matched clinical data were obtained from the cancer genome atlas
(7) data portal (URL: https://tcga-data.nci.nih.gov). In addition, a
second set of gene expression data was obtained from Rembrandt
(31) and downloaded via the array express database (URL:
http://www.ebi.ac.uk/arrayexpress, accession E-MTAB-3073). The
Rembrandt microarrays were RMA normalized and analyzed with
R ver. 3.2.1 and the affylmGUI package. Genome wide methyla-
tion (22, 46) data as well as the manufacturer’s annotation for each
CpG probe were obtained from the Gene Expression Omnibus
(GEO) Database (URL: http://www.ncbi.nlm.nih.gov/geo, acces-
sion GSE36278 and GSE60274, platform GEO accession
GPL13534). The GSEAPreranked module v5 for Gene set enrich-
ment analysis (47) was accessed from the gene pattern server
(URL: http://genepattern.broadinstitute.org) and GSEA was per-
formed with the fold changes as calculated by DESeq2.
Clinical samples
Thirty-ﬁve snap-frozen tumor samples were selected from the tumor
tissue collection of the Department of Neuropathology, Heinrich-
Heine-University, Duesseldorf, Germany and studied according to
protocols approved by the institutional review board. It was con-
ﬁrmed via standard histology that all samples had a tumor content
of at least 80%. Included were 12 primary glioblastomas WHO
grade IV (pGBM IV), 4 secondary glioblastomas WHO grade IV
(sGBM IV), 7 anaplastic astrocytomas WHO grade III (AA III) and
12 diffuse astrocytomas WHO grade II (A II). Classiﬁcation as sec-
ondary glioblastoma was based on the presence of a histologically
veriﬁed preceding lower grade astrocytic lesion. Non-neoplastic
brain control tissues were derived from four different individuals:
one from the temporal lobe of a 66-year-old male, one from the
occipital lobe of a 82-year-old female and two from cortex of a 76-
year-old male and a 72-year-old female, respectively. All non-
neoplastic tissues were surgical specimens (snap-frozen), three with
the clinical history of epileptic surgery, one with traumatic brain
injury. Extraction of DNA and RNA from frozen tumor tissue was
performed as has been described previously (38). The non-
neoplastic brain controls used for analysis of the mRNA expression
levels in glioma cell lines were commercially available total RNA
preparations derived from a 24-year-old male (BioChain, Newark,
CA, USA) and a 66-year-old female (Agilent Technologies, Santa
Clara, CA, USA).
cDNA synthesis and real-time PCR
cDNA was synthetized from 3 mg total RNA with the super script
II reverse transcriptase (Life Technologies, Carlsbad, CA) in a reac-
tion volume of 50 ml. cDNA of 12 ng was then used in a real-time
PCR performed with the Platinum SYBR green Kit (Life Technolo-
gies) in a StepOne Plus real-time PCR thermocycler (Applied
Biosystems, Foster City, CA). Initial incubation was performed at
958C for 10 minutes followed by 40 cycles of 958C for 10 s and
608C for one minute. Relative expression was calculated with the
DDCt method (29). All primer sequences used are provided in
Supporting Information Table 1.
Bisulfite sequencing
Bisulﬁte treatment was performed as previously described (38).
Bisulﬁte converted DNA of 100 ng was then ampliﬁed using a
HotStarTaq (Qiagen, Hilden, Germany) and the primer pairs indi-
cated in Supporting Information Table 1. PCR conditions are avail-
able on request. The ampliﬁed fragment is provided in Supporting
Information Fig. 1. Ampliﬁed DNA was puriﬁed with the Jet quick
kit (Genomed/Thermo Fisher, Waltham, MA) and processed for
Sanger sequencing on an ABI PRISMVR 377 machine (Applied
Biosystems).
Cell culture
Cell lines were cultured, obtained and characterized as has been
described previously (18) and cell line identity was conﬁrmed by
short tandem repeat analysis of 16 loci by CLS Cell Lines Services
(Eppelheim, Germany). After thawing, cells were passaged twelve
times or cultured for six weeks, respectively, at maximum. The
cells were all tested negatively for mycoplasma contamination by
PCR including positive and negative controls as has been described
by others (33). HEK293T cells expressing GFP or murine RELN
were kindly provided by Prof. Eckart F€orster (Ruhr University,
Bochum, Germany). Cell culture and 5-Aza-20-deoxycytidine and
trichostatin A treatment of glioblastoma cell lines were performed
as previously described (3, 18).
RELN production
HEK-293T cells expressing murine (m)RELN (or GFP as a con-
trol) (11) were seeded at a density of26000 cells/cm2 in complete
medium. After overnight incubation, the medium was exchanged to
fresh complete medium or starving medium (no FCS, 0.1% BSA).
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To remove serum remnants, the cells were washed once with the
starving medium. Then, the cells were allowed to grow and secrete
RELN for another 48 h. Afterwards, the supernatant was collected
and residual cells were removed by centrifugation at 200 3 g for 5
minutes. For experiments with the function blocking CR-50
antibody, a mouse isotype control IgG (#5415, clone G3A1; Cell
signaling technology, Danver, CO) or the CR-50 antibody (MBL,
Nagoya, Japan) were added at a ﬁnal concentration of 20 mg/ml.
Cloning and generation of stably transfected
cells
The ORF of human full length DAB1 in pCMV-Sport6 (Thermo
Fisher) was subcloned into the pIRESneo2 vector (Clontech, Palo
Alto, CA). As human and mouse DAB1 are identical on the protein
level within large parts of their N-terminus, the N-terminal portion
containing the murine 5F sequence (20) was cloned into the pIRES-
neo2 vector together with the C-terminus of human DAB1. This
resulted in a construct that is identical to a human DAB1-5F mutant
on protein level. For the establishment of stable cell lines, U87 and
U251 cells were seeded at a density of 7000 cells per cm2 on
Ø10 cm dishes (Sarstedt, Nuembrecht, Germany) and allowed to
grow for 48 h. Then, the cells were transfected with 1.5 mg pIRES-
neo2 empty vector (EV), hDAB1-WT//pIRES-Neo2 or hDAB1-
5F//pIRES-Neo2 with 12 ml of the transfection reagent Lipofect-
amine 2000 (Life Technologies). For the establishment of stably
transfected cells, G418 (Carl Roth, Karlsruhe, Germany) was added
to the medium at a concentration of 200 mg/ml (U87) to 400 mg/ml
(U251) and the cells were cultured for two weeks until resistant
cells emerged.
Plate coating for live cell imaging
Eight well m-slides (ibiTreat; Ibidi, Munich, Germany) were coated
with 5 mg/ml ﬁbronectin or 2 mg/ml laminin (all from Sigma-
Aldrich, St. Louis, Missouri) for 60 minutes. Then, the coating
solution was removed and the slides washed with sterile H2O. The
laminin coated plates were allowed to dry for 45 minutes at RT.
Finally, the plates were blocked with DPBS containing 0.5%
bovine serum album (BSA) for 30 minutes.
Two-dimensional-migration assay
Cells were seeded at a density of 6000 cells per cm2 on laminin or
ﬁbronectin coated 8 well m-slide dishes in CO2-independent
medium (Life Technologies) supplemented with 5% FCS, 2 mM
L-glutamine, 100 U/ml penicillin and 100 lg/ml streptomycin (Life
Technologies). Cells were allowed to adhere for 6 h, two volumes
of RELN or GFP conditioned CO2-independent medium were
added and afterwards cell motility was analyzed using a Leica
AF-6000 (Leica Microsystems, Wetzlar, Germany) microscope and
a microscope stage incubator to keep the temperature at 378C.
Pictures were taken every 20 minutes over a period of 12 h. At least
50 randomly chosen cells were tracked using ImageJ 1.47 (40) and
the manual tracking plugin. Immotile cells and cells that divided
during the observation period were excluded from tracking. To cal-
culate velocity and directionality, we imported the tracking ﬁles to
the chemotaxis and migration tool (Ibidi).
Proliferation assay
Cells per well of 1500 (U87) or 1000 (U251) were seeded on a
96-well plate in triplicates After 6 h, the medium was changed to
starving medium, another 100 ml GFP or RELN conditioned super-
natant was added and the cells were incubated at 378C and 5%
CO2. Every 24 h, three wells per condition were labeled with 1 mM
(ﬁnal concentration) Hoechst 33342 for 1 h. Then, four pictures
were taken with a low magniﬁcation (43) objective from randomly
chosen areas of the triplicate wells and analyzed with an automated
cell proﬁler pipeline (ver. 2.1.1) (8) to count the number of nuclei
present.
Cell cycle analysis
Cell cycle analysis was performed via propidium iodide staining.
After O/N starvation, cells were trypsinized and counted. Cells of
1 3 106 were ﬁxed in 70% precooled ethanol for 1 h on ice. The
cells were washed twice in DPBS, resuspended in staining mix
(ﬁnal concentration 50 mg/ml RNAseA, 40 mg/ml propidium iodide
and 0.05% saponin in DPBS) and incubated for 30 minutes at
378C. Then, the cells were analyzed on a FACS CantoII ﬂow
cytometer (Becton Dickinson) and gating as well as quantiﬁcation
was performed with ModFit LT v3.2 (Verity Software House,
Topsham, ME, USA).
Western blotting and detection of proteins
Western blotting was performed according to standard protocols.
For western blot analysis, 150 000 cells were seeded on Ø1.5 cm
tissue culture dishes (Sarstedt) and allowed to grow for 48 h.
Primary antibodies used were DAB1 (1:1000, #3328; Cell signal-
ing technology), p(Y220)-DAB1 (1:1000, #3327; Cell signaling
technology), caspase-3 and cleaved caspase-3 (1:1000, #14220,
clone D3R6Y; Cell signaling technology), p(S491)-DAB1
(ab5776, Abcam, Cambridge, UK) and tubulin as a loading control
(1:10 000, clone DM1A; Sigma-Aldrich, St. Louis, MO).
Anti-rabbit or anti-mouse IgG linked to horseradish peroxidase
(Santa Cruz, Dallas, Texas) were used as secondary antibodies
(1:10 000 dilution). After development with picoluminescence sub-
strate (Thermo Fisher) quantiﬁcation was performed on a LAS4000
imaging system (GE healthcare, Munich, Germany) using the
ImageQuant TL ver. 7.0 software (GE healthcare). For Reln immu-
nohistochemistry, we used the antibody clone E-5 (#sc-25346,
Santa Cruz Biotechnology, Dallas, Texas) following a standard
protocol (1:50 dilution, overnight incubation, 5 minutes heat-
induced antigen retrieval).
Mass spectrometry
Total cellular protein lysates were prepared and subjected to label-
free quantiﬁcation by SWATH-MS as published previously (42).
Brieﬂy, 100 mg of protein was subjected to tryptic digestion using
the FASP-protocol (50). Six aliquots (1 mg each) of the pooled pro-
tein digests were used for generation of the SWATH-library using
an 88 minutes-LC-gradient and a TOP40 IDA-method; database
searches were conducted with ProteinPilot 4.5 against the Uniprot
database (human). SWATH-MS-runs were accomplished with 1 mg
of the individual protein digests using the same LC-gradient and
SWATH-windows of 15 Da width (total m/z range 400–1000). In
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total, 1950 proteins were quantiﬁed using PeakView 2.1. Differen-
tial abundance of proteins was calculated based on non-normalized
protein counts with DESeq2 (30).
Proteome profiler assay
The phosphorylation of 43 different kinases and the amount of two
related proteins was detected with the proteome proﬁler assay (R&D
Systems, Minneapolis, MN). Cells were grown and stimulated with
GFP or mRELN as described above. The assay was performed
according to the manufacturer’s instructions. The chemiluminescent
signal was detected with a LAS4000 imaging system (GE
healthcare).
DuoSet IC ELISA
Commercially available ELISA assays (R&D Systems) for
STAT3(Y705) and ERK1(T202/Y204)/ERK2(T185/Y187) were
performed according to the manufacturer’s instructions. Brieﬂy,
96-well ELISA plates (R&D Systems) were coated with capture
antibody (diluted 1:180) in PBS. On the next day, the plates were
blocked with BSA in PBS, washed with washing buffer (0.05%
Tween-20 in PBS) and cell lysates were incubated for 2 h at RT on
the plates. Afterwards, the plates were washed again and detection
antibody was added (1:36 diluted). Then, streptavidin-HRP was
added for 20 minutes at RT. After washing, a commercially avail-
able substrate solution (R&D Systems) was added and the reaction
was stopped after 20 minutes with 2N H2SO4.
Data analysis
All analyzes were performed with GraphPad Prism 4.0 or higher
and R ver. 3.2.1. If not otherwise indicated, two-tailed t-tests were
used for statistical analysis. We only proceeded with post-tests if
the ANOVA or Kruskal-Wallis test indicated signiﬁcant differences
between groups (P< 0.05).
RESULTS
RELN pathway gene expression is correlated
with glioblastoma subtypes and shorter overall
survival
Analysis of agilent gene expression microarrays from the TCGA
database (7) revealed that RELN is signiﬁcantly upregulated in the
G-CIMP and neural as compared to the classical and mesenchymal
glioblastoma gene expression subtype (49). In line with this ﬁnd-
ing, RELN was signiﬁcantly related to IDH1 mutational status in
the TCGA dataset (Bonferroni corrected two-sided Mann-Whitney
test, P5 0.036) but not to mutations in EGFR, TP53, PTEN,
PIK3CA, PIK3R1, RB1 or NF1 (Supporting Information Fig. 1). Of
note, RELN mutations themselves were also detectable in a signiﬁ-
cant number of glioblastoma (7.89%), underscoring that RELN is
altered in this tumor type. For DAB1, upregulation was only
present in the neural subtype (Kruskall-Wallis test followed by
Dunn’s multiple comparison test, signiﬁcant changes are indicated;
Figure 1A,B). The upregulation of RELN and DAB1 in the neural
subtype was conﬁrmed by analysis of another large glioblastoma
cohort from Rembrandt (Figure 1E,F) (31).
When the gene expression data were combined with clinical data
and patients divided by the median into a low and a high expres-
sion subgroup, both high DAB1 and high RELN expression were
signiﬁcantly correlated with increased overall survival in glioblas-
toma patients in the TCGA dataset (Log-rank (Mantel-Cox) test,
P5 0.0026 (RELN) and P5 0.0069 (DAB1); Figure 1C,D).
Importantly, RELN remained signiﬁcantly (P< 0.05) associated
with survival in a Cox proportional-hazards regression model that
contained G-CIMP status, DAB1 expression as well as age (below
or above 50) as variables. Survival correlations could be conﬁrmed
in the Rembrandt dataset for RELN. High RELN expression was
signiﬁcantly correlated with longer overall survival (Log-rank
(Mantel-Cox) test, P5 0.0002; Figure 1G). For DAB1, there was
only a trend toward longer overall survival in the high expression
subgroup (Figure 1H).
RELN expression in glioblastomas is silenced by
promoter methylation
The genomic region around the RELN transcription startsite (6
2kb) contains a large 2kb CpG island as predicted by the CpG
island ﬁnder software (URL: http://dbcat.cgm.ntu.edu.tw). We
designed primers that amplify the part of the CpG island spanning
the transcription start site (TSS) (Supporting Information Fig. 2).
We analyzed two publicly available datasets that used the Illumina
450k bead array for methylation analysis and additionally con-
tained non-neoplastic brain tissue. We found that the CpGs that are
annotated to the RELN gene and that lie within the CpG island
(according to the Illumina annotation) are signiﬁcantly hypermethy-
lated in glioblastoma samples as compared to non-neoplastic brain.
In contrast, several CpGs in the gene body (including the ﬁrst exon
and 3-prime UTR according to Illumina annotation) of RELN were
hypomethylated (Figure 2A). Own bisulﬁte sequencing of the
region around the transcription start site revealed that RELN is
heavily hypermethylated in glioblastoma and that the methylation
status is positively correlated with malignancy grade (Supporting
Information Table 2). Hypermethylation of the RELN promoter
was signiﬁcantly more often found in glioblastomas as compared to
WHO grade II and WHO grade III astrocytomas (P< 0.001 and
P< 0.05, respectively, Fisher’s exact test; Figure 2B). The RELN
promoter was also nearly completely methylated in glioblastoma
cell lines in vitro and treatment with the demethylating agent 50-
Azacytidine (in combination with trichostatin A) led to a reduction
in promoter methylation (Supporting Information Table 3). Conse-
quently, the same treatment regimen led to a strong reexpression of
RELN in glioblastoma cell lines (Figure 2C). As such, there is
compelling evidence that RELN in glioblastoma tissues and cell
lines is silenced epigenetically by promoter hypermethylation.
RELN and DAB1 expression is correlated with
malignancy grade in gliomas and tissue
expression levels are retained in vitro
Real-time PCR analysis of an own panel of astrocytic tumors of
different WHO grades showed that both RELN and DAB1 are
strongly downregulated on the mRNA level and that the RELN
receptors, VLDLR and APOER2, are upregulated as compared to
non-neoplastic brain tissue. In addition, both RELN and DAB1
expression were inversely correlated with tumor grade and
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signiﬁcantly lower in glioblastomas as compared to WHO grade II
astrocytomas (Kruskal-Wallis test followed by Dunn’s multiple
comparison test, signiﬁcant changes are indicated; Figure 3A).
Loss of Reln expression in tumor cells was also conﬁrmed on the
protein level by immunohistochemistry although signiﬁcant intra-
as well as intertumoral heterogeneity could be observed (Support-
ing Information Fig. 3).
To establish a suitable model system for in vitro experiments,
we screened seven classical glioblastoma cell lines as well as four
stem-like cell lines for RELN and DAB1 expression via real-time
PCR (Figure 3C,D). Non-neoplastic brain tissues were used as con-
trols. Consistent with the data from the tissue samples (Figure 3A),
expression of both genes was absent or low in all glioblastoma cell
lines (classical and stem-like cells). We thus decided to make use
the classical cell lines for our further experiments. As classiﬁed by
ssGSEA, all classical cell lines tested corresponded to either the
classical or mesenchymal expression subtype (Figure 3B). Also
congruent with the tissue data, the expression of APOER2 was
high in the glioblastoma cell lines as compared to non-neoplastic
brain tissue (Figure 3E). The expression of VLDLR was highly
variable in glioblastoma cell lines (Figure 3F). We also reanalyzed
previously obtained next generation sequencing data of our cell
lines (18) to check if any other ligands for the receptors VLDLR
and APOER2 were expressed. Indeed, THBS1 and Clusterin were
highly expressed (RPKM> 10, Figure 3G).
We then decided to construct an expression system in which
DAB1 overexpression was driven from a pCMV promoter fol-
lowed by an IRES sequence. DAB1 overexpressing cells were
selected by adding G418 to the cell culture medium. A DAB1
mutant was used as an additional control. This mutant (5F) has all
ﬁve tyrosine residues mutated to phenylalanine that are phosphoryl-
ated following RELN stimulation (20). Interestingly, we observed
varying abundance of DAB1-WT proteins of different length in
U251 and U87. While in U87 the predominant band was visible at
60 kDa for both DAB1-WT and 5F, in U251 the predominant band
of the DAB1-WT protein was visible at 45 kDa. We checked that
Figure 1. RELN and DAB1 mRNA expression is correlated with
transcriptional subtypes and survival. A, B, C, D. Statistical comparison
of expression subtypes was performed by the non-parametric Kruskal-
Wallis test followed by Dunn’s multiple comparison test. Red lines indi-
cate means. C, D, G, H. Survival curves were compared with a log-
rank (Mantel-Cox) test. For survival analyzes, samples were divided by
the median expression into the low (red line) and high expression (black
line) subgroup. Significant changes are indicated (*5P< 0.05,
**5P< 0.01, ***5P< 0.001, ****5P< 0.0001). A. RELN expres-
sion is low in the mesenchymal and classical subtype and highest in
the neural and G-CIMP subtype in the TCGA dataset (Agilent platform).
B. DAB1 expression is significantly lower in the mesenchymal and clas-
sical subtype than in the neural subtype in the TCGA dataset. C. High
RELN expression is correlated with longer overall survival in the TCGA
dataset. D. High DAB1 expression is correlated with longer overall sur-
vival in the TCGA dataset. E. RELN expression is significantly lower in
the mesenchymal and classical subtype than in the neural subtype in
the Rembrandt dataset (Affymetrix platform). F. DAB1 expression is
low in the mesenchymal and classical subtype and highest in the neural
subtype in the Rembrandt dataset (probe set 228329_at). G. High
RELN expression is correlated with longer overall survival in the Rem-
brandt dataset. H. High DAB1 expression (probe set 228329_at) is cor-
related with longer overall survival in the Rembrandt dataset. Although
not significant, there is a strong trend toward longer overall survival in
the DAB1 high expression subgroup.
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the different cell lines had integrated full length DAB1-WT and
DAB1-5F at equal levels by semi-quantitative PCR as integration
artifacts could have potentially caused the length differences. For
this assay, we designed the primers in a way that one pair covers
the ﬁve-prime and one pair covers the three-prime border of the
insert. We quantiﬁed if the ﬁve-prime to three-prime ratio is altered
in one of the cell lines what was not the case. The integration of
both full-length constructs was equally efﬁcient in U251 and U87.
In addition, we ampliﬁed the full-length DAB1-WT and DAB1-5F
inserts from genomic DNA and veriﬁed that they did not contain
any mutations (Supporting Information Fig. 4). Thus, it appears
most likely that phosphorylation-dependent processing of DAB1—
as already described in neuronal cells (6)—might account for the
observed differences in western blotting.
Proteomics identifies E2F targets as well as
ERK1/2 and STAT3 phosphorylation as
downstream mediators of RELN signaling
To identify possible effects of RELN and DAB1 deregulation, we
subjected U87 cells expressing DAB1-WT or DAB1-5F to RELN
stimulation for 1 h and quantiﬁed both protein abundance and
phosphorylation status of proteins. The abundance of few individ-
ual proteins changed signiﬁcantly (P-adj.<0.1) comparing DAB1-
WT expressing with non-WT (empty vector and 5F) expressing
cells (Supporting Information Table 4). No additional changes
were observed on RELN stimulation. Interestingly, on a pathway
level, E2F target gene sets were signiﬁcantly downregulated in the
U87-DAB1-WT group as compared to empty vector or 5F cells
(GSEA; Figure 4A,B).
Figure 2. RELN is silenced by promoter hypermethylation in
glioblastoma tissues and cell lines. A. Both the array-based dataset
from GSE36278 (46) and GSE60274 (22) show significant hypermeth-
ylation in the CpG island spanning the transcription start site (TSS).
Significantly hypermethylated CpGs in glioblastoma (GBM) in compari-
son to non-neoplastic brain tissue (NB) (adj. P< 0.05) are indicated in
red, significantly hypomethylated CpGs in green (adj. P< 0.05) and
CpGs with no change in white. Hypermethylation is more pronounced
in the receptor tyrosine kinase (RTK) II (corresponding to the classical
subtype from the TCGA) and mesenchymal subtype that also show
reduced RELN mRNA levels. B. Bisulfite sequencing of the RELN pro-
moter reveals frequent hypermethylation in glioblastoma (also
compare Supporting Information Table 2). Hypermethylation is posi-
tively correlated with malignancy grade. Significant changes between
WHO grades (A II5 diffuse astrocytoma, AA III5 anaplastic astrocy-
toma, GBM5glioblastoma) are indicated (*5P< 0.05, **5P< 0.01,
***5P< 0.001, ****5P< 0.0001; Fisher’s exact test). C. Treatment
with 50-Azacytidine and trichostatin A leads to reexpression of RELN
as measured by real-time PCR. The RELN mRNA level is increased in
the glioblastoma cell lines A172, T98G, U138 and TP365 up to 75-fold.
Cells were treated with DMSO as control (CTRL), 500 nM 5-Aza-20-
deoxycytidine for 48 h1 trichostatin A for 24 h (A1 T1) or 1 mM 5-
Aza-20-deoxycytidine for 72 h11 mM trichostatin A for 24 h (A1 T2).
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In addition, the proteome proﬁler array that measures the
phosphorylation level of a number of kinases, indicated that
phosphorylation of STAT3, MAPK and p27 in U87 cells were
all lower in DAB1 expressing cells and that this effect was
potentiated by RELN stimulation and statistical analysis indicated
signiﬁcant differences between groups for all four phosphopro-
teins (one-way ANOVA, Figure 4C-F). The expression of
DAB1-WT and -5F protein and the effectiveness of RELN stim-
ulation was controlled by western blotting (Figure 4G). Results
of the proteome proﬁler were then conﬁrmed by ELISA in all
Figure 3. Classical glioblastoma cell lines recapitulate the changes
found in glioblastoma tumor tissue. A. Real-time PCR of RELN,
DAB1, VLDLR and APOER2 in astrocytic tumors of different grades (A
II: n511; AA III: n56; GBM IV: n59) relative to four non-neoplastic
brain samples (set to 1). Shown are means1SD. RELN expression is
inversely correlated with tumor grade and significantly higher in WHO
grade II astrocytomas than in glioblastomas. All significant changes
between WHO grades are indicated (*5P< 0.05, **5P< 0.01,
***5P< 0.001, ****5P< 0.0001; Kruskal-Wallis test followed by
Dunn’s multiple comparison test). B. GSEA prediction of the
glioblastoma subtype of the cell lines based on next generation
sequencing data. All cell lines tested belong to the mesenchymal or
classical subtype. C–F. Real-time PCR of RELN (C), DAB1 (D), VLDLR
(E) and APOER2 (F) expression in different glioblastoma cell lines as
compared to non-neoplastic brain tissue (NB). ARF1 was used as an
internal control. G. Expression of different APOER2 and VLDLR
ligands based on next generation sequencing data. While clusterin
(CLU) and Thrombospondin1 (THBS1) are expressed in different glio-
blastoma cell lines, RELN and APOE are not expressed in vitro.
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stable cell lines (Figure 5). In U87, there was a highly signiﬁcant
reduction of both ERK1(T202/Y204)/ERK2(T185/Y187) and
STAT3(Y705) phosphorylation in DAB1-WT cells (both RELN
and GFP-stimulated) as compared to empty vector cells treated
with GFP (P< 0.001 or <0.01, one-way ANOVA followed by
Dunnett’s post hoc test of all conditions vs. empty vec-
tor1GFP). Also, in U87 and U251 cells, ERK1/2 activity was
signiﬁcantly reduced in empty vector and DAB1-5F transfected
cells stimulated with RELN as compared to empty vector cells
treated with GFP (P< 0.01 and P< 0.001, one-way ANOVA
followed by Dunnett’s post hoc test of all conditions vs. empty
vector1GFP). For STAT3 in U251, there was no difference in
protein phosphorylation after RELN stimulation, but even a slight
increase in WT-GFP cells as compared to EV-GFP cells. Thus,
overlappingly between both cell lines we found a reduction in
ERK1/2 phosphorylation following RELN stimulation. Impor-
tantly, this effect could be rescued by the function blocking
CR-50 antibody, indicating its RELN-speciﬁcity (Supporting
Information Fig. 5).
Activation of RELN signaling leads to a
reduction in proliferation but does not affect
chemosensitivity
Activation of the DAB1/RELN signaling axis led to signiﬁcantly
decreased cell numbers on day four and ﬁve in both U251 and U87
cells expressing DAB1-WT with or without RELN stimulation
(repeated measures, two-way ANOVA with Bonferroni corrected
post-test, P< 0.001, Figure 6A,B). The DAB1-5F mutant did not
achieve comparable effects to DAB1-WT overexpression, strongly
arguing for the fact that RELN stimulated tyrosine phosphorylation
is important to convey DAB1 inhibitory effects on proliferation.
Only in U87 cells, there was a signiﬁcant decrease in cell numbers
on day ﬁve when EV1GFP cells were compared to 5F1RELN
cells (repeated measures, two-way ANOVA with Bonferroni cor-
rected post-test, P< 0.05). Together with the observation that
RELN stimulation itself in DAB1-WT cells was not able to reduce
the proliferation further, it thus may not be excluded that other
ligands contribute to inﬂuence this pathway in vitro, too. We ana-
lyzed if this change in proliferation is because of senescence,
Figure 4. Proteomic analysis reveals enrichment for E2F pathway
components in control cells compared to DAB overexpressing cells.
A. GSEA of proteomic data based on fold changes as calculated by
DESeq2. N55 in each group. E2F signaling is the main deregulated
pathway after DAB1-WT expression, represented by several signifi-
cant gene sets at P< 0.05 and FDR< 0.2. B. Enrichment plot for the
E2F gene set for DAB1-WT vs. empty vector cells. C–F. Quantifica-
tion of the proteome profiler analysis. Phosphorylation of ERK1/2 on
T202/Y204 and T185/Y183 (C), of STAT3 on Y705 (D) and S727 (F) as
well as phosphorylation of p27 on T198 are markedly decreased after
DAB1 expression and RELN stimulation. One-way ANOVA indicates
significant differences between groups for all four phosphorylation
sites. Shown are means1SD, n5 2. G, H. Representative western
blot and quantification of n53 western blots probed with P-DAB1
Y220, P-DAB1 S491 and total DAB1 antibody, shown are
means1SEM.
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apoptosis or alterations in the cell cycle in U251 cells. There was
no sign of senescence in our stable cell cultures as analyzed by ß-
galactosidase staining (data not shown). In addition, the cleaved
form of caspase-3 was undetectable. In contrast, the amount of cells
in G2/M was increased signiﬁcantly in DAB1-WT as compared to
empty vector transfected cells (two-way ANOVA followed by
Bonferroni corrected posttests, P< 0.001, Supporting Information
Fig. 6). There was no signiﬁcant difference between DAB1-5F and
empty vector transfected cells.
The antiproliferative effects of RELN could also be stated in a
different fashion. We speculated that adding recombinant RELN to
the supernatant of a cell line that expresses at least some DAB1
should select for cells with lower DAB1 expression. We used the
U118 cell line for this experiment as it showed the highest endoge-
nous DAB1 expression (Figure 3D). Indeed, after long-term
stimulation with RELN-conditioned medium for three weeks,
U118 cells showed a signiﬁcantly lower DAB1 expression as com-
pared to U118 cells cultured in control (GFP-) conditioned medium
(Figure 6D).
As DNA damage signaling is known to be inﬂuenced by E2F
targets (12) and others have reported an inﬂuence of RELN on che-
moresistance (28), we also assessed chemoresistance following
RELN/DAB1 manipulation. However, we could not observe any
change in chemoresistance of U87 cells to lomustine (Figure 6C).
DAB1 expression and effectiveness of RELN stimulation were
controlled by routine western blotting.
RELN has both DAB1-dependent and DAB1
tyrosine phosphorylation independent effects
on cell migration
We studied tumor cell migration following DAB1-WT and -5F
overexpression in our two cell lines (U251 and U87) under two dif-
ferent matrix conditions (ﬁbronection and laminin) (Figure 7A–D).
Across both cell lines and matrix conditions RELN-stimulated
DAB1-WT cells had markedly reduced migration in comparison to
empty vector (GFP) and 5F (GFP) cells. These comparisons were
concordantly signiﬁcant in U251 cells on ﬁbronectin and laminin
and on U87 cells on laminin. U87 RELN-stimulated DAB1-WT
cells on ﬁbronectin showed signiﬁcantly lower migration in com-
parison to 5F (GFP) cells and still a trend toward reduced migration
in comparison to empty vector (GFP) cells (one-way ANOVA, fol-
lowed by Tukey’s multiple comparison test, P< 0.05 for all signiﬁ-
cant comparisons). Thus, these ﬁndings argue for strong DAB1
tyrosine phosphorylation dependent suppressive RELN effects on
glioma cell migration.
Figure 5. ELISA assays corroborate influences of RELN signaling on
ERK1/2 and STAT3 phosphorylation. Phospho-STAT3(Y705) and Phospho-
ERK1(T202/Y204)/ERK2 (T185/Y187) DuoSet IC ELISAs in U87–A, B
and U251–C, D. Groups were compared with one-way ANOVA followed
by Dunnett’s post hoc test. Significant changes are indicated
(*5P< 0.05, **5P< 0.01, ***5P< 0.001, ****5P< 0.0001). Shown
are means1SD, n5 3. DAB1-WT expressing U87 cells show reduced
Phospho-STAT3 and Phospho-ERK1/2 levels under control (GFP stimula-
tion) conditions. In DAB1-WT cells, RELN treatment reduces the phoshor-
ylation further. In U251 cells, there is a RELN-induced reduction of ERK1/2
phosphorylation that is DAB1 (tyrosine phosphorylation)-independent. In
contrast to U87 cells, in U251 RELN does not alter the phosphorylation
levels of STAT3(Y705), suggesting cell line-specific effects of RELN on
STAT3 activity.
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Interestingly, we also observed DAB1 (tyrosine phosphoryla-
tion)-independent RELN effects: There was a signiﬁcant
decrease in migration comparing U87 5F (RELN) to U87 5F
(GFP) cells on ﬁbronection (one-way ANOVA, followed by
Tukey’s multiple comparison test, P< 0.05). A similar (although
non-signiﬁcant) trend was observed- independently of the matrix
condition used- in both cell lines not only for the comparison
5F (RELN vs. GFP-stimulated) but also for the comparison
empty vector (RELN vs. GFP-stimulated). Overall, particularly
when considering the U251 experiments on ﬁbronection, it
appeared that the DAB1 (tyrosine phosphorylation)-independent
RELN effects were lower in U251 than in U87. Importantly, the
reduction of velocity could be rescued by addition of CR-50,
again indicating that the observed effect is RELN-speciﬁc.
DAB1 expression and effectiveness of RELN stimulation were
controlled by routine western blotting (Figure 7E,F; representa-
tive example).
In addition, we checked if DAB1 or RELN regulate the
expression of the adhesion molecules ITGA3, ITGA5, ITGB1,
FAK or PXN (paxillin). However, there was no consistent sig-
niﬁcant difference between the empty vector cells and (RELN-
treated) DAB1-transfected cell lines (one-way ANOVA
followed by Dunnett’s post hoc test, Supporting Information
Fig. 7).
DISCUSSION
The reelin signaling pathway plays a pivotal role in brain develop-
ment by regulating neuronal migration and cortical layering (19).
In contrast to these physiological functions, the role of reelin sig-
naling in glioblastoma had not yet been investigated. We here can
show that the RELN gene is silenced via promoter hypermethyl-
ation in glioblastoma tumors and cell lines, a mechanism that had
also been observed in breast, pancreatic and gastric cancers (13,
44). Importantly, we found that DAB1 expression was also strongly
reduced in high-grade brain tumors. This suggests that downregula-
tion of RELN in brain tumor cells alone is not sufﬁcient to inacti-
vate the pathway. It is well possible that either RELN from the
surrounding healthy brain parenchyma and/or other ligands can
bind to the RELN receptors APOER2 and VLDLR, activate DAB1
and thereby exert effects on the tumor cells. Indeed, it had been
shown that thrombospondin 1, clusterin or ApoE can all bind to
APOER2 and VLDLR and interfere with RELN in vitro and in
vivo (5, 27). Our in vitro ﬁndings suggest that particularly thrombo-
spondin 1 is expressed by glioma cells.
We next assessed the correlation of RELN and DAB1 expres-
sion with WHO grade, glioblastoma expression subtype and
overall survival. RELN and DAB1 expression were signiﬁcantly
inversely associated with WHO malignancy grade. Moreover,
Figure 6. Activation of RELN signaling inhibits cellular proliferation.
A, B. Proliferation assay in U87 (A) and U251 (B) cells stably
expressing DAB1-WT or DAB1-5F stimulated with supernatants from
HEK293T cells expressing mRELN or GFP as a control. The influence
of DAB1-WT expression on the cell number with or without RELN
stimulation was highly significant (repeated measures, two-way
ANOVA followed by Bonferroni corrected post-tests, P< 0.001 on day
4 and 5). Shown are means6SD, n53. C. DAB1 expression and
RELN treatment do not alter resistance toward the chemotherapeutic
agent lomustine. Neither RELN treatment nor DAB1 expression did
influence the IC50 of U87 cells toward lomustine, n52. D. DAB1
expression is strongly decreased in U118 cells after long-term treat-
ment with mRELN. The expression was measured via real-time PCR.
Shown are means1SD, n53.
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high RELN transcriptional levels were associated with signiﬁ-
cantly longer overall survival in large glioblastoma patient
cohorts. This suggests the RELN/DAB1 signaling axis as a novel
candidate diagnostic and prognostic marker and potential
therapeutic target. Interestingly, when comparing the expression
of RELN and DAB1 between the different transcriptional
glioblastoma subtypes (49) highest expression levels were
observed in the neural subtype. This is in accord with the physi-
ological function of RELN signaling as the neural expression
subtype is suggestive of cells with a differentiated phenotype and
typiﬁed by the expression of neuron markers, such as NEFL,
GABRA1, SYT1 and SLC12A5 (49).
Figure 7. Activation of RELN signaling alters migration in a DAB1
(tyrosine phosphorylation)-dependent and -independent fashion.
Groups were compared with one-way ANOVA followed by Tukey’s
multiple comparison test. Significant changes are indicated
(*5P< 0.05, **5P< 0.01, ***5P< 0.001, ****5P< 0.0001).
Shown are means1SEM, n52–3. A, B. Velocity of U251 cells on
fibronectin (A) and laminin (B). DAB1-WT expressing cells that are
stimulated with RELN migrate markedly slower than cells expressing
the inactive 5F mutant or EV transfected cells. There is a trend toward
slower overall migration after RELN stimulation on laminin also in EV
and 5F cells, indicative of DAB1 (tyrosine phosphorylation)-independ-
ent effects on cell migration. C, D. Velocity of U87 cells on fibronec-
tin (C) and laminin (D). On fibronectin, DAB1-WT expressing cells that
are stimulated with RELN migrate markedly slower than GFP-
stimulated cells expressing the inactive 5F mutant or EV-transfected
cells. On laminin, RELN stimulated DAB1-WT cells show a signifi-
cantly slower migration in comparison to 5F (GFP) cells and still a
trend toward reduced migration in comparison to empty vector (GFP)
cells. In addition, RELN stimulated 5F cells migrate significantly
slower on fibronectin than GFP-stimulated cells and there is a trend
toward slower overall migration after RELN stimulation on laminin and
fibronectin for 5F and EV cells, indicative of DAB1 (tyrosine phospho-
rylation)-independent effects on cell migration. E, F. Western blot of
DAB1 protein and P-DAB1 Y220 in U87 (E) and U251. (F). While in
U87 the predominant band is visible at 60 kDa for both DAB1-WT and
5F, in U251 the predominant band of the DAB1-WT protein is visible
at 45 kDa, indicating higher basal activity of RELN signaling in U251
cells.
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In light of Reelin’s physiological function, it is somewhat aston-
ishing that the potential association between RELN signaling and
brain cancer pathology had not yet been systematically assessed.
This might be caused by hindrances in modelling this pathway, that
is, the cumbersome size of the RELN protein, the low expression
of RELN (and DAB1) in most glioma cell lines and the lack of vec-
tor constructs to overexpress human reelin in glioma cells. On
account of these limitations and the simultaneous downregulation
of DAB1 in glioblastomas described above, for our functional ana-
lyzes we decided to take an approach in which DAB1 was stably
overexpressed in two different qualities: (i) as DAB1-WT with the
full functionality of the DAB1 protein and (ii) DAB1-5F mutant
with point mutations at all ﬁve Dab1 tyrosine phosphorylation sites
(Tyr185, tyr198, Tyr200, Tyr220 and Tyr232). This DAB1-5F
mutant has been previously well characterized and is devoid of all
RELN-mediated tyrosine phosphorylation-dependent downstream
signaling effects (20). Empty vector cells served as an additional
control. As such, we were able to assess the common ﬁnal signal-
ing pathway with and without reelin stimulation but also com-
pletely free of endogenous RELN effects (5F-mutant and CR-50
blocking antibody experiments).
In this experimental setting, we observed major effects on
RELN/DAB1 signaling on glioma cell proliferation and migration.
DAB1-WT overexpression led to a signiﬁcant decrease in prolifera-
tion and this effect was RELN-dependent as it could not be
observed in cells expressing the DAB1-5F mutant. Consistently
with this ﬁnding, E2F signaling was the major pathway altered in
our proteomic screen comparing DAB1-WT and DAB1-5F
expressing U87 cell lines. E2F transcription factors are important
regulators of cell cycle progression (15). They are also known to be
frequently altered in glioblastoma, as for example mediated by
other well-known molecular alterations like RB1 mutations, CDK4
ampliﬁcation or CDKN2A deletion (7, 49). Our ﬁndings therefore
describe a new mechanism of E2F control, previously probably not
observed because of the fact that RELN signaling via DAB1 was
examined mostly in post-mitotic neurons.
In addition, we described cell line-speciﬁc effects of RELN sig-
naling on ERK1/2 as well as on STAT3 activity. In U87, DAB1
expression and RELN stimulation were able to reduce ERK1/2 and
STAT3 activity. Moreover, short term RELN stimulation after
medium exchange was able to reduce ERK1/2 activity in both
U251 and U87 cells. As U251 DAB1-WT cells in the proliferation
assays grew nonetheless much slower after longer (3–5 days)
growth factor removal and ERK and STAT3 phosphorylation were
not reduced in these cells, we speculate that alternative ligands,
secreted factors or adaptive responses to growth factor removal
may trigger this behavior. In contrast to neuronal migration, where
alterations in p-coﬁlin levels after RELN stimulation have been
reported (10, 11), we could not ﬁnd any change in p-coﬁlin to the
total coﬁlin ratio or a qualitative change in the actin cytoskeleton
(data not shown).
Nevertheless, functionally we observed a relevant impact of
RELN/DAB1 signaling on glioma cell migration. This suggests that
RELN acts only in small areas of the cell (precluding the analysis of
a quantitative phenotype) or by a coﬁlin-independent mechanism,
for example by regulation of N-WASP (48). In our rather elaborated
setting of migration assays involving different DAB1-
overexpressing clones under different matrix conditions with and
without RELN stimulation, the most consistent ﬁnding was a
signiﬁcant negative impact of RELN-dependent DAB1 activation
on tumor cell migration. However, as outlined above, we also
observed DAB1 (tyrosine phosphorylation)-independent RELN
effects and these appeared to be gradually different between the cell
lines (less pronounced in U251 on ﬁbronectin than in U87).
Although both lines are PTEN-deﬁcient (26), they differ in their
expression subtype and p53 status what might account for the cell-
line speciﬁc differences. More importantly, U251 (in comparison to
U87) also contains a much higher content of thrombospondin (Fig-
ure 3G). Thus, alternative ligand binding might mitigate the DAB1
(tyrosine phosphorylation)-independent RELN effects in U251 cells.
As thrombospondin has also been described to speciﬁcally bind to
ﬁbronectin, this interaction might additionally account for the
slightly different migrational behavior of U251 cells on this speciﬁc
matrix (24). We highlight this example here to underline the advant-
age of our approach studying RELN signaling by mainly comparing
DAB1-WT and DAB1-5F cells over an approach solely relying on
stimulation with recombinant RELN. The latter approach may be
more prone to uncontrolled interference with endogenous alternative
ligand binding and might thereby obscure distinct results.
In summary, we show that the canonical RELN signaling cas-
cade via DAB1 exerts tumor suppressive functions and is a yet
unknown barrier to cellular transformation in gliomagenesis. These
effects are mediated via suppression of E2F activity by the DAB1-
WT protein and harbor strong prognostic implications. Our ﬁndings
might thereby unearth novel, yet unrecognized treatment options in
glioblastomas.
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Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Figure 1. Analysis of RELN expression and recurrent muta-
tions in GBM. While there is no signiﬁcant difference
between EGFR-, NF1-, TP53-, PIK3CA-, PIK3R1-, PTEN-
and RB1-mutant vs. wildtype (WT) tumors, there is a small
but signiﬁcant difference between IDH1-mutant and WT-
tumors (Bonferroni corrected two-sided Mann-Whitney test,
P< 0.05).
Figure 2. Depiction of the region of the RELN promoter ana-
lyzed by bisulﬁte sequencing. CpG dinucleotides (red) are num-
bered according to their position relative to the transcription
start site (TSS). Primers are marked with grey arrows.
Figure 3. Reln protein expression as assessed by immunohisto-
chemistry. Reln is expressed in non-neoplastic brain tissue with
strongest staining in neurons of the grey matter (A, x400) but
positivity also in the white matter (B, x200, showing the transi-
tion zone between grey and white matter). Reln is also
expressed in tumor cells but in a very heterogeneous fashion C
(3400) and D (3200) show regions of differential Reln expres-
sion within a single case of IDH-wildtype glioblastoma. (E,
x200 and F, x200) Two further cases of glioblastoma with one
(E) completely devoid of Reln protein expression and the other
(F) exhibiting only interspersed Reln positive cells with some of
the cells most likely corresponding to intermixed reactive astro-
cytes. (G, x200) A case of IDH-mutant anaplastic astrocytic
with very low to absent Reln protein expression. (H, x400) A
case of IDH-mutant WHO grade II diffuse astrocytoma with
uniform Reln expression close to the levels observed in non-
neoplastic brain tissue.
Figure 4. A) Outline of the strategy for semiquantitative PCR.
The ﬁve-prime PCR product is located in the CMV promoter,
followed by the DAB1 full length ORF. The three-prime prod-
uct is ampliﬁed from a site between the ORF and the IRES site.
B) Semiquantitative PCR of the regions ﬂanking the DAB1-WT
and DAB1-5F expression construct on the three-prime and ﬁve-
prime end. All cell lines tested show integration of the full-
length construct at an equal level. M, Marker (100 bp DNA lad-
der plus); 1, positive control (20 ng DAB1-WT DNA con-
struct); 2, negative control (ultrapure water). A-F, Five-prime
region PCR of stably transfected U87MG and U251 cell lines:
A, U87-MG1EV; B, U87-MG1DAB1-WT; C, U87-
MG1DAB1-5F; D, U2511EV; E, U2511DAB1-WT; F,
U2511DAB1-5F. G-L, PCR of the three-prime region from
stably transfected U87-MG and U251 cell lines: G, U87-
MG1EV; H, U87-MG1DAB1-WT; I, U87-MG1DAB1-5F;
J, U2511 EV; K, U2511DAB1-WT; L, U2511DAB1-5F. C)
Quantiﬁcation of the PCR as shown in -B). The ﬂuorescence
intensities were calculated as ratio of the ﬁve-prime PCR inten-
sity divided by the three-prime PCR intensity. 1, positive con-
trol A, U87-MG1EV; B, U87-MG1DAB1-WT; C, U87-
MG1DAB1-5F; D, U2511EV; E, U2511DAB1-WT; F,
U2511DAB1-5F. D) PCR of full length DAB1 inserts. M,
Marker (100 bp DNA ladder plus); A, U87-MG1DAB1-WT;
C, U87-MG1DAB1-5F; D, U2511DAB1-WT; E, U251
1DAB1-5F.
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Figure 5. Both reduction of ERK1/2 phosphorylation (A and B)
and migration (C and D) can be rescued by addition of the CR-
50 antibody that blocks the function of mRELN. Shown are
means1 SD. Groups were compared by one-way ANOVA fol-
lowed by Tukey’s post hoc test.
Figure 6. A) Cell cycle distribution of stably transfected U251
cells. While the fraction of cells in G1 is signiﬁcantly reduced,
the fraction of cells in G2/M is signiﬁcantly increased in
DAB1-WT expressing cells as compared to empty vector cells
(two-way ANOVA followed by Bonferroni corrected posttests,
P< 0.001). In contrast, there are no signiﬁcant differences
between empty vector and DAB1-5F expressing cells. B) Cas-
pase 3 western blot analysis in U251 cells. Only full-length cas-
pase 3 can be detected in all stable cell lines, while cleaved
caspase 3 is absent.
Figure 7. Real-time PCR analysis of the adhesion molecules
PXN, FAK, ITGA3, ITGA5 and ITGB1. Shown are
means1 SD, n52. There was no consistent signiﬁcant differ-
ence between the empty vector cells and (RELN-treated)
DAB1-transfected cell lines (one-way ANOVA followed by
Dunnett’s post hoc test, all conditions vs. empty vector1GFP).
Table 1. Primers used for bisulﬁte sequencing and real-time
PCR analyses.
Table 2. Overview of the methylation status (1/-), the methyla-
tion score and the methylation pattern of RELN as detected by
direct sodium bisulﬁte sequencing of the RELN promoter region
(CpGs sites in Supporting Information Fig. 1). mRNA expres-
sion levels are also provided. Allmost all glioblastomas show
hypermethylation of the RELN promoter (for % samples hyper-
methylated in the different WHO grades compare Fig. 2B). For
promoter methylation scoring, the CG sites were ﬁrst semiquan-
titatively assigned to the categories unmethylated (no cytosine
detectable, 50), weakly methylated (peak for cytosine detecta-
ble, but smaller that thymine, 51), moderately methylated (C
and T at equal amounts detectable, 52) and strongly methylated
(thymine peak smaller than cytosine, 53). Then, the scores for
each individual sample were summed across the whole investi-
gated CpG site to determine the overall methylation score.
Tumors with a score 22 were considered as hypermethylated
(1), tumors with a score <22 as not hypermethylated (-) com-
pared to the non-neoplastic controls.
Table 3. Methylation analysis of the RELN promoter after 5-
Aza-20deoxycytidine treatment in different cell lines. Treatment
with 5-Aza-20deoxycytidine in combination with trichostatin A
reduces the methylation in all cell lines, although signiﬁcant
methylation still remains.
Table 4. Differentially abundant proteins as identiﬁed by
DESeq2 at P-adjusted< 0.1. Proteins that are less abundant in
DAB1-WT cells are labeled in green, whereas proteins that are
more abundant in DAB1-WT cells are shown in red.
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